{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "4ab84889",
      "metadata": {
        "id": "4ab84889",
        "outputId": "4307c8e6-c2a6-4f95-8ff0-d2879439f43b"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: tqdm in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (4.64.0)\n",
            "Requirement already satisfied: colorama in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from tqdm) (0.4.4)\n"
          ]
        }
      ],
      "source": [
        "!pip install tqdm"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "cfdac330",
      "metadata": {
        "id": "cfdac330"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "\n",
        "df = pd.read_excel('medicines_output_european_public_assessment_reports_en.xlsx')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "303a30b0",
      "metadata": {
        "id": "303a30b0",
        "outputId": "942c3bc3-274e-43e9-c1d8-c497521079b0"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Content type:</th>\n",
              "      <th>European public assessment reports (EPARs)</th>\n",
              "      <th>Output generated at:</th>\n",
              "      <th>Tue, 05/12/2023 - 01:46</th>\n",
              "      <th>Unnamed: 4</th>\n",
              "      <th>Unnamed: 5</th>\n",
              "      <th>Unnamed: 6</th>\n",
              "      <th>Unnamed: 7</th>\n",
              "      <th>Unnamed: 8</th>\n",
              "      <th>Unnamed: 9</th>\n",
              "      <th>...</th>\n",
              "      <th>Unnamed: 20</th>\n",
              "      <th>Unnamed: 21</th>\n",
              "      <th>Unnamed: 22</th>\n",
              "      <th>Unnamed: 23</th>\n",
              "      <th>Unnamed: 24</th>\n",
              "      <th>Unnamed: 25</th>\n",
              "      <th>Unnamed: 26</th>\n",
              "      <th>Unnamed: 27</th>\n",
              "      <th>Unnamed: 28</th>\n",
              "      <th>Unnamed: 29</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Domenico Scarlattilaan 6 * 1083 HS Amsterdam *...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Tel.: +31 (0)88 781 6000</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Send a question via our website: www.ema.europ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "  Content type: European public assessment reports (EPARs)  \\\n",
              "0           NaN                                        NaN   \n",
              "1           NaN                                        NaN   \n",
              "2           NaN                                        NaN   \n",
              "3           NaN                                        NaN   \n",
              "4           NaN                                        NaN   \n",
              "\n",
              "  Output generated at: Tue, 05/12/2023 - 01:46 Unnamed: 4 Unnamed: 5  \\\n",
              "0                  NaN                     NaN        NaN        NaN   \n",
              "1                  NaN                     NaN        NaN        NaN   \n",
              "2                  NaN                     NaN        NaN        NaN   \n",
              "3                  NaN                     NaN        NaN        NaN   \n",
              "4                  NaN                     NaN        NaN        NaN   \n",
              "\n",
              "                                          Unnamed: 6 Unnamed: 7 Unnamed: 8  \\\n",
              "0  Domenico Scarlattilaan 6 * 1083 HS Amsterdam *...        NaN        NaN   \n",
              "1                           Tel.: +31 (0)88 781 6000        NaN        NaN   \n",
              "2  Send a question via our website: www.ema.europ...        NaN        NaN   \n",
              "3                                                NaN        NaN        NaN   \n",
              "4                                                NaN        NaN        NaN   \n",
              "\n",
              "  Unnamed: 9  ... Unnamed: 20 Unnamed: 21 Unnamed: 22 Unnamed: 23 Unnamed: 24  \\\n",
              "0        NaN  ...         NaN         NaN         NaN         NaN         NaN   \n",
              "1        NaN  ...         NaN         NaN         NaN         NaN         NaN   \n",
              "2        NaN  ...         NaN         NaN         NaN         NaN         NaN   \n",
              "3        NaN  ...         NaN         NaN         NaN         NaN         NaN   \n",
              "4        NaN  ...         NaN         NaN         NaN         NaN         NaN   \n",
              "\n",
              "  Unnamed: 25 Unnamed: 26 Unnamed: 27 Unnamed: 28 Unnamed: 29  \n",
              "0         NaN         NaN         NaN         NaN         NaN  \n",
              "1         NaN         NaN         NaN         NaN         NaN  \n",
              "2         NaN         NaN         NaN         NaN         NaN  \n",
              "3         NaN         NaN         NaN         NaN         NaN  \n",
              "4         NaN         NaN         NaN         NaN         NaN  \n",
              "\n",
              "[5 rows x 30 columns]"
            ]
          },
          "execution_count": 5,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "df.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "4080298a",
      "metadata": {
        "id": "4080298a",
        "outputId": "96f2385b-c6e6-49f2-bee3-dfe55c2eb5a0"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th>7</th>\n",
              "      <th>Category</th>\n",
              "      <th>Medicine name</th>\n",
              "      <th>Therapeutic area</th>\n",
              "      <th>International non-proprietary name (INN) / common name</th>\n",
              "      <th>Active substance</th>\n",
              "      <th>Product number</th>\n",
              "      <th>Patient safety</th>\n",
              "      <th>Authorisation status</th>\n",
              "      <th>ATC code</th>\n",
              "      <th>Additional monitoring</th>\n",
              "      <th>...</th>\n",
              "      <th>Vet pharmacotherapeutic group</th>\n",
              "      <th>Date of opinion</th>\n",
              "      <th>Decision date</th>\n",
              "      <th>Revision number</th>\n",
              "      <th>Condition / indication</th>\n",
              "      <th>Species</th>\n",
              "      <th>ATCvet code</th>\n",
              "      <th>First published</th>\n",
              "      <th>Revision date</th>\n",
              "      <th>URL</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Human</td>\n",
              "      <td>Ryeqo</td>\n",
              "      <td>Leiomyoma</td>\n",
              "      <td>relugolix, estradiol, norethisterone acetate</td>\n",
              "      <td>Relugolix, norethisterone acetate, estradiol h...</td>\n",
              "      <td>EMEA/H/C/005267</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>H01CC54</td>\n",
              "      <td>yes</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2021-07-16 00:00:00</td>\n",
              "      <td>2023-10-30 01:00:00</td>\n",
              "      <td>6</td>\n",
              "      <td>Ryeqo is indicated in adult women of reproduct...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2021-05-19 14:14:00</td>\n",
              "      <td>2023-12-04 18:41:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Human</td>\n",
              "      <td>Yesafili</td>\n",
              "      <td>Macular Edema;  Retinal Vein Occlusion;  Diabe...</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>EMEA/H/C/006022</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>S01LA05</td>\n",
              "      <td>yes</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-07-20 00:00:00</td>\n",
              "      <td>2023-11-29 01:00:00</td>\n",
              "      <td>1</td>\n",
              "      <td>Yesafili is indicated for adults for the treat...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-07-17 16:27:00</td>\n",
              "      <td>2023-12-04 18:15:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Human</td>\n",
              "      <td>Leflunomide medac</td>\n",
              "      <td>Arthritis, Rheumatoid</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>EMEA/H/C/001227</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L04AA13</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-10-31 01:00:00</td>\n",
              "      <td>19</td>\n",
              "      <td>Leflunomide is indicated for the treatment of ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2018-01-30 14:10:00</td>\n",
              "      <td>2023-12-04 17:56:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Human</td>\n",
              "      <td>Filgrastim Hexal</td>\n",
              "      <td>Neutropenia;  Hematopoietic Stem Cell Transpla...</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>EMEA/H/C/000918</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L03AA02</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-11-30 01:00:00</td>\n",
              "      <td>24</td>\n",
              "      <td>Reduction in the duration of neutropenia and t...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2018-05-24 17:15:00</td>\n",
              "      <td>2023-12-04 17:43:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Human</td>\n",
              "      <td>Opzelura</td>\n",
              "      <td>Vitiligo</td>\n",
              "      <td>ruxolitinib</td>\n",
              "      <td>ruxolitinib phosphate</td>\n",
              "      <td>EMEA/H/C/005843</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>D11AH</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-02-23 01:00:00</td>\n",
              "      <td>2023-10-19 00:00:00</td>\n",
              "      <td>2</td>\n",
              "      <td>Opzelura is indicated for the treatment of non...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-02-22 15:05:00</td>\n",
              "      <td>2023-12-04 17:35:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2036</th>\n",
              "      <td>Human</td>\n",
              "      <td>Liprolog</td>\n",
              "      <td>Diabetes Mellitus</td>\n",
              "      <td>insulin lispro</td>\n",
              "      <td>insulin lispro</td>\n",
              "      <td>EMEA/H/C/000143</td>\n",
              "      <td>no</td>\n",
              "      <td>Withdrawn</td>\n",
              "      <td>A10AB04</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2001-02-19 01:00:00</td>\n",
              "      <td>0</td>\n",
              "      <td>For the treatment of patients with diabetes me...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2001-02-19 01:00:00</td>\n",
              "      <td>2001-08-01 00:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2037</th>\n",
              "      <td>Human</td>\n",
              "      <td>EchoGen</td>\n",
              "      <td>Echocardiography</td>\n",
              "      <td>dodecafluoropentane</td>\n",
              "      <td>dodecafluoropentane</td>\n",
              "      <td>EMEA/H/C/000149</td>\n",
              "      <td>no</td>\n",
              "      <td>Withdrawn</td>\n",
              "      <td>V08DA</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2001-01-22 01:00:00</td>\n",
              "      <td>0</td>\n",
              "      <td>EchoGen is a transpulmonary echocardiographic ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2001-01-22 01:00:00</td>\n",
              "      <td>2001-05-22 00:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2038</th>\n",
              "      <td>Human</td>\n",
              "      <td>Ecokinase</td>\n",
              "      <td>Myocardial Infarction</td>\n",
              "      <td>reteplase</td>\n",
              "      <td>reteplase</td>\n",
              "      <td>EMEA/H/C/000106</td>\n",
              "      <td>no</td>\n",
              "      <td>Withdrawn</td>\n",
              "      <td>B01AD07</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1999-07-30 00:00:00</td>\n",
              "      <td>0</td>\n",
              "      <td>Thrombolytic therapy of acute myocardial infar...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1999-07-30 00:00:00</td>\n",
              "      <td>2000-12-12 01:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2039</th>\n",
              "      <td>Human</td>\n",
              "      <td>Primavax</td>\n",
              "      <td>Hepatitis B;  Tetanus;  Immunization;  Diphtheria</td>\n",
              "      <td>diphtheria, tetanus and hepatitis B (rDNA) vac...</td>\n",
              "      <td>Diphtheria toxoid, hepatitis B, recombinant su...</td>\n",
              "      <td>EMEA/H/C/000156</td>\n",
              "      <td>no</td>\n",
              "      <td>Withdrawn</td>\n",
              "      <td>J07CA</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2000-07-27 00:00:00</td>\n",
              "      <td>0</td>\n",
              "      <td>This vaccine is indicated for active immunizat...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2000-07-27 00:00:00</td>\n",
              "      <td>2000-12-04 01:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2040</th>\n",
              "      <td>Human</td>\n",
              "      <td>Pylori-Chek</td>\n",
              "      <td>Breath Tests;  Helicobacter Infections</td>\n",
              "      <td>13C-urea</td>\n",
              "      <td>urea (13C)</td>\n",
              "      <td>EMEA/H/C/000182</td>\n",
              "      <td>no</td>\n",
              "      <td>Withdrawn</td>\n",
              "      <td>V04CX</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2000-07-05 02:00:00</td>\n",
              "      <td>0</td>\n",
              "      <td>Pylori-Chek may be used for in vivo diagnosis ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2000-07-05 02:00:00</td>\n",
              "      <td>2000-07-17 02:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>2041 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "7    Category      Medicine name  \\\n",
              "0       Human              Ryeqo   \n",
              "1       Human           Yesafili   \n",
              "2       Human  Leflunomide medac   \n",
              "3       Human   Filgrastim Hexal   \n",
              "4       Human           Opzelura   \n",
              "...       ...                ...   \n",
              "2036    Human           Liprolog   \n",
              "2037    Human            EchoGen   \n",
              "2038    Human          Ecokinase   \n",
              "2039    Human           Primavax   \n",
              "2040    Human        Pylori-Chek   \n",
              "\n",
              "7                                      Therapeutic area  \\\n",
              "0                                             Leiomyoma   \n",
              "1     Macular Edema;  Retinal Vein Occlusion;  Diabe...   \n",
              "2                                 Arthritis, Rheumatoid   \n",
              "3     Neutropenia;  Hematopoietic Stem Cell Transpla...   \n",
              "4                                              Vitiligo   \n",
              "...                                                 ...   \n",
              "2036                                  Diabetes Mellitus   \n",
              "2037                                   Echocardiography   \n",
              "2038                              Myocardial Infarction   \n",
              "2039  Hepatitis B;  Tetanus;  Immunization;  Diphtheria   \n",
              "2040             Breath Tests;  Helicobacter Infections   \n",
              "\n",
              "7    International non-proprietary name (INN) / common name  \\\n",
              "0          relugolix, estradiol, norethisterone acetate       \n",
              "1                                           aflibercept       \n",
              "2                                           leflunomide       \n",
              "3                                            filgrastim       \n",
              "4                                           ruxolitinib       \n",
              "...                                                 ...       \n",
              "2036                                     insulin lispro       \n",
              "2037                                dodecafluoropentane       \n",
              "2038                                          reteplase       \n",
              "2039  diphtheria, tetanus and hepatitis B (rDNA) vac...       \n",
              "2040                                           13C-urea       \n",
              "\n",
              "7                                      Active substance   Product number  \\\n",
              "0     Relugolix, norethisterone acetate, estradiol h...  EMEA/H/C/005267   \n",
              "1                                           aflibercept  EMEA/H/C/006022   \n",
              "2                                           leflunomide  EMEA/H/C/001227   \n",
              "3                                            filgrastim  EMEA/H/C/000918   \n",
              "4                                 ruxolitinib phosphate  EMEA/H/C/005843   \n",
              "...                                                 ...              ...   \n",
              "2036                                     insulin lispro  EMEA/H/C/000143   \n",
              "2037                                dodecafluoropentane  EMEA/H/C/000149   \n",
              "2038                                          reteplase  EMEA/H/C/000106   \n",
              "2039  Diphtheria toxoid, hepatitis B, recombinant su...  EMEA/H/C/000156   \n",
              "2040                                         urea (13C)  EMEA/H/C/000182   \n",
              "\n",
              "7    Patient safety Authorisation status ATC code Additional monitoring  ...  \\\n",
              "0                no           Authorised  H01CC54                   yes  ...   \n",
              "1                no           Authorised  S01LA05                   yes  ...   \n",
              "2                no           Authorised  L04AA13                    no  ...   \n",
              "3                no           Authorised  L03AA02                    no  ...   \n",
              "4                no           Authorised    D11AH                    no  ...   \n",
              "...             ...                  ...      ...                   ...  ...   \n",
              "2036             no            Withdrawn  A10AB04                    no  ...   \n",
              "2037             no            Withdrawn    V08DA                    no  ...   \n",
              "2038             no            Withdrawn  B01AD07                    no  ...   \n",
              "2039             no            Withdrawn    J07CA                    no  ...   \n",
              "2040             no            Withdrawn    V04CX                    no  ...   \n",
              "\n",
              "7    Vet pharmacotherapeutic group      Date of opinion        Decision date  \\\n",
              "0                              NaN  2021-07-16 00:00:00  2023-10-30 01:00:00   \n",
              "1                              NaN  2023-07-20 00:00:00  2023-11-29 01:00:00   \n",
              "2                              NaN                  NaN  2023-10-31 01:00:00   \n",
              "3                              NaN                  NaN  2023-11-30 01:00:00   \n",
              "4                              NaN  2023-02-23 01:00:00  2023-10-19 00:00:00   \n",
              "...                            ...                  ...                  ...   \n",
              "2036                           NaN                  NaN  2001-02-19 01:00:00   \n",
              "2037                           NaN                  NaN  2001-01-22 01:00:00   \n",
              "2038                           NaN                  NaN  1999-07-30 00:00:00   \n",
              "2039                           NaN                  NaN  2000-07-27 00:00:00   \n",
              "2040                           NaN                  NaN  2000-07-05 02:00:00   \n",
              "\n",
              "7    Revision number                             Condition / indication  \\\n",
              "0                  6  Ryeqo is indicated in adult women of reproduct...   \n",
              "1                  1  Yesafili is indicated for adults for the treat...   \n",
              "2                 19  Leflunomide is indicated for the treatment of ...   \n",
              "3                 24  Reduction in the duration of neutropenia and t...   \n",
              "4                  2  Opzelura is indicated for the treatment of non...   \n",
              "...              ...                                                ...   \n",
              "2036               0  For the treatment of patients with diabetes me...   \n",
              "2037               0  EchoGen is a transpulmonary echocardiographic ...   \n",
              "2038               0  Thrombolytic therapy of acute myocardial infar...   \n",
              "2039               0  This vaccine is indicated for active immunizat...   \n",
              "2040               0  Pylori-Chek may be used for in vivo diagnosis ...   \n",
              "\n",
              "7    Species ATCvet code      First published        Revision date  \\\n",
              "0        NaN         NaN  2021-05-19 14:14:00  2023-12-04 18:41:00   \n",
              "1        NaN         NaN  2023-07-17 16:27:00  2023-12-04 18:15:00   \n",
              "2        NaN         NaN  2018-01-30 14:10:00  2023-12-04 17:56:00   \n",
              "3        NaN         NaN  2018-05-24 17:15:00  2023-12-04 17:43:00   \n",
              "4        NaN         NaN  2023-02-22 15:05:00  2023-12-04 17:35:00   \n",
              "...      ...         ...                  ...                  ...   \n",
              "2036     NaN         NaN  2001-02-19 01:00:00  2001-08-01 00:00:00   \n",
              "2037     NaN         NaN  2001-01-22 01:00:00  2001-05-22 00:00:00   \n",
              "2038     NaN         NaN  1999-07-30 00:00:00  2000-12-12 01:00:00   \n",
              "2039     NaN         NaN  2000-07-27 00:00:00  2000-12-04 01:00:00   \n",
              "2040     NaN         NaN  2000-07-05 02:00:00  2000-07-17 02:00:00   \n",
              "\n",
              "7                                                   URL  \n",
              "0     https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "1     https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2     https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "3     https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "4     https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "...                                                 ...  \n",
              "2036  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2037  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2038  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2039  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2040  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "\n",
              "[2041 rows x 30 columns]"
            ]
          },
          "execution_count": 235,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "df1 = df.iloc[7:]\n",
        "df1.columns = df1.iloc[0]\n",
        "\n",
        "df1 = df1[1:]\n",
        "df1.reset_index(drop=True, inplace=True)\n",
        "df1 = df1.dropna(how='all').dropna(how='all', axis=1)\n",
        "df1"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "aaa51a81",
      "metadata": {
        "id": "aaa51a81",
        "outputId": "b520b7a2-b8c6-4de2-c1f1-271c6e50732b"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th>7</th>\n",
              "      <th>Category</th>\n",
              "      <th>Medicine name</th>\n",
              "      <th>Therapeutic area</th>\n",
              "      <th>International non-proprietary name (INN) / common name</th>\n",
              "      <th>Active substance</th>\n",
              "      <th>Product number</th>\n",
              "      <th>Patient safety</th>\n",
              "      <th>Authorisation status</th>\n",
              "      <th>ATC code</th>\n",
              "      <th>Additional monitoring</th>\n",
              "      <th>...</th>\n",
              "      <th>Vet pharmacotherapeutic group</th>\n",
              "      <th>Date of opinion</th>\n",
              "      <th>Decision date</th>\n",
              "      <th>Revision number</th>\n",
              "      <th>Condition / indication</th>\n",
              "      <th>Species</th>\n",
              "      <th>ATCvet code</th>\n",
              "      <th>First published</th>\n",
              "      <th>Revision date</th>\n",
              "      <th>URL</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Human</td>\n",
              "      <td>Ryeqo</td>\n",
              "      <td>Leiomyoma</td>\n",
              "      <td>relugolix, estradiol, norethisterone acetate</td>\n",
              "      <td>Relugolix, norethisterone acetate, estradiol h...</td>\n",
              "      <td>EMEA/H/C/005267</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>H01CC54</td>\n",
              "      <td>yes</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2021-07-16 00:00:00</td>\n",
              "      <td>2023-10-30 01:00:00</td>\n",
              "      <td>6</td>\n",
              "      <td>Ryeqo is indicated in adult women of reproduct...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2021-05-19 14:14:00</td>\n",
              "      <td>2023-12-04 18:41:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Human</td>\n",
              "      <td>Yesafili</td>\n",
              "      <td>Macular Edema;  Retinal Vein Occlusion;  Diabe...</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>EMEA/H/C/006022</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>S01LA05</td>\n",
              "      <td>yes</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-07-20 00:00:00</td>\n",
              "      <td>2023-11-29 01:00:00</td>\n",
              "      <td>1</td>\n",
              "      <td>Yesafili is indicated for adults for the treat...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-07-17 16:27:00</td>\n",
              "      <td>2023-12-04 18:15:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Human</td>\n",
              "      <td>Leflunomide medac</td>\n",
              "      <td>Arthritis, Rheumatoid</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>EMEA/H/C/001227</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L04AA13</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-10-31 01:00:00</td>\n",
              "      <td>19</td>\n",
              "      <td>Leflunomide is indicated for the treatment of ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2018-01-30 14:10:00</td>\n",
              "      <td>2023-12-04 17:56:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Human</td>\n",
              "      <td>Filgrastim Hexal</td>\n",
              "      <td>Neutropenia;  Hematopoietic Stem Cell Transpla...</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>EMEA/H/C/000918</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L03AA02</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-11-30 01:00:00</td>\n",
              "      <td>24</td>\n",
              "      <td>Reduction in the duration of neutropenia and t...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2018-05-24 17:15:00</td>\n",
              "      <td>2023-12-04 17:43:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Human</td>\n",
              "      <td>Opzelura</td>\n",
              "      <td>Vitiligo</td>\n",
              "      <td>ruxolitinib</td>\n",
              "      <td>ruxolitinib phosphate</td>\n",
              "      <td>EMEA/H/C/005843</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>D11AH</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-02-23 01:00:00</td>\n",
              "      <td>2023-10-19 00:00:00</td>\n",
              "      <td>2</td>\n",
              "      <td>Opzelura is indicated for the treatment of non...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-02-22 15:05:00</td>\n",
              "      <td>2023-12-04 17:35:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1853</th>\n",
              "      <td>Veterinary</td>\n",
              "      <td>Nobivac Bb</td>\n",
              "      <td>NaN</td>\n",
              "      <td>live vaccine against Bordetella bronchiseptica...</td>\n",
              "      <td>live Bordetella bronchiseptica bacteria strain...</td>\n",
              "      <td>EMEA/V/C/000068</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>NaN</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>Immunologicals for felidae,</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2014-10-17 00:00:00</td>\n",
              "      <td>9</td>\n",
              "      <td>For active immunisation of cats, of 1 month of...</td>\n",
              "      <td>Cats</td>\n",
              "      <td>QI06AE02</td>\n",
              "      <td>2014-10-17 00:00:00</td>\n",
              "      <td>2014-11-04 15:30:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/veterin...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1864</th>\n",
              "      <td>Veterinary</td>\n",
              "      <td>Melovem</td>\n",
              "      <td>NaN</td>\n",
              "      <td>meloxicam</td>\n",
              "      <td>meloxicam</td>\n",
              "      <td>EMEA/V/C/000152</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>NaN</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>Oxicams</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2014-06-06 00:00:00</td>\n",
              "      <td>5</td>\n",
              "      <td>CattleFor use in acute respiratory infection w...</td>\n",
              "      <td>Pigs; Calves</td>\n",
              "      <td>QM01AC06</td>\n",
              "      <td>2014-06-06 00:00:00</td>\n",
              "      <td>2014-06-19 14:10:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/veterin...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1870</th>\n",
              "      <td>Veterinary</td>\n",
              "      <td>Porcilis AR-T DF</td>\n",
              "      <td>NaN</td>\n",
              "      <td>adjuvanted vaccine against progressive atrophi...</td>\n",
              "      <td>protein dO (non-toxic deletion derivative of P...</td>\n",
              "      <td>EMEA/V/C/000055</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>NaN</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>Immunologicals for suidae</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2014-04-25 01:09:21</td>\n",
              "      <td>6</td>\n",
              "      <td>For the reduction of clinical signs of progres...</td>\n",
              "      <td>Pigs (gilts and sows)</td>\n",
              "      <td>QI09AB04</td>\n",
              "      <td>2014-04-25 01:09:21</td>\n",
              "      <td>2014-05-05 18:40:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/veterin...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1871</th>\n",
              "      <td>Veterinary</td>\n",
              "      <td>Porcilis Porcoli Diluvac Forte (previously Por...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>vaccine to provide passive immunity to the pro...</td>\n",
              "      <td>F4ab (K88ab) fimbrial adhesin, F4ac (K88ac) fi...</td>\n",
              "      <td>EMEA/V/C/000024</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>NaN</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>Immunologicals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2014-04-04 02:09:21</td>\n",
              "      <td>7</td>\n",
              "      <td>For the passive immunisation of piglets by act...</td>\n",
              "      <td>Pigs (gilts and sows)</td>\n",
              "      <td>QI09AB02</td>\n",
              "      <td>2014-04-04 02:09:21</td>\n",
              "      <td>2014-04-14 19:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/veterin...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1878</th>\n",
              "      <td>Veterinary</td>\n",
              "      <td>Masivet</td>\n",
              "      <td>NaN</td>\n",
              "      <td>masitinib mesilate</td>\n",
              "      <td>Masitinib mesilate</td>\n",
              "      <td>EMEA/V/C/000128</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>NaN</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>Antineoplastic agents</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2013-09-24 00:00:00</td>\n",
              "      <td>6</td>\n",
              "      <td>Treatment of non-resectable dog mast-cell tumo...</td>\n",
              "      <td>Dogs</td>\n",
              "      <td>QL01XE90</td>\n",
              "      <td>2013-09-24 00:00:00</td>\n",
              "      <td>2013-09-26 16:01:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/veterin...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>1600 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "7       Category                                      Medicine name  \\\n",
              "0          Human                                              Ryeqo   \n",
              "1          Human                                           Yesafili   \n",
              "2          Human                                  Leflunomide medac   \n",
              "3          Human                                   Filgrastim Hexal   \n",
              "4          Human                                           Opzelura   \n",
              "...          ...                                                ...   \n",
              "1853  Veterinary                                         Nobivac Bb   \n",
              "1864  Veterinary                                            Melovem   \n",
              "1870  Veterinary                                   Porcilis AR-T DF   \n",
              "1871  Veterinary  Porcilis Porcoli Diluvac Forte (previously Por...   \n",
              "1878  Veterinary                                            Masivet   \n",
              "\n",
              "7                                      Therapeutic area  \\\n",
              "0                                             Leiomyoma   \n",
              "1     Macular Edema;  Retinal Vein Occlusion;  Diabe...   \n",
              "2                                 Arthritis, Rheumatoid   \n",
              "3     Neutropenia;  Hematopoietic Stem Cell Transpla...   \n",
              "4                                              Vitiligo   \n",
              "...                                                 ...   \n",
              "1853                                                NaN   \n",
              "1864                                                NaN   \n",
              "1870                                                NaN   \n",
              "1871                                                NaN   \n",
              "1878                                                NaN   \n",
              "\n",
              "7    International non-proprietary name (INN) / common name  \\\n",
              "0          relugolix, estradiol, norethisterone acetate       \n",
              "1                                           aflibercept       \n",
              "2                                           leflunomide       \n",
              "3                                            filgrastim       \n",
              "4                                           ruxolitinib       \n",
              "...                                                 ...       \n",
              "1853  live vaccine against Bordetella bronchiseptica...       \n",
              "1864                                          meloxicam       \n",
              "1870  adjuvanted vaccine against progressive atrophi...       \n",
              "1871  vaccine to provide passive immunity to the pro...       \n",
              "1878                                 masitinib mesilate       \n",
              "\n",
              "7                                      Active substance   Product number  \\\n",
              "0     Relugolix, norethisterone acetate, estradiol h...  EMEA/H/C/005267   \n",
              "1                                           aflibercept  EMEA/H/C/006022   \n",
              "2                                           leflunomide  EMEA/H/C/001227   \n",
              "3                                            filgrastim  EMEA/H/C/000918   \n",
              "4                                 ruxolitinib phosphate  EMEA/H/C/005843   \n",
              "...                                                 ...              ...   \n",
              "1853  live Bordetella bronchiseptica bacteria strain...  EMEA/V/C/000068   \n",
              "1864                                          meloxicam  EMEA/V/C/000152   \n",
              "1870  protein dO (non-toxic deletion derivative of P...  EMEA/V/C/000055   \n",
              "1871  F4ab (K88ab) fimbrial adhesin, F4ac (K88ac) fi...  EMEA/V/C/000024   \n",
              "1878                                 Masitinib mesilate  EMEA/V/C/000128   \n",
              "\n",
              "7    Patient safety Authorisation status ATC code Additional monitoring  ...  \\\n",
              "0                no           Authorised  H01CC54                   yes  ...   \n",
              "1                no           Authorised  S01LA05                   yes  ...   \n",
              "2                no           Authorised  L04AA13                    no  ...   \n",
              "3                no           Authorised  L03AA02                    no  ...   \n",
              "4                no           Authorised    D11AH                    no  ...   \n",
              "...             ...                  ...      ...                   ...  ...   \n",
              "1853             no           Authorised      NaN                    no  ...   \n",
              "1864             no           Authorised      NaN                    no  ...   \n",
              "1870             no           Authorised      NaN                    no  ...   \n",
              "1871             no           Authorised      NaN                    no  ...   \n",
              "1878             no           Authorised      NaN                    no  ...   \n",
              "\n",
              "7    Vet pharmacotherapeutic group      Date of opinion        Decision date  \\\n",
              "0                              NaN  2021-07-16 00:00:00  2023-10-30 01:00:00   \n",
              "1                              NaN  2023-07-20 00:00:00  2023-11-29 01:00:00   \n",
              "2                              NaN                  NaN  2023-10-31 01:00:00   \n",
              "3                              NaN                  NaN  2023-11-30 01:00:00   \n",
              "4                              NaN  2023-02-23 01:00:00  2023-10-19 00:00:00   \n",
              "...                            ...                  ...                  ...   \n",
              "1853  Immunologicals for felidae,                   NaN  2014-10-17 00:00:00   \n",
              "1864                       Oxicams                  NaN  2014-06-06 00:00:00   \n",
              "1870     Immunologicals for suidae                  NaN  2014-04-25 01:09:21   \n",
              "1871                Immunologicals                  NaN  2014-04-04 02:09:21   \n",
              "1878         Antineoplastic agents                  NaN  2013-09-24 00:00:00   \n",
              "\n",
              "7    Revision number                             Condition / indication  \\\n",
              "0                  6  Ryeqo is indicated in adult women of reproduct...   \n",
              "1                  1  Yesafili is indicated for adults for the treat...   \n",
              "2                 19  Leflunomide is indicated for the treatment of ...   \n",
              "3                 24  Reduction in the duration of neutropenia and t...   \n",
              "4                  2  Opzelura is indicated for the treatment of non...   \n",
              "...              ...                                                ...   \n",
              "1853               9  For active immunisation of cats, of 1 month of...   \n",
              "1864               5  CattleFor use in acute respiratory infection w...   \n",
              "1870               6  For the reduction of clinical signs of progres...   \n",
              "1871               7  For the passive immunisation of piglets by act...   \n",
              "1878               6  Treatment of non-resectable dog mast-cell tumo...   \n",
              "\n",
              "7                   Species ATCvet code      First published  \\\n",
              "0                       NaN         NaN  2021-05-19 14:14:00   \n",
              "1                       NaN         NaN  2023-07-17 16:27:00   \n",
              "2                       NaN         NaN  2018-01-30 14:10:00   \n",
              "3                       NaN         NaN  2018-05-24 17:15:00   \n",
              "4                       NaN         NaN  2023-02-22 15:05:00   \n",
              "...                     ...         ...                  ...   \n",
              "1853                   Cats    QI06AE02  2014-10-17 00:00:00   \n",
              "1864           Pigs; Calves    QM01AC06  2014-06-06 00:00:00   \n",
              "1870  Pigs (gilts and sows)    QI09AB04  2014-04-25 01:09:21   \n",
              "1871  Pigs (gilts and sows)    QI09AB02  2014-04-04 02:09:21   \n",
              "1878                   Dogs    QL01XE90  2013-09-24 00:00:00   \n",
              "\n",
              "7           Revision date                                                URL  \n",
              "0     2023-12-04 18:41:00  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "1     2023-12-04 18:15:00  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2     2023-12-04 17:56:00  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "3     2023-12-04 17:43:00  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "4     2023-12-04 17:35:00  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "...                   ...                                                ...  \n",
              "1853  2014-11-04 15:30:00  https://www.ema.europa.eu/en/medicines/veterin...  \n",
              "1864  2014-06-19 14:10:00  https://www.ema.europa.eu/en/medicines/veterin...  \n",
              "1870  2014-05-05 18:40:00  https://www.ema.europa.eu/en/medicines/veterin...  \n",
              "1871  2014-04-14 19:00:00  https://www.ema.europa.eu/en/medicines/veterin...  \n",
              "1878  2013-09-26 16:01:00  https://www.ema.europa.eu/en/medicines/veterin...  \n",
              "\n",
              "[1600 rows x 30 columns]"
            ]
          },
          "execution_count": 7,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "df2 = df1[df1['Authorisation status'] == 'Authorised']\n",
        "df2"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "a7bd369b",
      "metadata": {
        "id": "a7bd369b",
        "outputId": "9f3a03d1-5ce4-4d57-9219-5ccea89a2595"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "0       https://www.ema.europa.eu/en/medicines/human/E...\n",
              "1       https://www.ema.europa.eu/en/medicines/human/E...\n",
              "2       https://www.ema.europa.eu/en/medicines/human/E...\n",
              "3       https://www.ema.europa.eu/en/medicines/human/E...\n",
              "4       https://www.ema.europa.eu/en/medicines/human/E...\n",
              "                              ...                        \n",
              "1853    https://www.ema.europa.eu/en/medicines/veterin...\n",
              "1864    https://www.ema.europa.eu/en/medicines/veterin...\n",
              "1870    https://www.ema.europa.eu/en/medicines/veterin...\n",
              "1871    https://www.ema.europa.eu/en/medicines/veterin...\n",
              "1878    https://www.ema.europa.eu/en/medicines/veterin...\n",
              "Name: URL, Length: 1600, dtype: object"
            ]
          },
          "execution_count": 10,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "urls = df2['URL']\n",
        "urls"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "7878be28",
      "metadata": {
        "id": "7878be28"
      },
      "outputs": [],
      "source": [
        "import time\n",
        "from selenium import webdriver"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "a20e0307",
      "metadata": {
        "id": "a20e0307"
      },
      "outputs": [],
      "source": [
        "import time\n",
        "from selenium import webdriver\n",
        "\n",
        "with open(\"medecines_regulation.csv\", \"w\") as file:\n",
        "    file.write(\"title; inn_common; therap_area; date_authorisation; revision; last_update \\n\")\n",
        "\n",
        "driver = webdriver.Chrome(executable_path = \"C:\\webdrivers\\chromedriver.exe\")\n",
        "\n",
        "driver.get(\"https://www.ema.europa.eu/en/search?f%5B0%5D=ema_med_status%3A100108&f%5B1%5D=ema_med_status%3A100109&f%5B2%5D=ema_med_status%3A100111&f%5B3%5D=ema_medicine_bundle%3Aema_medicine&f%5B4%5D=ema_search_categories%3A83&f%5B5%5D=ema_search_categories%3A84\")\n",
        "driver.maximize_window()\n",
        "time.sleep(2)\n",
        "\n",
        "# Accept all cookies\n",
        "l=driver.find_element(\"link text\", \"Accept all cookies\")\n",
        "l.click()\n",
        "time.sleep(2)\n",
        "\n",
        "# close button\n",
        "b =driver.find_element('xpath', '//*[@id=\"cookie-consent-banner\"]/div/div/div[2]/button')\n",
        "b.click()\n",
        "\n",
        "# drop withdrawn\n",
        "w =driver.find_element('xpath', '/html/body/div[2]/div/main/div/div/div[3]/div[1]/div[2]/div/a[3]/span')\n",
        "w.click()\n",
        "time.sleep(1)\n",
        "\n",
        "# drop refused\n",
        "w =driver.find_element('xpath', '/html/body/div[2]/div/main/div/div/div[3]/div[1]/div[2]/div/a[3]/span/span[1]')\n",
        "w.click()\n",
        "time.sleep(2)\n",
        "\n",
        "# drop veterinary\n",
        "w =driver.find_element('xpath', '/html/body/div[2]/div/main/div/div/div[3]/div[1]/div[2]/div/a[5]/span')\n",
        "w.click()\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "a70379f9",
      "metadata": {
        "id": "a70379f9"
      },
      "outputs": [],
      "source": [
        "urls = []\n",
        "condition = True\n",
        "while condition:\n",
        "    listMed = driver.find_elements('xpath', '//div[contains(@class, \"teaser-title card-title bcl-heading\")]')\n",
        "    for el in listMed:\n",
        "        url = el.find_element('css selector', 'a')\n",
        "        urls.append(url.get_property('href'))\n",
        "\n",
        "    try:\n",
        "        us = driver.find_elements('xpath', '//a[@class=\"page-link\"]')[-2]\n",
        "        driver.execute_script(\"arguments[0].click();\", us)\n",
        "    except:\n",
        "        condition = False\n",
        ""
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "69ed7773",
      "metadata": {
        "scrolled": true,
        "id": "69ed7773"
      },
      "outputs": [],
      "source": [
        "urls"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "c0046405",
      "metadata": {
        "scrolled": true,
        "id": "c0046405"
      },
      "outputs": [],
      "source": [
        "from tqdm import tqdm\n",
        "\n",
        "descriptions = []\n",
        "driver = webdriver.Chrome(executable_path = \"C:\\webdrivers\\chromedriver.exe\")\n",
        "driver.get(urls[1])\n",
        "driver.maximize_window()\n",
        "time.sleep(2)\n",
        " # Accept all cookies\n",
        "l=driver.find_element(\"link text\", \"Accept all cookies\")\n",
        "l.click()\n",
        "time.sleep(2)\n",
        "\n",
        "    # close button\n",
        "b =driver.find_element('xpath', '//*[@id=\"cookie-consent-banner\"]/div/div/div[2]/button')\n",
        "b.click()\n",
        "\n",
        "for i in urls[1456:]:\n",
        "    driver.get(i)\n",
        "\n",
        "    name = driver.find_element('xpath', '//div[@class=\"heading-title\"]/h1/span').text\n",
        "    active_substance = driver.find_element('xpath', '//*[@id=\"block-system-main-block\"]/article/div[1]/div[2]/div/div[3]/div[1]/dl/dd[2]').text\n",
        "    common_name = driver.find_element('xpath', '//*[@id=\"block-system-main-block\"]/article/div[1]/div[2]/div/div[3]/div[1]/dl/dd[3]').text\n",
        "    therap_area = driver.find_element('xpath', '//*[@id=\"block-system-main-block\"]/article/div[1]/div[2]/div/div[3]/div[1]/dl/dd[4]').text\n",
        "    #therapeutic_indication = driver.find_elements('xpath', '//*[@id=\"block-system-main-block\"]/article/div[1]/div[2]/div/div[3]/div[3]')[0].text # + ' ' + driver.find_elements('xpath', '//*[@id=\"block-system-main-block\"]/article/div[1]/div[2]/div/div[3]/div[3]')[1].text\n",
        "\n",
        "\n",
        "    # Medicament usage\n",
        "    usa = driver.find_element('xpath', \"//span[contains(text(),'used') and contains(text(),'?')]\")\n",
        "    driver.execute_script('arguments[0].scrollIntoView(true)', usa)\n",
        "    time.sleep(3)\n",
        "    usa.find_element('xpath', '../..').click()\n",
        "    usa.find_elements('xpath', '../../..')[-1].text\n",
        "    usa.find_elements('xpath', '../../..')[-1].text\n",
        "    usage = usa.find_elements('xpath', '../../..')[-1].text\n",
        "    time.sleep(3)\n",
        "\n",
        "\n",
        "    # Medicament risks\n",
        "    usb = driver.find_element('xpath', \"//span[contains(text(),'risk') or contains(text(),'side effects') or contains(text(),'side-effects') and contains(text(),'?')]\")\n",
        "    driver.execute_script('arguments[0].scrollIntoView(true)', usb)\n",
        "    time.sleep(3)\n",
        "    usb.find_element('xpath', '../..').click()\n",
        "    usb.find_elements('xpath', '../../..')[0].text\n",
        "    usb.find_elements('xpath', '../../..')[0].text\n",
        "    risk = usb.find_elements('xpath', '../../..')[0].text\n",
        "\n",
        "    prodJ = {\n",
        "        'name' : name,\n",
        "        'active_substance' : active_substance,\n",
        "        'common_name' : common_name,\n",
        "        'therap_area' : therap_area,\n",
        "        'therapeutic_indication' : therapeutic_indication,\n",
        "        'usage': usage,\n",
        "        'risk' : risk,\n",
        "        'medicamentLink': i\n",
        "    }\n",
        "    descriptions.append(prodJ)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "22496bdf",
      "metadata": {
        "id": "22496bdf"
      },
      "outputs": [],
      "source": [
        "usa = driver.find_element('xpath', \"//span[contains(text(),'used?') and contains(text(),'?')]\")\n",
        "driver.execute_script('arguments[0].scrollIntoView(true)', usa)\n",
        "time.sleep(3)\n",
        "usa.find_element('xpath', '../..').click()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "9411bdfe",
      "metadata": {
        "id": "9411bdfe",
        "outputId": "2b7b7a10-4a1e-4d08-996c-89be8d3294d7"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "{'name': 'Ryeqo',\n",
              " 'active_substance': 'relugolix\\nnorethisterone acetate\\nestradiol hemihydrate',\n",
              " 'common_name': 'relugolix\\nestradiol\\nnorethisterone acetate',\n",
              " 'therap_area': 'Leiomyoma',\n",
              " 'therapeutic_indication': 'Therapeutic indication\\nRyeqo is indicated in adult women of reproductive age for:\\n- treatment of moderate to severe symptoms of uterine fibroids,\\n- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.',\n",
              " 'usage': 'How is Ryeqo used?\\nThe medicine can only be obtained with a prescription and treatment should be started by a doctor experienced in diagnosing and treating uterine fibroids or endometriosis.',\n",
              " 'risk': 'What are the risks associated with Ryeqo?\\nThe most common side effects with Ryeqo (which may affect up to 1 in 10 people) include headaches, hot flushes and bleeding from the womb.\\nRyeqo must not be used in women who have, or have had, venous thromboembolism (blood clots in the veins) or those who have had a stroke or a heart attack. It must also not be used in women who have a blood clotting disorder, osteoporosis, migraines or headaches with neurological symptoms, cancers that are influenced by sex hormones (such as breast cancer or genital cancer), liver tumours, or abnormal liver function, or in those who are pregnant, breastfeeding or have genital bleeding of unknown cause.',\n",
              " 'medicamentLink': 'https://www.ema.europa.eu/en/medicines/human/EPAR/ryeqo'}"
            ]
          },
          "execution_count": 26,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "descriptions[0]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "8349005a",
      "metadata": {
        "id": "8349005a"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "\n",
        "df1 = pd.DataFrame(descriptions)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "29d722db",
      "metadata": {
        "id": "29d722db"
      },
      "outputs": [],
      "source": [
        "df.to_csv('EMAdataEn.csv', index=False)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "6bffaf4d",
      "metadata": {
        "id": "6bffaf4d"
      },
      "outputs": [],
      "source": [
        "ndf = pd.merge(df, df1, left_on='name', right_on='Medicine name', how='outer')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "52797140",
      "metadata": {
        "id": "52797140",
        "outputId": "ec228be0-0eed-4023-a809-eabed07797a9"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>name</th>\n",
              "      <th>active_substance</th>\n",
              "      <th>common_name</th>\n",
              "      <th>therap_area</th>\n",
              "      <th>therapeutic_indication</th>\n",
              "      <th>usage</th>\n",
              "      <th>risk</th>\n",
              "      <th>medicamentLink</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Ryeqo</td>\n",
              "      <td>relugolix\\nnorethisterone acetate\\nestradiol h...</td>\n",
              "      <td>relugolix\\nestradiol\\nnorethisterone acetate</td>\n",
              "      <td>Leiomyoma</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Ryeqo used?\\nThe medicine can only be o...</td>\n",
              "      <td>What are the risks associated with Ryeqo?\\nThe...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Yesafili</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>Macular Edema\\nRetinal Vein Occlusion\\nDiabeti...</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Yesafili used?\\nYesafili is available a...</td>\n",
              "      <td>What are the risks associated with Yesafili?\\n...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Leflunomide medac</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>Arthritis, Rheumatoid</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Leflunomide medac used?\\nLeflunomide me...</td>\n",
              "      <td>What are the benefit and risk of Leflunomide m...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Filgrastim Hexal</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>Neutropenia\\nHematopoietic Stem Cell Transplan...</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Filgrastim Hexal used?\\nFilgrastim Hexa...</td>\n",
              "      <td>What is the risk associated with Filgrastim He...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Opzelura</td>\n",
              "      <td>ruxolitinib phosphate</td>\n",
              "      <td>ruxolitinib</td>\n",
              "      <td>Vitiligo</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Opzelura used?\\nOpzelura can only be ob...</td>\n",
              "      <td>What are the risks associated with Opzelura?\\n...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>110</th>\n",
              "      <td>Eryseng</td>\n",
              "      <td>Erysipelothrix rhusiopathiae, strain R32E11 (i...</td>\n",
              "      <td>Erysipelothrix rhusiopathiae</td>\n",
              "      <td>Pigs</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Eryseng used for?\\nEryseng is used to ...</td>\n",
              "      <td>What is the risk associated with Eryseng?\\nThe...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/veterin...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>111</th>\n",
              "      <td>Activyl</td>\n",
              "      <td>indoxacarb</td>\n",
              "      <td>indoxacarb</td>\n",
              "      <td>Dogs\\nCats</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Activyl used for?\\nActivyl is used to ...</td>\n",
              "      <td>What is the risk associated with Activyl?\\nDog...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/veterin...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>112</th>\n",
              "      <td>Fungitraxx</td>\n",
              "      <td>Itraconazole</td>\n",
              "      <td>itraconazole</td>\n",
              "      <td>Avian</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Fungitraxx used for?\\nFungitraxx is us...</td>\n",
              "      <td>What is the risk associated with Fungitraxx?\\n...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/veterin...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>113</th>\n",
              "      <td>Clevor</td>\n",
              "      <td>ropinirole hydrochloride</td>\n",
              "      <td>ropinirole</td>\n",
              "      <td>Dogs</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Clevor used?\\nClevor is an eye drop sol...</td>\n",
              "      <td>What are the risks associated with Clevor?\\nTh...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/veterin...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>114</th>\n",
              "      <td>Meloxidyl</td>\n",
              "      <td>meloxicam</td>\n",
              "      <td>meloxicam</td>\n",
              "      <td>Dogs\\nCats\\nCattle\\nPigs\\nHorses</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Meloxidyl used for?\\nIn dogs, Meloxidy...</td>\n",
              "      <td>What is the risk associated with Meloxidyl?\\nI...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/veterin...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>1559 rows × 8 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "                  name                                   active_substance  \\\n",
              "0                Ryeqo  relugolix\\nnorethisterone acetate\\nestradiol h...   \n",
              "1             Yesafili                                        aflibercept   \n",
              "2    Leflunomide medac                                        leflunomide   \n",
              "3     Filgrastim Hexal                                         filgrastim   \n",
              "4             Opzelura                              ruxolitinib phosphate   \n",
              "..                 ...                                                ...   \n",
              "110            Eryseng  Erysipelothrix rhusiopathiae, strain R32E11 (i...   \n",
              "111            Activyl                                         indoxacarb   \n",
              "112         Fungitraxx                                       Itraconazole   \n",
              "113             Clevor                           ropinirole hydrochloride   \n",
              "114          Meloxidyl                                          meloxicam   \n",
              "\n",
              "                                      common_name  \\\n",
              "0    relugolix\\nestradiol\\nnorethisterone acetate   \n",
              "1                                     aflibercept   \n",
              "2                                     leflunomide   \n",
              "3                                      filgrastim   \n",
              "4                                     ruxolitinib   \n",
              "..                                            ...   \n",
              "110                  Erysipelothrix rhusiopathiae   \n",
              "111                                    indoxacarb   \n",
              "112                                  itraconazole   \n",
              "113                                    ropinirole   \n",
              "114                                     meloxicam   \n",
              "\n",
              "                                           therap_area  \\\n",
              "0                                            Leiomyoma   \n",
              "1    Macular Edema\\nRetinal Vein Occlusion\\nDiabeti...   \n",
              "2                                Arthritis, Rheumatoid   \n",
              "3    Neutropenia\\nHematopoietic Stem Cell Transplan...   \n",
              "4                                             Vitiligo   \n",
              "..                                                 ...   \n",
              "110                                               Pigs   \n",
              "111                                         Dogs\\nCats   \n",
              "112                                              Avian   \n",
              "113                                               Dogs   \n",
              "114                   Dogs\\nCats\\nCattle\\nPigs\\nHorses   \n",
              "\n",
              "                                therapeutic_indication  \\\n",
              "0    Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1    Therapeutic indication\\nKirsty is indicated fo...   \n",
              "2    Therapeutic indication\\nKirsty is indicated fo...   \n",
              "3    Therapeutic indication\\nKirsty is indicated fo...   \n",
              "4    Therapeutic indication\\nKirsty is indicated fo...   \n",
              "..                                                 ...   \n",
              "110  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "111  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "112  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "113  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "114  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "\n",
              "                                                 usage  \\\n",
              "0    How is Ryeqo used?\\nThe medicine can only be o...   \n",
              "1    How is Yesafili used?\\nYesafili is available a...   \n",
              "2    How is Leflunomide medac used?\\nLeflunomide me...   \n",
              "3    How is Filgrastim Hexal used?\\nFilgrastim Hexa...   \n",
              "4    How is Opzelura used?\\nOpzelura can only be ob...   \n",
              "..                                                 ...   \n",
              "110  What is Eryseng used for?\\nEryseng is used to ...   \n",
              "111  What is Activyl used for?\\nActivyl is used to ...   \n",
              "112  What is Fungitraxx used for?\\nFungitraxx is us...   \n",
              "113  How is Clevor used?\\nClevor is an eye drop sol...   \n",
              "114  What is Meloxidyl used for?\\nIn dogs, Meloxidy...   \n",
              "\n",
              "                                                  risk  \\\n",
              "0    What are the risks associated with Ryeqo?\\nThe...   \n",
              "1    What are the risks associated with Yesafili?\\n...   \n",
              "2    What are the benefit and risk of Leflunomide m...   \n",
              "3    What is the risk associated with Filgrastim He...   \n",
              "4    What are the risks associated with Opzelura?\\n...   \n",
              "..                                                 ...   \n",
              "110  What is the risk associated with Eryseng?\\nThe...   \n",
              "111  What is the risk associated with Activyl?\\nDog...   \n",
              "112  What is the risk associated with Fungitraxx?\\n...   \n",
              "113  What are the risks associated with Clevor?\\nTh...   \n",
              "114  What is the risk associated with Meloxidyl?\\nI...   \n",
              "\n",
              "                                        medicamentLink  \n",
              "0    https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "1    https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2    https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "3    https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "4    https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "..                                                 ...  \n",
              "110  https://www.ema.europa.eu/en/medicines/veterin...  \n",
              "111  https://www.ema.europa.eu/en/medicines/veterin...  \n",
              "112  https://www.ema.europa.eu/en/medicines/veterin...  \n",
              "113  https://www.ema.europa.eu/en/medicines/veterin...  \n",
              "114  https://www.ema.europa.eu/en/medicines/veterin...  \n",
              "\n",
              "[1559 rows x 8 columns]"
            ]
          },
          "execution_count": 229,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "ndf"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "417ddbb3",
      "metadata": {
        "id": "417ddbb3"
      },
      "outputs": [],
      "source": [
        "ndf.to_csv('EMAdataEn1.csv', index=False)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "5ffaa14f",
      "metadata": {
        "id": "5ffaa14f",
        "outputId": "80437b93-0158-465e-8684-8c2a59ce221a"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th>7</th>\n",
              "      <th>Category</th>\n",
              "      <th>name</th>\n",
              "      <th>Therapeutic area</th>\n",
              "      <th>International non-proprietary name (INN) / common name</th>\n",
              "      <th>Active substance</th>\n",
              "      <th>Product number</th>\n",
              "      <th>Patient safety</th>\n",
              "      <th>Authorisation status</th>\n",
              "      <th>ATC code</th>\n",
              "      <th>Additional monitoring</th>\n",
              "      <th>...</th>\n",
              "      <th>Vet pharmacotherapeutic group</th>\n",
              "      <th>Date of opinion</th>\n",
              "      <th>Decision date</th>\n",
              "      <th>Revision number</th>\n",
              "      <th>Condition / indication</th>\n",
              "      <th>Species</th>\n",
              "      <th>ATCvet code</th>\n",
              "      <th>First published</th>\n",
              "      <th>Revision date</th>\n",
              "      <th>URL</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Human</td>\n",
              "      <td>Ryeqo</td>\n",
              "      <td>Leiomyoma</td>\n",
              "      <td>relugolix, estradiol, norethisterone acetate</td>\n",
              "      <td>Relugolix, norethisterone acetate, estradiol h...</td>\n",
              "      <td>EMEA/H/C/005267</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>H01CC54</td>\n",
              "      <td>yes</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2021-07-16 00:00:00</td>\n",
              "      <td>2023-10-30 01:00:00</td>\n",
              "      <td>6</td>\n",
              "      <td>Ryeqo is indicated in adult women of reproduct...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2021-05-19 14:14:00</td>\n",
              "      <td>2023-12-04 18:41:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Human</td>\n",
              "      <td>Yesafili</td>\n",
              "      <td>Macular Edema;  Retinal Vein Occlusion;  Diabe...</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>EMEA/H/C/006022</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>S01LA05</td>\n",
              "      <td>yes</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-07-20 00:00:00</td>\n",
              "      <td>2023-11-29 01:00:00</td>\n",
              "      <td>1</td>\n",
              "      <td>Yesafili is indicated for adults for the treat...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-07-17 16:27:00</td>\n",
              "      <td>2023-12-04 18:15:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Human</td>\n",
              "      <td>Leflunomide medac</td>\n",
              "      <td>Arthritis, Rheumatoid</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>EMEA/H/C/001227</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L04AA13</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-10-31 01:00:00</td>\n",
              "      <td>19</td>\n",
              "      <td>Leflunomide is indicated for the treatment of ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2018-01-30 14:10:00</td>\n",
              "      <td>2023-12-04 17:56:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Human</td>\n",
              "      <td>Filgrastim Hexal</td>\n",
              "      <td>Neutropenia;  Hematopoietic Stem Cell Transpla...</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>EMEA/H/C/000918</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L03AA02</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-11-30 01:00:00</td>\n",
              "      <td>24</td>\n",
              "      <td>Reduction in the duration of neutropenia and t...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2018-05-24 17:15:00</td>\n",
              "      <td>2023-12-04 17:43:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Human</td>\n",
              "      <td>Opzelura</td>\n",
              "      <td>Vitiligo</td>\n",
              "      <td>ruxolitinib</td>\n",
              "      <td>ruxolitinib phosphate</td>\n",
              "      <td>EMEA/H/C/005843</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>D11AH</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-02-23 01:00:00</td>\n",
              "      <td>2023-10-19 00:00:00</td>\n",
              "      <td>2</td>\n",
              "      <td>Opzelura is indicated for the treatment of non...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2023-02-22 15:05:00</td>\n",
              "      <td>2023-12-04 17:35:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2036</th>\n",
              "      <td>Human</td>\n",
              "      <td>Liprolog</td>\n",
              "      <td>Diabetes Mellitus</td>\n",
              "      <td>insulin lispro</td>\n",
              "      <td>insulin lispro</td>\n",
              "      <td>EMEA/H/C/000143</td>\n",
              "      <td>no</td>\n",
              "      <td>Withdrawn</td>\n",
              "      <td>A10AB04</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2001-02-19 01:00:00</td>\n",
              "      <td>0</td>\n",
              "      <td>For the treatment of patients with diabetes me...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2001-02-19 01:00:00</td>\n",
              "      <td>2001-08-01 00:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2037</th>\n",
              "      <td>Human</td>\n",
              "      <td>EchoGen</td>\n",
              "      <td>Echocardiography</td>\n",
              "      <td>dodecafluoropentane</td>\n",
              "      <td>dodecafluoropentane</td>\n",
              "      <td>EMEA/H/C/000149</td>\n",
              "      <td>no</td>\n",
              "      <td>Withdrawn</td>\n",
              "      <td>V08DA</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2001-01-22 01:00:00</td>\n",
              "      <td>0</td>\n",
              "      <td>EchoGen is a transpulmonary echocardiographic ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2001-01-22 01:00:00</td>\n",
              "      <td>2001-05-22 00:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2038</th>\n",
              "      <td>Human</td>\n",
              "      <td>Ecokinase</td>\n",
              "      <td>Myocardial Infarction</td>\n",
              "      <td>reteplase</td>\n",
              "      <td>reteplase</td>\n",
              "      <td>EMEA/H/C/000106</td>\n",
              "      <td>no</td>\n",
              "      <td>Withdrawn</td>\n",
              "      <td>B01AD07</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1999-07-30 00:00:00</td>\n",
              "      <td>0</td>\n",
              "      <td>Thrombolytic therapy of acute myocardial infar...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1999-07-30 00:00:00</td>\n",
              "      <td>2000-12-12 01:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2039</th>\n",
              "      <td>Human</td>\n",
              "      <td>Primavax</td>\n",
              "      <td>Hepatitis B;  Tetanus;  Immunization;  Diphtheria</td>\n",
              "      <td>diphtheria, tetanus and hepatitis B (rDNA) vac...</td>\n",
              "      <td>Diphtheria toxoid, hepatitis B, recombinant su...</td>\n",
              "      <td>EMEA/H/C/000156</td>\n",
              "      <td>no</td>\n",
              "      <td>Withdrawn</td>\n",
              "      <td>J07CA</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2000-07-27 00:00:00</td>\n",
              "      <td>0</td>\n",
              "      <td>This vaccine is indicated for active immunizat...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2000-07-27 00:00:00</td>\n",
              "      <td>2000-12-04 01:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2040</th>\n",
              "      <td>Human</td>\n",
              "      <td>Pylori-Chek</td>\n",
              "      <td>Breath Tests;  Helicobacter Infections</td>\n",
              "      <td>13C-urea</td>\n",
              "      <td>urea (13C)</td>\n",
              "      <td>EMEA/H/C/000182</td>\n",
              "      <td>no</td>\n",
              "      <td>Withdrawn</td>\n",
              "      <td>V04CX</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2000-07-05 02:00:00</td>\n",
              "      <td>0</td>\n",
              "      <td>Pylori-Chek may be used for in vivo diagnosis ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2000-07-05 02:00:00</td>\n",
              "      <td>2000-07-17 02:00:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>1759 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "7    Category               name  \\\n",
              "0       Human              Ryeqo   \n",
              "1       Human           Yesafili   \n",
              "2       Human  Leflunomide medac   \n",
              "3       Human   Filgrastim Hexal   \n",
              "4       Human           Opzelura   \n",
              "...       ...                ...   \n",
              "2036    Human           Liprolog   \n",
              "2037    Human            EchoGen   \n",
              "2038    Human          Ecokinase   \n",
              "2039    Human           Primavax   \n",
              "2040    Human        Pylori-Chek   \n",
              "\n",
              "7                                      Therapeutic area  \\\n",
              "0                                             Leiomyoma   \n",
              "1     Macular Edema;  Retinal Vein Occlusion;  Diabe...   \n",
              "2                                 Arthritis, Rheumatoid   \n",
              "3     Neutropenia;  Hematopoietic Stem Cell Transpla...   \n",
              "4                                              Vitiligo   \n",
              "...                                                 ...   \n",
              "2036                                  Diabetes Mellitus   \n",
              "2037                                   Echocardiography   \n",
              "2038                              Myocardial Infarction   \n",
              "2039  Hepatitis B;  Tetanus;  Immunization;  Diphtheria   \n",
              "2040             Breath Tests;  Helicobacter Infections   \n",
              "\n",
              "7    International non-proprietary name (INN) / common name  \\\n",
              "0          relugolix, estradiol, norethisterone acetate       \n",
              "1                                           aflibercept       \n",
              "2                                           leflunomide       \n",
              "3                                            filgrastim       \n",
              "4                                           ruxolitinib       \n",
              "...                                                 ...       \n",
              "2036                                     insulin lispro       \n",
              "2037                                dodecafluoropentane       \n",
              "2038                                          reteplase       \n",
              "2039  diphtheria, tetanus and hepatitis B (rDNA) vac...       \n",
              "2040                                           13C-urea       \n",
              "\n",
              "7                                      Active substance   Product number  \\\n",
              "0     Relugolix, norethisterone acetate, estradiol h...  EMEA/H/C/005267   \n",
              "1                                           aflibercept  EMEA/H/C/006022   \n",
              "2                                           leflunomide  EMEA/H/C/001227   \n",
              "3                                            filgrastim  EMEA/H/C/000918   \n",
              "4                                 ruxolitinib phosphate  EMEA/H/C/005843   \n",
              "...                                                 ...              ...   \n",
              "2036                                     insulin lispro  EMEA/H/C/000143   \n",
              "2037                                dodecafluoropentane  EMEA/H/C/000149   \n",
              "2038                                          reteplase  EMEA/H/C/000106   \n",
              "2039  Diphtheria toxoid, hepatitis B, recombinant su...  EMEA/H/C/000156   \n",
              "2040                                         urea (13C)  EMEA/H/C/000182   \n",
              "\n",
              "7    Patient safety Authorisation status ATC code Additional monitoring  ...  \\\n",
              "0                no           Authorised  H01CC54                   yes  ...   \n",
              "1                no           Authorised  S01LA05                   yes  ...   \n",
              "2                no           Authorised  L04AA13                    no  ...   \n",
              "3                no           Authorised  L03AA02                    no  ...   \n",
              "4                no           Authorised    D11AH                    no  ...   \n",
              "...             ...                  ...      ...                   ...  ...   \n",
              "2036             no            Withdrawn  A10AB04                    no  ...   \n",
              "2037             no            Withdrawn    V08DA                    no  ...   \n",
              "2038             no            Withdrawn  B01AD07                    no  ...   \n",
              "2039             no            Withdrawn    J07CA                    no  ...   \n",
              "2040             no            Withdrawn    V04CX                    no  ...   \n",
              "\n",
              "7    Vet pharmacotherapeutic group      Date of opinion        Decision date  \\\n",
              "0                              NaN  2021-07-16 00:00:00  2023-10-30 01:00:00   \n",
              "1                              NaN  2023-07-20 00:00:00  2023-11-29 01:00:00   \n",
              "2                              NaN                  NaN  2023-10-31 01:00:00   \n",
              "3                              NaN                  NaN  2023-11-30 01:00:00   \n",
              "4                              NaN  2023-02-23 01:00:00  2023-10-19 00:00:00   \n",
              "...                            ...                  ...                  ...   \n",
              "2036                           NaN                  NaN  2001-02-19 01:00:00   \n",
              "2037                           NaN                  NaN  2001-01-22 01:00:00   \n",
              "2038                           NaN                  NaN  1999-07-30 00:00:00   \n",
              "2039                           NaN                  NaN  2000-07-27 00:00:00   \n",
              "2040                           NaN                  NaN  2000-07-05 02:00:00   \n",
              "\n",
              "7    Revision number                             Condition / indication  \\\n",
              "0                  6  Ryeqo is indicated in adult women of reproduct...   \n",
              "1                  1  Yesafili is indicated for adults for the treat...   \n",
              "2                 19  Leflunomide is indicated for the treatment of ...   \n",
              "3                 24  Reduction in the duration of neutropenia and t...   \n",
              "4                  2  Opzelura is indicated for the treatment of non...   \n",
              "...              ...                                                ...   \n",
              "2036               0  For the treatment of patients with diabetes me...   \n",
              "2037               0  EchoGen is a transpulmonary echocardiographic ...   \n",
              "2038               0  Thrombolytic therapy of acute myocardial infar...   \n",
              "2039               0  This vaccine is indicated for active immunizat...   \n",
              "2040               0  Pylori-Chek may be used for in vivo diagnosis ...   \n",
              "\n",
              "7    Species ATCvet code      First published        Revision date  \\\n",
              "0        NaN         NaN  2021-05-19 14:14:00  2023-12-04 18:41:00   \n",
              "1        NaN         NaN  2023-07-17 16:27:00  2023-12-04 18:15:00   \n",
              "2        NaN         NaN  2018-01-30 14:10:00  2023-12-04 17:56:00   \n",
              "3        NaN         NaN  2018-05-24 17:15:00  2023-12-04 17:43:00   \n",
              "4        NaN         NaN  2023-02-22 15:05:00  2023-12-04 17:35:00   \n",
              "...      ...         ...                  ...                  ...   \n",
              "2036     NaN         NaN  2001-02-19 01:00:00  2001-08-01 00:00:00   \n",
              "2037     NaN         NaN  2001-01-22 01:00:00  2001-05-22 00:00:00   \n",
              "2038     NaN         NaN  1999-07-30 00:00:00  2000-12-12 01:00:00   \n",
              "2039     NaN         NaN  2000-07-27 00:00:00  2000-12-04 01:00:00   \n",
              "2040     NaN         NaN  2000-07-05 02:00:00  2000-07-17 02:00:00   \n",
              "\n",
              "7                                                   URL  \n",
              "0     https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "1     https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2     https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "3     https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "4     https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "...                                                 ...  \n",
              "2036  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2037  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2038  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2039  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "2040  https://www.ema.europa.eu/en/medicines/human/E...  \n",
              "\n",
              "[1759 rows x 30 columns]"
            ]
          },
          "execution_count": 236,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "df1 = df1.rename(columns={\"Medicine name\": \"name\"})\n",
        "df1 = df1[df1['Category'] == 'Human']\n",
        "df1"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "b526a34b",
      "metadata": {
        "id": "b526a34b",
        "outputId": "ea1da5df-a8dd-4342-dd4e-e7612ce241ed"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Category</th>\n",
              "      <th>name</th>\n",
              "      <th>International non-proprietary name (INN) / common name</th>\n",
              "      <th>Active substance</th>\n",
              "      <th>Product number</th>\n",
              "      <th>Patient safety</th>\n",
              "      <th>Authorisation status</th>\n",
              "      <th>ATC code</th>\n",
              "      <th>Additional monitoring</th>\n",
              "      <th>Generic</th>\n",
              "      <th>...</th>\n",
              "      <th>Decision date</th>\n",
              "      <th>Revision number</th>\n",
              "      <th>Condition / indication</th>\n",
              "      <th>First published</th>\n",
              "      <th>Revision date</th>\n",
              "      <th>URL</th>\n",
              "      <th>therap_area</th>\n",
              "      <th>therapeutic_indication</th>\n",
              "      <th>usage</th>\n",
              "      <th>risk</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Human</td>\n",
              "      <td>Ryeqo</td>\n",
              "      <td>relugolix, estradiol, norethisterone acetate</td>\n",
              "      <td>Relugolix, norethisterone acetate, estradiol h...</td>\n",
              "      <td>EMEA/H/C/005267</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>H01CC54</td>\n",
              "      <td>yes</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-30 01:00:00</td>\n",
              "      <td>6</td>\n",
              "      <td>Ryeqo is indicated in adult women of reproduct...</td>\n",
              "      <td>2021-05-19 14:14:00</td>\n",
              "      <td>2023-12-04 18:41:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Leiomyoma</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Ryeqo used?\\nThe medicine can only be o...</td>\n",
              "      <td>What are the risks associated with Ryeqo?\\nThe...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Human</td>\n",
              "      <td>Yesafili</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>EMEA/H/C/006022</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>S01LA05</td>\n",
              "      <td>yes</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-11-29 01:00:00</td>\n",
              "      <td>1</td>\n",
              "      <td>Yesafili is indicated for adults for the treat...</td>\n",
              "      <td>2023-07-17 16:27:00</td>\n",
              "      <td>2023-12-04 18:15:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Macular Edema\\nRetinal Vein Occlusion\\nDiabeti...</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Yesafili used?\\nYesafili is available a...</td>\n",
              "      <td>What are the risks associated with Yesafili?\\n...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Human</td>\n",
              "      <td>Leflunomide medac</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>EMEA/H/C/001227</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L04AA13</td>\n",
              "      <td>no</td>\n",
              "      <td>yes</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-31 01:00:00</td>\n",
              "      <td>19</td>\n",
              "      <td>Leflunomide is indicated for the treatment of ...</td>\n",
              "      <td>2018-01-30 14:10:00</td>\n",
              "      <td>2023-12-04 17:56:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Arthritis, Rheumatoid</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Leflunomide medac used?\\nLeflunomide me...</td>\n",
              "      <td>What are the benefit and risk of Leflunomide m...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Human</td>\n",
              "      <td>Filgrastim Hexal</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>EMEA/H/C/000918</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L03AA02</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-11-30 01:00:00</td>\n",
              "      <td>24</td>\n",
              "      <td>Reduction in the duration of neutropenia and t...</td>\n",
              "      <td>2018-05-24 17:15:00</td>\n",
              "      <td>2023-12-04 17:43:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Neutropenia\\nHematopoietic Stem Cell Transplan...</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Filgrastim Hexal used?\\nFilgrastim Hexa...</td>\n",
              "      <td>What is the risk associated with Filgrastim He...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Human</td>\n",
              "      <td>Opzelura</td>\n",
              "      <td>ruxolitinib</td>\n",
              "      <td>ruxolitinib phosphate</td>\n",
              "      <td>EMEA/H/C/005843</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>D11AH</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-19 00:00:00</td>\n",
              "      <td>2</td>\n",
              "      <td>Opzelura is indicated for the treatment of non...</td>\n",
              "      <td>2023-02-22 15:05:00</td>\n",
              "      <td>2023-12-04 17:35:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Vitiligo</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Opzelura used?\\nOpzelura can only be ob...</td>\n",
              "      <td>What are the risks associated with Opzelura?\\n...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1662</th>\n",
              "      <td>Human</td>\n",
              "      <td>Kuvan</td>\n",
              "      <td>sapropterin</td>\n",
              "      <td>Sapropterin dihydrochloride</td>\n",
              "      <td>EMEA/H/C/000943</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>A16AX07</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2020-01-16 01:00:00</td>\n",
              "      <td>20</td>\n",
              "      <td>Kuvan is indicated for the treatment of hyperp...</td>\n",
              "      <td>2018-04-12 12:00:00</td>\n",
              "      <td>2020-03-04 18:24:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Phenylketonurias</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Kuvan and what is it used for?\\nKuvan ...</td>\n",
              "      <td>What are the risks associated with Kuvan?\\nThe...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1676</th>\n",
              "      <td>Human</td>\n",
              "      <td>Clopidogrel/Acetylsalicylic acid Zentiva (prev...</td>\n",
              "      <td>clopidogrel, acetylsalicylic acid</td>\n",
              "      <td>clopidogrel, Acetylsalicylic acid</td>\n",
              "      <td>EMEA/H/C/001144</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>B01AC30</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-09-19 00:00:00</td>\n",
              "      <td>22</td>\n",
              "      <td>Acute Coronary SyndromeMyocardial Infarction</td>\n",
              "      <td>2018-01-18 14:41:00</td>\n",
              "      <td>2019-11-13 15:20:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Acute Coronary Syndrome\\nMyocardial Infarction</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Clopidogrel/Acetylsalicylic acid Zenti...</td>\n",
              "      <td>What is the risk associated with Clopidogrel/A...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1682</th>\n",
              "      <td>Human</td>\n",
              "      <td>Savene</td>\n",
              "      <td>dexrazoxane</td>\n",
              "      <td>dexrazoxane hydrochloride</td>\n",
              "      <td>EMEA/H/C/000682</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>V03AF02</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-01-11 01:00:00</td>\n",
              "      <td>14</td>\n",
              "      <td>Savene is indicated for the treatment of anthr...</td>\n",
              "      <td>2018-02-08 01:00:00</td>\n",
              "      <td>2019-10-08 14:50:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Extravasation of Diagnostic and Therapeutic Ma...</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Savene used for?\\nSavene is used to tr...</td>\n",
              "      <td>What is the risk associated with Savene?\\nThe ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1688</th>\n",
              "      <td>Human</td>\n",
              "      <td>Vedrop</td>\n",
              "      <td>tocofersolan</td>\n",
              "      <td>tocofersolan</td>\n",
              "      <td>EMEA/H/C/000920</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>A11HA08</td>\n",
              "      <td>yes</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-05-16 00:00:00</td>\n",
              "      <td>13</td>\n",
              "      <td>Vedrop is indicated in vitamin-E deficiency du...</td>\n",
              "      <td>2018-07-24 00:00:00</td>\n",
              "      <td>2019-08-22 14:10:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Cholestasis\\nVitamin E Deficiency</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Vedrop and what is it used for?\\nVedro...</td>\n",
              "      <td>What are the risks associated with Vedrop?\\nTh...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1697</th>\n",
              "      <td>Human</td>\n",
              "      <td>Wilzin</td>\n",
              "      <td>zinc</td>\n",
              "      <td>zinc</td>\n",
              "      <td>EMEA/H/C/000535</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>A16AX05</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-05-16 00:00:00</td>\n",
              "      <td>11</td>\n",
              "      <td>Treatment of Wilson's disease.</td>\n",
              "      <td>2017-02-14 12:04:00</td>\n",
              "      <td>2019-06-14 16:22:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Hepatolenticular Degeneration</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Wilzin used for?\\nWilzin is used to tr...</td>\n",
              "      <td>What is the risk associated with Wilzin?\\nThe ...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>1340 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "     Category                                               name  \\\n",
              "0       Human                                              Ryeqo   \n",
              "1       Human                                           Yesafili   \n",
              "2       Human                                  Leflunomide medac   \n",
              "3       Human                                   Filgrastim Hexal   \n",
              "4       Human                                           Opzelura   \n",
              "...       ...                                                ...   \n",
              "1662    Human                                              Kuvan   \n",
              "1676    Human  Clopidogrel/Acetylsalicylic acid Zentiva (prev...   \n",
              "1682    Human                                             Savene   \n",
              "1688    Human                                             Vedrop   \n",
              "1697    Human                                             Wilzin   \n",
              "\n",
              "     International non-proprietary name (INN) / common name  \\\n",
              "0          relugolix, estradiol, norethisterone acetate       \n",
              "1                                           aflibercept       \n",
              "2                                           leflunomide       \n",
              "3                                            filgrastim       \n",
              "4                                           ruxolitinib       \n",
              "...                                                 ...       \n",
              "1662                                        sapropterin       \n",
              "1676                  clopidogrel, acetylsalicylic acid       \n",
              "1682                                        dexrazoxane       \n",
              "1688                                       tocofersolan       \n",
              "1697                                               zinc       \n",
              "\n",
              "                                       Active substance   Product number  \\\n",
              "0     Relugolix, norethisterone acetate, estradiol h...  EMEA/H/C/005267   \n",
              "1                                           aflibercept  EMEA/H/C/006022   \n",
              "2                                           leflunomide  EMEA/H/C/001227   \n",
              "3                                            filgrastim  EMEA/H/C/000918   \n",
              "4                                 ruxolitinib phosphate  EMEA/H/C/005843   \n",
              "...                                                 ...              ...   \n",
              "1662                        Sapropterin dihydrochloride  EMEA/H/C/000943   \n",
              "1676                  clopidogrel, Acetylsalicylic acid  EMEA/H/C/001144   \n",
              "1682                          dexrazoxane hydrochloride  EMEA/H/C/000682   \n",
              "1688                                       tocofersolan  EMEA/H/C/000920   \n",
              "1697                                               zinc  EMEA/H/C/000535   \n",
              "\n",
              "     Patient safety Authorisation status ATC code Additional monitoring  \\\n",
              "0                no           Authorised  H01CC54                   yes   \n",
              "1                no           Authorised  S01LA05                   yes   \n",
              "2                no           Authorised  L04AA13                    no   \n",
              "3                no           Authorised  L03AA02                    no   \n",
              "4                no           Authorised    D11AH                    no   \n",
              "...             ...                  ...      ...                   ...   \n",
              "1662             no           Authorised  A16AX07                    no   \n",
              "1676             no           Authorised  B01AC30                    no   \n",
              "1682             no           Authorised  V03AF02                    no   \n",
              "1688             no           Authorised  A11HA08                   yes   \n",
              "1697             no           Authorised  A16AX05                    no   \n",
              "\n",
              "     Generic  ...        Decision date Revision number  \\\n",
              "0         no  ...  2023-10-30 01:00:00               6   \n",
              "1         no  ...  2023-11-29 01:00:00               1   \n",
              "2        yes  ...  2023-10-31 01:00:00              19   \n",
              "3         no  ...  2023-11-30 01:00:00              24   \n",
              "4         no  ...  2023-10-19 00:00:00               2   \n",
              "...      ...  ...                  ...             ...   \n",
              "1662      no  ...  2020-01-16 01:00:00              20   \n",
              "1676      no  ...  2019-09-19 00:00:00              22   \n",
              "1682      no  ...  2019-01-11 01:00:00              14   \n",
              "1688      no  ...  2019-05-16 00:00:00              13   \n",
              "1697      no  ...  2019-05-16 00:00:00              11   \n",
              "\n",
              "                                 Condition / indication      First published  \\\n",
              "0     Ryeqo is indicated in adult women of reproduct...  2021-05-19 14:14:00   \n",
              "1     Yesafili is indicated for adults for the treat...  2023-07-17 16:27:00   \n",
              "2     Leflunomide is indicated for the treatment of ...  2018-01-30 14:10:00   \n",
              "3     Reduction in the duration of neutropenia and t...  2018-05-24 17:15:00   \n",
              "4     Opzelura is indicated for the treatment of non...  2023-02-22 15:05:00   \n",
              "...                                                 ...                  ...   \n",
              "1662  Kuvan is indicated for the treatment of hyperp...  2018-04-12 12:00:00   \n",
              "1676       Acute Coronary SyndromeMyocardial Infarction  2018-01-18 14:41:00   \n",
              "1682  Savene is indicated for the treatment of anthr...  2018-02-08 01:00:00   \n",
              "1688  Vedrop is indicated in vitamin-E deficiency du...  2018-07-24 00:00:00   \n",
              "1697                     Treatment of Wilson's disease.  2017-02-14 12:04:00   \n",
              "\n",
              "            Revision date                                                URL  \\\n",
              "0     2023-12-04 18:41:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1     2023-12-04 18:15:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "2     2023-12-04 17:56:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "3     2023-12-04 17:43:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "4     2023-12-04 17:35:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "...                   ...                                                ...   \n",
              "1662  2020-03-04 18:24:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1676  2019-11-13 15:20:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1682  2019-10-08 14:50:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1688  2019-08-22 14:10:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1697  2019-06-14 16:22:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "\n",
              "                                            therap_area  \\\n",
              "0                                             Leiomyoma   \n",
              "1     Macular Edema\\nRetinal Vein Occlusion\\nDiabeti...   \n",
              "2                                 Arthritis, Rheumatoid   \n",
              "3     Neutropenia\\nHematopoietic Stem Cell Transplan...   \n",
              "4                                              Vitiligo   \n",
              "...                                                 ...   \n",
              "1662                                   Phenylketonurias   \n",
              "1676     Acute Coronary Syndrome\\nMyocardial Infarction   \n",
              "1682  Extravasation of Diagnostic and Therapeutic Ma...   \n",
              "1688                  Cholestasis\\nVitamin E Deficiency   \n",
              "1697                      Hepatolenticular Degeneration   \n",
              "\n",
              "                                 therapeutic_indication  \\\n",
              "0     Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1     Therapeutic indication\\nKirsty is indicated fo...   \n",
              "2     Therapeutic indication\\nKirsty is indicated fo...   \n",
              "3     Therapeutic indication\\nKirsty is indicated fo...   \n",
              "4     Therapeutic indication\\nKirsty is indicated fo...   \n",
              "...                                                 ...   \n",
              "1662  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1676  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1682  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1688  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1697  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "\n",
              "                                                  usage  \\\n",
              "0     How is Ryeqo used?\\nThe medicine can only be o...   \n",
              "1     How is Yesafili used?\\nYesafili is available a...   \n",
              "2     How is Leflunomide medac used?\\nLeflunomide me...   \n",
              "3     How is Filgrastim Hexal used?\\nFilgrastim Hexa...   \n",
              "4     How is Opzelura used?\\nOpzelura can only be ob...   \n",
              "...                                                 ...   \n",
              "1662  What is Kuvan and what is it used for?\\nKuvan ...   \n",
              "1676  What is Clopidogrel/Acetylsalicylic acid Zenti...   \n",
              "1682  What is Savene used for?\\nSavene is used to tr...   \n",
              "1688  What is Vedrop and what is it used for?\\nVedro...   \n",
              "1697  What is Wilzin used for?\\nWilzin is used to tr...   \n",
              "\n",
              "                                                   risk  \n",
              "0     What are the risks associated with Ryeqo?\\nThe...  \n",
              "1     What are the risks associated with Yesafili?\\n...  \n",
              "2     What are the benefit and risk of Leflunomide m...  \n",
              "3     What is the risk associated with Filgrastim He...  \n",
              "4     What are the risks associated with Opzelura?\\n...  \n",
              "...                                                 ...  \n",
              "1662  What are the risks associated with Kuvan?\\nThe...  \n",
              "1676  What is the risk associated with Clopidogrel/A...  \n",
              "1682  What is the risk associated with Savene?\\nThe ...  \n",
              "1688  What are the risks associated with Vedrop?\\nTh...  \n",
              "1697  What is the risk associated with Wilzin?\\nThe ...  \n",
              "\n",
              "[1340 rows x 30 columns]"
            ]
          },
          "execution_count": 237,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "fulldf = df1.join(ndf.set_index('name'), on='name')\n",
        "fulldf = fulldf.drop(['active_substance', 'common_name','Therapeutic area', 'medicamentLink'], axis=1)\n",
        "fulldf = fulldf.dropna(axis=1, how='all')\n",
        "fulldf = fulldf.dropna(axis=0, how='all')\n",
        "fulldf = fulldf[fulldf['usage'].notna()]\n",
        "fulldf = fulldf[fulldf['Authorisation status'] == 'Authorised']\n",
        "fulldf"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "64955147",
      "metadata": {
        "id": "64955147"
      },
      "outputs": [],
      "source": [
        "fulldf.to_csv('EMAdataEn2.csv', index=False)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "aa693351",
      "metadata": {
        "id": "aa693351"
      },
      "outputs": [],
      "source": [
        "fulldf = pd.read_csv('EMAdataEn2.csv')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "b928b3f8",
      "metadata": {
        "id": "b928b3f8",
        "outputId": "d37a1f12-034d-42a1-f2e4-17305434b04e"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Category</th>\n",
              "      <th>name</th>\n",
              "      <th>International non-proprietary name (INN) / common name</th>\n",
              "      <th>Active substance</th>\n",
              "      <th>Product number</th>\n",
              "      <th>Patient safety</th>\n",
              "      <th>Authorisation status</th>\n",
              "      <th>ATC code</th>\n",
              "      <th>Additional monitoring</th>\n",
              "      <th>Generic</th>\n",
              "      <th>...</th>\n",
              "      <th>Decision date</th>\n",
              "      <th>Revision number</th>\n",
              "      <th>Condition / indication</th>\n",
              "      <th>First published</th>\n",
              "      <th>Revision date</th>\n",
              "      <th>URL</th>\n",
              "      <th>therap_area</th>\n",
              "      <th>therapeutic_indication</th>\n",
              "      <th>usage</th>\n",
              "      <th>risk</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Human</td>\n",
              "      <td>Ryeqo</td>\n",
              "      <td>relugolix, estradiol, norethisterone acetate</td>\n",
              "      <td>Relugolix, norethisterone acetate, estradiol h...</td>\n",
              "      <td>EMEA/H/C/005267</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>H01CC54</td>\n",
              "      <td>yes</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-30 01:00:00</td>\n",
              "      <td>6.0</td>\n",
              "      <td>Ryeqo is indicated in adult women of reproduct...</td>\n",
              "      <td>2021-05-19 14:14:00</td>\n",
              "      <td>2023-12-04 18:41:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Leiomyoma</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Ryeqo used?\\nThe medicine can only be o...</td>\n",
              "      <td>What are the risks associated with Ryeqo?\\nThe...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Human</td>\n",
              "      <td>Yesafili</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>EMEA/H/C/006022</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>S01LA05</td>\n",
              "      <td>yes</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-11-29 01:00:00</td>\n",
              "      <td>1.0</td>\n",
              "      <td>Yesafili is indicated for adults for the treat...</td>\n",
              "      <td>2023-07-17 16:27:00</td>\n",
              "      <td>2023-12-04 18:15:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Macular Edema\\nRetinal Vein Occlusion\\nDiabeti...</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Yesafili used?\\nYesafili is available a...</td>\n",
              "      <td>What are the risks associated with Yesafili?\\n...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Human</td>\n",
              "      <td>Leflunomide medac</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>EMEA/H/C/001227</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L04AA13</td>\n",
              "      <td>no</td>\n",
              "      <td>yes</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-31 01:00:00</td>\n",
              "      <td>19.0</td>\n",
              "      <td>Leflunomide is indicated for the treatment of ...</td>\n",
              "      <td>2018-01-30 14:10:00</td>\n",
              "      <td>2023-12-04 17:56:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Arthritis, Rheumatoid</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Leflunomide medac used?\\nLeflunomide me...</td>\n",
              "      <td>What are the benefit and risk of Leflunomide m...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Human</td>\n",
              "      <td>Filgrastim Hexal</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>EMEA/H/C/000918</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L03AA02</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-11-30 01:00:00</td>\n",
              "      <td>24.0</td>\n",
              "      <td>Reduction in the duration of neutropenia and t...</td>\n",
              "      <td>2018-05-24 17:15:00</td>\n",
              "      <td>2023-12-04 17:43:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Neutropenia\\nHematopoietic Stem Cell Transplan...</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Filgrastim Hexal used?\\nFilgrastim Hexa...</td>\n",
              "      <td>What is the risk associated with Filgrastim He...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Human</td>\n",
              "      <td>Opzelura</td>\n",
              "      <td>ruxolitinib</td>\n",
              "      <td>ruxolitinib phosphate</td>\n",
              "      <td>EMEA/H/C/005843</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>D11AH</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-19 00:00:00</td>\n",
              "      <td>2.0</td>\n",
              "      <td>Opzelura is indicated for the treatment of non...</td>\n",
              "      <td>2023-02-22 15:05:00</td>\n",
              "      <td>2023-12-04 17:35:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Vitiligo</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Opzelura used?\\nOpzelura can only be ob...</td>\n",
              "      <td>What are the risks associated with Opzelura?\\n...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "  Category               name  \\\n",
              "0    Human              Ryeqo   \n",
              "1    Human           Yesafili   \n",
              "2    Human  Leflunomide medac   \n",
              "3    Human   Filgrastim Hexal   \n",
              "4    Human           Opzelura   \n",
              "\n",
              "  International non-proprietary name (INN) / common name  \\\n",
              "0       relugolix, estradiol, norethisterone acetate       \n",
              "1                                        aflibercept       \n",
              "2                                        leflunomide       \n",
              "3                                         filgrastim       \n",
              "4                                        ruxolitinib       \n",
              "\n",
              "                                    Active substance   Product number  \\\n",
              "0  Relugolix, norethisterone acetate, estradiol h...  EMEA/H/C/005267   \n",
              "1                                        aflibercept  EMEA/H/C/006022   \n",
              "2                                        leflunomide  EMEA/H/C/001227   \n",
              "3                                         filgrastim  EMEA/H/C/000918   \n",
              "4                              ruxolitinib phosphate  EMEA/H/C/005843   \n",
              "\n",
              "  Patient safety Authorisation status ATC code Additional monitoring Generic  \\\n",
              "0             no           Authorised  H01CC54                   yes      no   \n",
              "1             no           Authorised  S01LA05                   yes      no   \n",
              "2             no           Authorised  L04AA13                    no     yes   \n",
              "3             no           Authorised  L03AA02                    no      no   \n",
              "4             no           Authorised    D11AH                    no      no   \n",
              "\n",
              "   ...        Decision date Revision number  \\\n",
              "0  ...  2023-10-30 01:00:00             6.0   \n",
              "1  ...  2023-11-29 01:00:00             1.0   \n",
              "2  ...  2023-10-31 01:00:00            19.0   \n",
              "3  ...  2023-11-30 01:00:00            24.0   \n",
              "4  ...  2023-10-19 00:00:00             2.0   \n",
              "\n",
              "                              Condition / indication      First published  \\\n",
              "0  Ryeqo is indicated in adult women of reproduct...  2021-05-19 14:14:00   \n",
              "1  Yesafili is indicated for adults for the treat...  2023-07-17 16:27:00   \n",
              "2  Leflunomide is indicated for the treatment of ...  2018-01-30 14:10:00   \n",
              "3  Reduction in the duration of neutropenia and t...  2018-05-24 17:15:00   \n",
              "4  Opzelura is indicated for the treatment of non...  2023-02-22 15:05:00   \n",
              "\n",
              "         Revision date                                                URL  \\\n",
              "0  2023-12-04 18:41:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1  2023-12-04 18:15:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "2  2023-12-04 17:56:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "3  2023-12-04 17:43:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "4  2023-12-04 17:35:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "\n",
              "                                         therap_area  \\\n",
              "0                                          Leiomyoma   \n",
              "1  Macular Edema\\nRetinal Vein Occlusion\\nDiabeti...   \n",
              "2                              Arthritis, Rheumatoid   \n",
              "3  Neutropenia\\nHematopoietic Stem Cell Transplan...   \n",
              "4                                           Vitiligo   \n",
              "\n",
              "                              therapeutic_indication  \\\n",
              "0  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "2  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "3  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "4  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "\n",
              "                                               usage  \\\n",
              "0  How is Ryeqo used?\\nThe medicine can only be o...   \n",
              "1  How is Yesafili used?\\nYesafili is available a...   \n",
              "2  How is Leflunomide medac used?\\nLeflunomide me...   \n",
              "3  How is Filgrastim Hexal used?\\nFilgrastim Hexa...   \n",
              "4  How is Opzelura used?\\nOpzelura can only be ob...   \n",
              "\n",
              "                                                risk  \n",
              "0  What are the risks associated with Ryeqo?\\nThe...  \n",
              "1  What are the risks associated with Yesafili?\\n...  \n",
              "2  What are the benefit and risk of Leflunomide m...  \n",
              "3  What is the risk associated with Filgrastim He...  \n",
              "4  What are the risks associated with Opzelura?\\n...  \n",
              "\n",
              "[5 rows x 30 columns]"
            ]
          },
          "execution_count": 17,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "fulldf.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "d33803dd",
      "metadata": {
        "id": "d33803dd",
        "outputId": "fb946282-18fd-4215-932f-9c0b96bd27c4"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting deep-translator\n",
            "  Downloading deep_translator-1.11.4-py3-none-any.whl (42 kB)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.23.0 in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from deep-translator) (2.27.1)\n",
            "Requirement already satisfied: beautifulsoup4<5.0.0,>=4.9.1 in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from deep-translator) (4.11.1)\n",
            "Requirement already satisfied: soupsieve>1.2 in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from beautifulsoup4<5.0.0,>=4.9.1->deep-translator) (2.3.1)\n",
            "Requirement already satisfied: urllib3<1.27,>=1.21.1 in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from requests<3.0.0,>=2.23.0->deep-translator) (1.26.9)\n",
            "Requirement already satisfied: charset-normalizer~=2.0.0 in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from requests<3.0.0,>=2.23.0->deep-translator) (2.0.4)\n",
            "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from requests<3.0.0,>=2.23.0->deep-translator) (2.10)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from requests<3.0.0,>=2.23.0->deep-translator) (2021.10.8)\n",
            "Installing collected packages: deep-translator\n",
            "Successfully installed deep-translator-1.11.4\n"
          ]
        }
      ],
      "source": [
        "!pip install -U deep-translator"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "c79993ec",
      "metadata": {
        "id": "c79993ec"
      },
      "outputs": [],
      "source": [
        "from deep_translator import GoogleTranslator"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "76313ed2",
      "metadata": {
        "id": "76313ed2",
        "outputId": "9ac779bd-0989-46f5-8797-c04c8fd990f8"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "'Bonne journée'"
            ]
          },
          "execution_count": 6,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "GoogleTranslator(source='auto', target='fr').translate(\"guten Tag\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "d9193dae",
      "metadata": {
        "id": "d9193dae",
        "outputId": "3105f07c-22c4-4e03-da7c-14c4e5ebaadf"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "Index(['Catégorie', 'nom',\n",
              "       'Dénomination commune internationale (DCI) / nom commun',\n",
              "       'Substance active', 'Numéro de produit', 'Sécurité du patient',\n",
              "       'Statut d'autorisation', 'Code ATC', 'Surveillance supplémentaire',\n",
              "       'Générique', 'Biosimilaire', 'Approbation conditionnelle',\n",
              "       'Circonstances exceptionnelles', 'Évaluation accélérée',\n",
              "       'Médecine orpheline', 'Date de l'autorisation de mise sur le marché',\n",
              "       'Date de refus d'autorisation de mise sur le marché',\n",
              "       'Titulaire de l'autorisation de mise sur le marché/nom de l'entreprise',\n",
              "       'Groupe pharmacothérapeutique humain', 'Date de l'avis',\n",
              "       'Date de décision', 'Numéro de révision', 'État/indication',\n",
              "       'Première publication', 'Date de révision', 'URL', 'zone_thérapeutique',\n",
              "       'indication_thérapeutique', 'usage', 'risque'],\n",
              "      dtype='object')"
            ]
          },
          "execution_count": 64,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "fulldf1 = fulldf.copy()\n",
        "fulldf1['Condition / indication'] = fulldf1['Condition / indication'].astype('str')\n",
        "translator = GoogleTranslator(source='auto', target='fr')\n",
        "\n",
        "# translate columns' name using rename function\n",
        "fulldf1.rename(columns=lambda x: translator.translate(x), inplace=True)\n",
        "\n",
        "# translated column names\n",
        "fulldf1.columns"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "7b63570d",
      "metadata": {
        "id": "7b63570d",
        "outputId": "27a4f5df-a681-48e0-a6fe-310615072a0c"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: nltk in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (3.7)\n",
            "Requirement already satisfied: joblib in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from nltk) (1.3.2)\n",
            "Requirement already satisfied: regex>=2021.8.3 in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from nltk) (2022.3.15)\n",
            "Requirement already satisfied: tqdm in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from nltk) (4.64.0)\n",
            "Requirement already satisfied: click in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from nltk) (8.0.4)\n",
            "Requirement already satisfied: colorama in c:\\users\\bmd tech\\anaconda3\\lib\\site-packages (from click->nltk) (0.4.4)\n"
          ]
        }
      ],
      "source": [
        "!pip install nltk"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "fc275772",
      "metadata": {
        "id": "fc275772",
        "outputId": "e973dae4-8f6d-4aa5-8c74-71275ffecb1b"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "Index(['Catégorie', 'nom', 'Substance active', 'Numéro de produit',\n",
              "       'Sécurité du patient', 'Statut d'autorisation',\n",
              "       'Surveillance supplémentaire', 'Générique', 'Biosimilaire',\n",
              "       'Approbation conditionnelle', 'Circonstances exceptionnelles',\n",
              "       'Évaluation accélérée', 'Médecine orpheline', 'Première publication',\n",
              "       'URL', 'zone_thérapeutique', 'indication_thérapeutique', 'usage',\n",
              "       'risque', 'État/indication'],\n",
              "      dtype='object')"
            ]
          },
          "execution_count": 53,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "col = (fulldf1.applymap(type) == str).all(0)\n",
        "d1f = fulldf1.loc[: , col]\n",
        "d1f.columns"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "42668463",
      "metadata": {
        "id": "42668463",
        "outputId": "c4da6d14-14a1-4f40-cb63-5ee1a65a5a1f"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "IOPub data rate exceeded.\n",
            "The notebook server will temporarily stop sending output\n",
            "to the client in order to avoid crashing it.\n",
            "To change this limit, set the config variable\n",
            "`--NotebookApp.iopub_data_rate_limit`.\n",
            "\n",
            "Current values:\n",
            "NotebookApp.iopub_data_rate_limit=1000000.0 (bytes/sec)\n",
            "NotebookApp.rate_limit_window=3.0 (secs)\n",
            "\n"
          ]
        }
      ],
      "source": [
        "import nltk\n",
        "\n",
        "translations = {}\n",
        "col = (fulldf1.applymap(type) == str).all(0)\n",
        "d1f = fulldf1.loc[: , col]\n",
        "for column in d1f.columns:\n",
        "    # unique elements of the column\n",
        "    unique_elements = d1f[column].unique()\n",
        "    for element in unique_elements:\n",
        "        if len(element)<5000:\n",
        "            # add translation to the dictionary\n",
        "            translations[element] = translator.translate(element)\n",
        "\n",
        "        else:\n",
        "            x = nltk.tokenize.sent_tokenize(element)\n",
        "            sentences = []\n",
        "            for sentence in x:\n",
        "                sentence = translator.translate(sentence)\n",
        "                sentences.append(sentence)\n",
        "                translations[element] = sentences\n",
        "\n",
        "print(translations)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "d9ba6b32",
      "metadata": {
        "id": "d9ba6b32",
        "outputId": "7340992c-e9e1-42eb-9e9d-c93c2605696d"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "{'Humain': 'Humain',\n",
              " 'Ryeqo': 'Ryeqo',\n",
              " 'Des safili': 'Des safili',\n",
              " 'Léflunomide médicament': 'Léflunomide médicament',\n",
              " 'Filgrastim Hexal': 'Filgrastim Hexal',\n",
              " 'Opzelura': 'Opzelura',\n",
              " 'Ziextenzo': 'Ziextenzo',\n",
              " 'Découper': 'Découper',\n",
              " 'Lévitra': 'Lévitra',\n",
              " 'Rilutek': 'Rilutek',\n",
              " 'Clopidogrel Krka': 'Clopidogrel Krka',\n",
              " 'Hycamtine': 'Hycamtine',\n",
              " 'Pylobactell': 'Pylobactell',\n",
              " 'Fulphila': 'Fulphila',\n",
              " 'Orladeyo': 'Orladeyo',\n",
              " 'Semglee': 'Semglee',\n",
              " 'Ogivri': 'Ogivri',\n",
              " 'Kirsty (anciennement Kixelle)': 'Kirsty (anciennement Kixelle)',\n",
              " 'Juillet': 'Juillet',\n",
              " 'Dovprela (anciennement Prétomanide FGK)': 'Dovprela (anciennement Prétomanide FGK)',\n",
              " 'Tu rattraperas': 'Tu rattraperas',\n",
              " 'Otezla': 'Otezla',\n",
              " 'Plavix': 'Plavix',\n",
              " 'Cialis': 'Cialis',\n",
              " 'Ozawadé': 'Ozawadé',\n",
              " 'Ocaliva': 'Ocaliva',\n",
              " 'Praluent': 'Praluent',\n",
              " 'Xélévia': 'Xélévia',\n",
              " 'Rubraca': 'Rubraca',\n",
              " 'Calydité': 'Calydité',\n",
              " 'Inaqovi': 'Inaqovi',\n",
              " 'Yuflyma': 'Yuflyma',\n",
              " 'Tu avais du vent': 'Tu avais du vent',\n",
              " 'Soliris': 'Soliris',\n",
              " 'Thalidomide BMS (anciennement Thalidomide Celgene)': 'Thalidomide BMS (anciennement Thalidomide Celgene)',\n",
              " 'Abevmy': 'Abevmy',\n",
              " 'Evusheld': 'Evusheld',\n",
              " 'Neuraceq': 'Neuraceq',\n",
              " 'Pylclari': 'Pylclari',\n",
              " 'Xolair': 'Xolair',\n",
              " 'Omidrie': 'Omidrie',\n",
              " 'devenir plus fort': 'devenir plus fort',\n",
              " 'Pépaxti': 'Pépaxti',\n",
              " 'Nuceiva': 'Nuceiva',\n",
              " 'Trumenba': 'Trumenba',\n",
              " 'Rihimio': 'Lihimio',\n",
              " 'Blitzima': 'Blitzima',\n",
              " 'Rixathon': 'Rixathon',\n",
              " 'Orgovykh': 'Orgovykh',\n",
              " 'Trizivir': 'Trizivir',\n",
              " 'Trixeo Aérosphère': 'Trixeo Aérosphère',\n",
              " 'Slényto': 'Slényto',\n",
              " 'Truxima': 'Truxima',\n",
              " 'Ruxience': 'Ruxience',\n",
              " 'Annoncer': 'Annoncer',\n",
              " 'MabThera': 'MabThera',\n",
              " 'Vyvgart': 'Vyvgart',\n",
              " 'Aérosphère de Riltrava': 'Aérosphère de Riltrava',\n",
              " 'Pirfénidone Viatris': 'Pirfénidone Viatris',\n",
              " 'Zesly': 'Zesly',\n",
              " 'Cyramza': 'Cyramza',\n",
              " 'Pravafénix': 'Pravafenix',\n",
              " 'Técartus': 'Técartlus',\n",
              " 'Orserdu': 'Orserdu',\n",
              " 'Triumeq': 'Triumeq',\n",
              " 'Dans la pluie': 'Dans la pluie',\n",
              " 'Prévenir 13': 'Prévenir 13',\n",
              " 'Kivexa': 'Kivexa',\n",
              " 'Apexnar': 'Apexnar',\n",
              " 'Tasigna': 'Tasigna',\n",
              " 'Co-organisé': 'Co-organisé',\n",
              " 'Holoclar': 'Holoclar',\n",
              " 'Bétaféron': 'Bétaféron',\n",
              " 'Emtricitabine/Ténofovir disoproxil Zentiva': 'Emtricitabine/Ténofovir disoproxil Zentiva',\n",
              " 'Pradaxa': 'Pradaxa',\n",
              " 'Zabdène': 'Zabden',\n",
              " \"S'habiller\": \"S'habiller\",\n",
              " 'Blincyto': 'Blincyto',\n",
              " 'Ebglyss': 'Ebglyss',\n",
              " 'Carmustine medac (anciennement Carmustine Obvius)': 'Carmustine medac (anciennement Carmustine Obvius)',\n",
              " 'Symkev': 'Symkev',\n",
              " 'Toujeo (anciennement Optisulin)': 'Toujeo (anciennement Optisulin)',\n",
              " 'Talvey': 'Talvey',\n",
              " 'Voxzogo': 'Voxzogo',\n",
              " 'Herwenda': 'Herwenda',\n",
              " 'Prégabaline Sandoz': 'Prégabaline Sandoz',\n",
              " 'Takhzyro': 'Takhzyro',\n",
              " 'Agumedi': 'Agumedi',\n",
              " 'Spikevax (anciennement COVID-19 Vaccine Moderna)': 'Spikevax (anciennement COVID-19 Vaccine Moderna)',\n",
              " 'Gavreto': 'Gavreto',\n",
              " 'Époétine Alfa Hexal': 'Époétine Alfa Hexal',\n",
              " 'Binocrite': 'Binocrite',\n",
              " 'Prometax': 'Prometax',\n",
              " 'Fetcro': 'Fetcro',\n",
              " 'Respect': 'Respect',\n",
              " 'Olluminant': 'Ils brillent',\n",
              " 'Résout': 'Résout',\n",
              " 'Ninlaro': 'Ninlaro',\n",
              " 'Vanflyta': 'Vanflyta',\n",
              " 'Exjade': 'Exjade',\n",
              " 'Espérer': 'Espérer',\n",
              " 'Tepmetka': 'Tepmetka',\n",
              " 'Vyxeos liposomal (anciennement connu sous le nom de Vyxeos)': 'Vyxeos liposomal (anciennement connu sous le nom de Vyxeos)',\n",
              " 'Kisqali': 'Kisqali',\n",
              " 'Spectrile': 'Spectrile',\n",
              " 'Obizur': 'Obizur',\n",
              " 'Tysabri': 'Tysabri',\n",
              " 'Nordimet': 'Nordimet',\n",
              " 'Pégasys': 'Pégasys',\n",
              " 'Ozurdex': 'Ozurdex',\n",
              " 'Scratch': 'Gratter',\n",
              " 'Éfavirenz/Emtricitabine/Ténofovir disoproxil Mylan': 'Éfavirenz/Emtricitabine/Ténofovir Disoproxil Mylan',\n",
              " 'Tagrisso': 'Tagrisso',\n",
              " 'Résumé': 'CV',\n",
              " 'Darzalex': 'Darzalex',\n",
              " 'Revatio': 'Revatio',\n",
              " \"L'Iowa\": \"L'Iowa\",\n",
              " 'Jaypirca': 'Jaypirca',\n",
              " 'Suboxone': 'Suboxone',\n",
              " 'Vyepti': 'Vyepti',\n",
              " 'Leqvi': 'Leqvi',\n",
              " 'Posaconazole AHCL': 'Posaconazole AHCL',\n",
              " 'Gazyvaro': 'Gazyvaro',\n",
              " 'Wakix': 'Wakix',\n",
              " 'de Tyr': 'ils sont Taureau',\n",
              " 'Mylotarg': 'Mylotarg',\n",
              " 'Kauliv': 'Kauliv',\n",
              " 'Enbrel': 'Enbrel',\n",
              " 'Lumykras': 'Lumykras',\n",
              " 'Glivec': 'Glivec',\n",
              " 'Briviact (en Italie : Nubriveo)': 'Briviact (en Italie : Nubriveo)',\n",
              " 'Tecentriq': 'Tecentriq',\n",
              " 'Artésunate Amivas': 'Artésunate Amivas',\n",
              " 'Vargatef': 'Vargatef',\n",
              " 'Symphonie': 'Symphonie',\n",
              " 'Bimzelx': 'Bimzelx',\n",
              " 'Livmarli': 'Livmarli',\n",
              " 'Mouvement': 'Mouvement',\n",
              " 'Sildénafil Actavis': 'Sildénafil Actavis',\n",
              " 'Cresemba': 'Cresemba',\n",
              " 'Xeljanz': 'Xeljanz',\n",
              " 'Ocrévus': 'Ocrévus',\n",
              " 'Entyvio': 'Entyvio',\n",
              " 'Silodosine rappelée': 'Silodosine rappelée',\n",
              " 'Lunsumio': 'Lunsumio',\n",
              " 'Skyrizi': 'Skyrizi',\n",
              " 'Zirabev': 'Zirabev',\n",
              " 'Lonquex': 'Lonquex',\n",
              " 'Velmétia': 'Velmétia',\n",
              " 'Oyavas': 'Oyavas',\n",
              " 'Talmanco (anciennement Tadalafil Generics)': 'Talmanco (anciennement Tadalafil Generics)',\n",
              " 'Zokinvy': 'Zokinvy',\n",
              " 'Vdéfendre': 'Vdéfendre',\n",
              " 'Nuvaxovid': 'Nuvaxovid',\n",
              " 'VidPrevtyn bêta': 'VidPrevtyn bêta',\n",
              " 'Pistolet Ellipta': 'Pistolet Ellipta',\n",
              " 'Fasenra': 'Fasenra',\n",
              " 'Degarelix Accord': 'Degarelix Accord',\n",
              " 'Rizmoïque': 'Rizmoïque',\n",
              " 'Vimpat': 'Vimpat',\n",
              " 'Zéjula': 'Elle a bâillé',\n",
              " 'Xospata': 'Xospata',\n",
              " 'Lacosamide UCB': 'Lacosamide UCB',\n",
              " 'Il a avalé': 'Il a avalé',\n",
              " 'Préhébreu': 'Pré-hébreu',\n",
              " 'Zutectra': 'Zutectra',\n",
              " 'Idacio': 'Idacio',\n",
              " 'Réfixie': 'Refixé',\n",
              " 'Imnovid (anciennement Pomalidomide Celgene)': 'Imnovid (anciennement Pomalidomide Celgene)',\n",
              " 'Lojuxta': 'Lojuxta',\n",
              " 'Flebogamma DIF (anciennement Flebogammadif)': 'Flebogamma DIF (anciennement Flebogammadif)',\n",
              " 'Skytrofa (anciennement Lonapegsomatropin Ascendis Pharma)': 'Skytrofa (anciennement Lonapegsomatropin Ascendis Pharma)',\n",
              " 'Mobile': 'Mobile',\n",
              " 'Tavnéos': 'Tavnéos',\n",
              " 'Calquence': 'Calquence',\n",
              " 'CoAprovel': 'CoAprovel',\n",
              " 'Champix': 'Champix',\n",
              " 'Venclyxto': 'Venclyxto',\n",
              " 'Comirnaty': 'Comirnaty',\n",
              " 'Prunes': 'Pruneaux',\n",
              " 'Fycompa': 'Fycompa',\n",
              " 'Benlysta': 'Benlysta',\n",
              " 'Keytruda': 'Keytruda',\n",
              " 'Karvéside': 'Karvéside',\n",
              " 'Ouicarta': 'Ouicarta',\n",
              " 'Sprycel': 'Sprycel',\n",
              " 'Xofigo': 'Xofigo',\n",
              " 'Tecvayli': 'Tecvayli',\n",
              " 'Trelegy Ellipta': 'Trelegy Ellipta',\n",
              " 'Raxone': 'Raxone',\n",
              " 'Opdivo': 'Opdivo',\n",
              " 'Élébrato Ellipta': 'Élébrato Ellipta',\n",
              " 'Adtralza': 'Adtralza',\n",
              " 'Advagraf': 'Advagraf',\n",
              " 'Lemtrada': 'Lemtrada',\n",
              " 'Accord Pémétrexed': 'Accord Pémétrexed',\n",
              " 'Emselex': 'Emselex',\n",
              " 'Qarziba (anciennement Dinutuximab Beta USA et Dinutuximab Beta Apeiron)': 'Qarziba (anciennement Dinutuximab Beta USA et Dinutuximab Beta Apeiron)',\n",
              " 'Simulect': 'Simulect',\n",
              " 'Coup de cœur de la ville': 'Coup de cœur de la ville',\n",
              " 'Rude': 'Grossier',\n",
              " 'Mounjaro': 'Mounjaro',\n",
              " 'Récupérez la boîte': 'Récupérez la boîte',\n",
              " 'Défitel': 'Défitel',\n",
              " 'Pedmarqsi': 'Pedmarqsi',\n",
              " 'Blenrep': 'Blenrep',\n",
              " 'Norvir': 'Norvir',\n",
              " 'Actelsar HCT': 'Actelsar HCT',\n",
              " 'Telmisartan Actavis': 'Telmisartan Actavis',\n",
              " 'Prolia': 'Prolia',\n",
              " 'Heplisav B': 'Heplisav B',\n",
              " 'Brintellix': 'Brintellix',\n",
              " 'Halaven': 'Halaven',\n",
              " 'Thiotèpa Riemser': 'Thiotèpa Riemser',\n",
              " 'Prialt': 'Prialt',\n",
              " 'Neulasta': 'Neulasta',\n",
              " 'Alli (anciennement Orlistat GSK)': 'Alli (anciennement Orlistat GSK)',\n",
              " 'Revlimid': 'Revlimid',\n",
              " 'Fintépla': 'Pomme de terre fine',\n",
              " 'Mavenclad': 'Mavenclad',\n",
              " 'Sunosi': 'Sunosi',\n",
              " 'Instantyl': 'Instantyl',\n",
              " 'Kalétra': 'Kalétra',\n",
              " 'Cancidas (anciennement Caspofungin MSD)': 'Cancidas (anciennement Caspofungin MSD)',\n",
              " 'Lytgobi': 'Lytgobi',\n",
              " 'Paxlovide': 'Paxlovide',\n",
              " 'Veklury': 'Veklury',\n",
              " 'GHRYVELIN (anciennement Macimorelin Aeterna Zentaris)': 'GHRYVELIN (anciennement Macimorelin Aeterna Zentaris)',\n",
              " 'Briumvi': 'Briumvi',\n",
              " 'Zolgensma': 'Zolgensma',\n",
              " 'Modigraf': 'Modigraf',\n",
              " 'Myalepta': 'Myalepta',\n",
              " 'Armisarte (anciennement Pemetrexed Actavis)': 'Armisarte (anciennement Pemetrexed Actavis)',\n",
              " 'Filsuvez': 'Filsuvez',\n",
              " 'Xéplion': 'Xéplion',\n",
              " 'Zimbus Breezhaler': 'Zimbus Breezhaler',\n",
              " 'Atectura Breezhaler': 'Atectura Breezhaler',\n",
              " 'RoActemra': 'RoActemra',\n",
              " 'Yervoy': 'Yervoy',\n",
              " 'Enerzair Breezhaler': 'Enerzair Breezhaler',\n",
              " 'Bemrist Breezhaler': 'Bemrist Breezhaler',\n",
              " 'Ranivisio': 'Ranivisio',\n",
              " 'Xevudy': 'Xevudy',\n",
              " 'Farydak': 'Farydak',\n",
              " 'De Cambys': 'De Cambys',\n",
              " 'Lacosamide Adroiq': 'Lacosamide Adroiq',\n",
              " 'Les plénières': 'Les plénières',\n",
              " 'Sugammadex Adroiq': 'Sugammadex Adroiq',\n",
              " 'Spinraza': 'Spinraza',\n",
              " 'Accord sur le rivaroxaban': 'Accord sur le rivaroxaban',\n",
              " 'cometriq': 'commettre',\n",
              " 'Breyanzi': 'Breyanzi',\n",
              " 'Alofisel': 'Alofisel',\n",
              " 'Déchets': 'Déchets',\n",
              " 'Synagogue': 'Synagogue',\n",
              " 'Jcovden (anciennement COVID-19 Vaccine Janssen)': 'Jcovden (anciennement COVID-19 Vaccine Janssen)',\n",
              " 'Lisse': 'Lisse',\n",
              " 'Saphnélo': 'Saphnélo',\n",
              " 'Tévimbra': 'Erreur',\n",
              " 'Zubsolv': 'Zubsolv',\n",
              " 'Dupicent': 'Dupicent',\n",
              " 'Reblozyl': 'Reblozyl',\n",
              " 'Tezspire': 'Tezspire',\n",
              " 'Bortézomib Hospira': 'Bortézomib Hospira',\n",
              " 'Rybelsus': 'Rybelsus',\n",
              " 'Lucentis': 'Lucentis',\n",
              " 'GONAL-f': 'GONAL-f',\n",
              " 'Vaxchora': 'Vaxchora',\n",
              " 'Aldurazyme': 'Aldurazyme',\n",
              " 'Rems': 'Rems',\n",
              " 'Azacitidine Mylan': 'Azacitidine Mylan',\n",
              " 'Saxenda': 'Saxenda',\n",
              " 'Tepkinly': 'Tepkinly',\n",
              " 'Enrylaze': 'Enrylaze',\n",
              " 'Kimmtrak': 'Kimmtrak',\n",
              " 'Colorespirer': 'Colorespirer',\n",
              " 'Vantavo (anciennement Alendronate sodique et colécalciférol, MSD)': 'Vantavo (anciennement Alendronate sodique et colécalciférol, MSD)',\n",
              " 'Fosavance': 'Fosavance',\n",
              " 'Cholib': 'Cholib',\n",
              " 'Zarzio': 'Zarzio',\n",
              " 'Avance': 'Avance',\n",
              " 'Ovitrelle': 'Ovitrelle',\n",
              " 'CellCept': 'CellCept',\n",
              " 'Lixiane': 'Lixiane',\n",
              " 'Rotation': 'Rotation',\n",
              " 'Recovelle': 'Recovelle',\n",
              " 'à Adyn': 'à Adyn',\n",
              " 'Phoclivie': 'Phoclivie',\n",
              " 'Tyenne': 'Tyenne',\n",
              " 'Son frère': 'Son frère',\n",
              " 'Locametz': 'Locametz',\n",
              " 'Docétaxel Kabi': 'Comme le docétaxel',\n",
              " 'Exforge HCT': 'Exforge HCT',\n",
              " 'SomaKit TOC': 'SomaKit TOC',\n",
              " 'Hepcludex': 'Hepcludex',\n",
              " 'Imatinib Teva': 'Imatinib Teva',\n",
              " 'Ziagen': 'Ziagen',\n",
              " 'Zavicefta': 'Zavicefta',\n",
              " 'Synjardy': 'Synjardy',\n",
              " 'Glyxambi': 'Glyxambi',\n",
              " 'Erléada': 'Erléada',\n",
              " 'Époration': 'Époration',\n",
              " 'Dafiro HCT': 'Dafiro HCT',\n",
              " 'Biopoin': 'Biopoin',\n",
              " 'Copalia HCT': 'Copalia HCT',\n",
              " 'Trépulmix': 'Trépulmix',\n",
              " 'Sovaldi': 'Sovaldi',\n",
              " 'Vosevi': 'Vosevi',\n",
              " 'Harvoni': 'Harvoni',\n",
              " 'Fermé': 'Fermé',\n",
              " 'Ultomiris': 'Ultomiris',\n",
              " 'Abrysvo': 'Abrysvo',\n",
              " 'Myfénax': 'Myfenax',\n",
              " 'Brimica Genuair': 'Brimica Genuair',\n",
              " 'Aérosphère de Bevespi': 'Aérosphère de Bevespi',\n",
              " 'Accord Abiratérone': 'Accord Abiratérone',\n",
              " 'Changements': 'Changements',\n",
              " 'ellaOne': 'ellaOne',\n",
              " 'Olanzapine Teva': 'Olanzapine Teva',\n",
              " 'Amglidie': 'Amglidie',\n",
              " 'Orphacol': 'Orphacol',\n",
              " 'Races': 'Les courses',\n",
              " 'Rivastigmine Sandoz': 'Rivastigmine Sandoz',\n",
              " 'Imbruvica': 'Imbruvica',\n",
              " 'Accord sur le lénalidomide': 'Accord sur le lénalidomide',\n",
              " 'Évrysdi': 'Evrysdi',\n",
              " 'Rybrevant': 'Rybrevant',\n",
              " 'Alunbrig': 'Alunbrig',\n",
              " 'Vantobra (anciennement Tobramycine PARI)': 'Vantobra (anciennement Tobramycine PARI)',\n",
              " 'LysaKare': 'LysaKare',\n",
              " 'Vyndaqel': 'Vyndaqel',\n",
              " 'Replier': 'Replier',\n",
              " 'Scemblix': 'Scemblix',\n",
              " 'Lévétiracétam Soleil': 'Lévétiracétam Soleil',\n",
              " 'Vaxneuvance': 'Vaxneuvance',\n",
              " 'Imjudo': 'Imjudo',\n",
              " 'Lutathera': 'Lutathera',\n",
              " 'Adcirca (anciennement Tadalafil Lilly)': 'Adcirca (anciennement Tadalafil Lilly)',\n",
              " 'Procysbi': 'Procysbi',\n",
              " 'Retsevmo': 'Retsevmo',\n",
              " 'Fortacine': 'Fortacine',\n",
              " 'Vitrakvi': 'Vitrakvi',\n",
              " 'Tenkasi (anciennement Orbactiv)': 'Tenkasi (anciennement Orbactiv)',\n",
              " 'Tadalafil Lilly': 'Tadalafil Lilly',\n",
              " 'Lynparza': 'Lynparza',\n",
              " 'Infanrix Hexa': 'Infanrix Hexa',\n",
              " 'Vaxzevria (anciennement vaccin contre la COVID-19 AstraZeneca)': 'Vaxzevria (anciennement vaccin contre la COVID-19 AstraZeneca)',\n",
              " 'Ristabène': 'Ristabène',\n",
              " 'Herzuma': 'Herzuma',\n",
              " 'Appréciation': 'Appréciation',\n",
              " 'Vizamyl': 'Vizamyl',\n",
              " 'Héfia': 'Héfia',\n",
              " 'Hyrimoz': 'Hyrimoz',\n",
              " 'Tecfidera': 'Tecfidera',\n",
              " 'Omnitrope': 'Omnitrope',\n",
              " 'Strimvelis': 'Strimvelis',\n",
              " 'Serré': 'Serré',\n",
              " 'Thésavel': 'Thésavel',\n",
              " 'Veyvondi': 'Veyvondi',\n",
              " 'Apealea': 'Apealea',\n",
              " 'Januvia': 'Januvia',\n",
              " \"C'est du gâteau\": \"C'est du gâteau\",\n",
              " 'Lumeblue (anciennement connu sous le nom de chlorure de méthylthioninium Cosmo)': 'Lumeblue (anciennement connu sous le nom de chlorure de méthylthioninium Cosmo)',\n",
              " 'Lyrique': 'Lyrique',\n",
              " \"Acide chénodésoxycholique Leadiant (anciennement connu sous le nom d'acide chénodésoxycholique sigma-tau)\": \"Acide chénodésoxycholique Leadiant (anciennement connu sous le nom d'acide chénodésoxycholique sigma-tau)\",\n",
              " 'Jinarc': 'Jinarc',\n",
              " 'Viagra': 'Viagra',\n",
              " 'Idelvion': 'Idelvion',\n",
              " 'Pelgraz': 'Pelgraz',\n",
              " 'Mélatonine Neurim': 'Mélatonine Neurim',\n",
              " \"C'est fou\": \"C'est fou\",\n",
              " 'Mepsevii': 'Mepsevii',\n",
              " 'Accord docétaxel': 'Accord docétaxel',\n",
              " 'Déférasirox Accord': 'Déférasirox Accord',\n",
              " 'Bénépals': 'Bénépals',\n",
              " 'Jardiance': 'Jardiance',\n",
              " 'Victoire': 'Victoire',\n",
              " 'Eyléa': 'Eyléa',\n",
              " 'Néparvis': 'Néparvis',\n",
              " 'à Beov': 'à Beov',\n",
              " 'Tandemact': 'Tandemact',\n",
              " 'Mektovi': 'Mektovi',\n",
              " 'Entresto': 'Entresto',\n",
              " 'Exigible': 'Requis',\n",
              " 'Vegzelma': 'Vegzelma',\n",
              " 'Lédaga': \"Souffle d'air\",\n",
              " 'Abiratérone Mylan': 'Abiratérone Mylan',\n",
              " 'Lonsurf': 'Lonsurf',\n",
              " 'Trémélimumab AstraZeneca': 'Trémélimumab AstraZeneca',\n",
              " 'Soleil tériparatide': 'Soleil tériparatide',\n",
              " 'Aripiprazole Mylan Pharma (anciennement Aripiprazole Pharmathen)': 'Aripiprazole Mylan Pharma (anciennement Aripiprazole Pharmathen)',\n",
              " 'Natpar': 'Natpar',\n",
              " 'Akynzéo': 'Akynzéo',\n",
              " 'Esbriet': 'Esbriet',\n",
              " 'Emgalité': 'Emgalité',\n",
              " 'Nepexto': 'Nepexto',\n",
              " 'Embouteillage': 'Embouteillage',\n",
              " 'Irbésartan Teva': 'Irbésartan Teva',\n",
              " 'Zolsketil liposomal pégylé': 'Jus de gel liposomal Zolsketil',\n",
              " 'Celdoxome liposomal pégylé': 'Celdoxome liposomal pégylé',\n",
              " 'Caelyx liposomal pégylé': 'Caelyx liposomal pégylé',\n",
              " 'Révinty Ellipta': 'Révinty Ellipta',\n",
              " 'Vumérité': 'Vumérité',\n",
              " 'Bimervax': 'Bimervax',\n",
              " 'Révolade': 'Révolade',\n",
              " 'Tafins': 'Tafins',\n",
              " 'Passe respiratoire': 'Passe respiratoire',\n",
              " 'eurasien': 'Eurasie',\n",
              " 'Reyataz': 'Reyataz',\n",
              " 'Qinlock': 'Qinlock',\n",
              " 'Bavencio': 'Bavencio',\n",
              " 'Cosentyx': 'Cosentyx',\n",
              " 'Renouveler': 'Renouveler',\n",
              " 'Vie': 'Vie',\n",
              " 'Lupkynis': 'Lupkynis',\n",
              " 'NovoMix': 'NovoMix',\n",
              " 'Enjaymo': 'Enjaymo',\n",
              " 'Actos': 'Actos',\n",
              " 'Cerdelga': 'Cerdelga',\n",
              " 'Ilarus': 'Ilarus',\n",
              " \"C'est ça\": \"C'est ça\",\n",
              " 'Xultophie': 'Xultophie',\n",
              " 'Duloxétine Mylan': 'Duloxétine Mylan',\n",
              " 'Efmody': 'Efmody',\n",
              " 'Ecansya (anciennement Capécitabine Krka)': 'Ecansya (anciennement Capécitabine Krka)',\n",
              " 'Diacomit': 'Diacomit',\n",
              " 'Aquipte': 'Aquipte',\n",
              " 'Regkirona': 'Regkirona',\n",
              " 'Tolucombi': 'Tolucombi',\n",
              " 'Dengvaxia': 'Dengvaxia',\n",
              " 'Ervébo': 'Ervébo',\n",
              " 'Técovirimat SIGA': 'Técovirimat SIGA',\n",
              " 'je promets': 'je promets',\n",
              " 'Kinpeygo': 'Kinpeygo',\n",
              " 'Bloqué': 'Bloqué',\n",
              " 'Absent': 'Absent',\n",
              " 'Accord Fingolimod': 'Accord Fingolimod',\n",
              " 'Saut ovale': 'Saut ovale',\n",
              " 'Azilecte': 'Azilectes',\n",
              " 'Nexpovio': 'Nexpovio',\n",
              " 'Jalra': 'Jalra',\n",
              " 'Galvus': 'Galvus',\n",
              " 'Xiliarx': 'Xiliarx',\n",
              " 'Némdatine': 'Némdatine',\n",
              " 'Tobi Podhaler': 'Tobi Podhaler',\n",
              " 'Compétitif': 'Compétitif',\n",
              " 'Caprelsa': 'Caprelsa',\n",
              " 'Accord Lacosamide': 'Accord Lacosamide',\n",
              " 'Buvidal': 'Buvidal',\n",
              " 'Tivicay': 'Tivicay',\n",
              " 'Aimovig': 'Aimovig',\n",
              " 'Deltiba': 'Deltiba',\n",
              " 'Mayzent': 'Mayzent',\n",
              " 'Uniformité': 'Uniformité',\n",
              " 'Accord Tolvaptan': 'Accord Tolvaptan',\n",
              " 'Mircera': 'Mircera',\n",
              " 'Bonviva': 'Bonviva',\n",
              " 'Trodelvy': 'Trodelvy',\n",
              " 'Illuminateurs': 'Illuminateurs',\n",
              " 'Lantus': 'Lantus',\n",
              " 'Trecondi': 'Trecondi',\n",
              " 'Vpriv': 'Vpriv',\n",
              " 'Plérixafor Accord': 'Plérixafor Accord',\n",
              " 'Fluenz Tétra': 'Fluenz Tétra',\n",
              " 'Camzyos': 'Camzyos',\n",
              " 'Flucelvax Tétra': 'Flucelvax Tétra',\n",
              " 'Renagel': 'Renagel',\n",
              " 'Ruconest': 'Ruconest',\n",
              " 'Erelzi': 'Erelzi',\n",
              " 'Arikayce liposomal': 'Arikayce liposomal',\n",
              " 'Pifeltro': 'Pifeltro',\n",
              " 'Delstrigo': 'Delstrigo',\n",
              " 'Ristfor': 'Ristfor',\n",
              " 'Efficacité': 'Efficacité',\n",
              " 'Janvier': 'Janvier',\n",
              " 'Fluad Tétra': 'Fluad Tétra',\n",
              " 'Brilique': 'Brilique',\n",
              " 'Ébymect': 'Ébymect',\n",
              " 'Accord capécitabine': 'Accord capécitabine',\n",
              " 'Néoclarté': 'Néoclarté',\n",
              " \"L'air\": 'Repaire',\n",
              " 'Azomyr': 'Azomyr',\n",
              " 'Xarelto': 'Xarelto',\n",
              " 'Idéfirix': 'Idefirix',\n",
              " 'Khydalba': 'Khydalba',\n",
              " 'Ofev': 'Ofev',\n",
              " 'Pardureon': 'Parduréon',\n",
              " 'Siklos': 'Siklos',\n",
              " 'Vers Sogro': 'Vers Sogro',\n",
              " 'Ztalmy': 'Ztalmy',\n",
              " 'Jakavi': 'Jakavi',\n",
              " 'Bouccola': 'Bouccola',\n",
              " 'Oprymée': 'Oprymée',\n",
              " 'Rotarix': 'Rotarix',\n",
              " 'Omvoh': 'Omvoh',\n",
              " 'terreux': 'terreux',\n",
              " 'Vokanamet': 'Vokanamet',\n",
              " 'Luxturna': 'Luxturna',\n",
              " 'Orkambi': 'Orkambi',\n",
              " 'Cabazitaxel Accord': 'Cabazitaxel Accord',\n",
              " 'Géfitinib Mylan': 'Géfitinib Mylan',\n",
              " 'Abecma': 'Abecma',\n",
              " 'Invoquez-nous': 'Invoquez-nous',\n",
              " 'Revestif': 'Revestif',\n",
              " 'Emtricitabine/Ténofovir disoproxil Mylan': 'Emtricitabine/Ténofovir disoproxil Mylan',\n",
              " 'Beaucoup': 'Beaucoup',\n",
              " 'Xofluza': 'Xofluza',\n",
              " 'Jyséleca': 'Jyséleca',\n",
              " 'Supposé': 'Supposé',\n",
              " 'Vavorem': 'Je voudrais travailler',\n",
              " 'Lénalidomide Krka (anciennement Lénalidomide Krka d.d. Novo mesto)': 'Lénalidomide Krka (anciennement Lénalidomide Krka d.d. Novo mesto)',\n",
              " 'trio de café': 'trio de café',\n",
              " 'Alymsys': 'Alymsys',\n",
              " 'Retacrit': 'Retacrit',\n",
              " 'Tsarvykti': 'Tsarvykti',\n",
              " 'Kovaltry': 'Kovaltry',\n",
              " 'Miglustat Dipharma': 'Miglustat Dipharma',\n",
              " 'Rydapt': 'Rydapt',\n",
              " 'Kisplykh': 'Kisplykh',\n",
              " 'Paresse': 'Paresse',\n",
              " 'Gardasil 9': 'Gardasil 9',\n",
              " 'Qaialdo': 'Qaialdo',\n",
              " 'Sifrol': 'Sifrol',\n",
              " 'Mirapexine': 'Mirapexine',\n",
              " 'Accofil': 'Accofil',\n",
              " 'Vipidie': 'Vipidie',\n",
              " \"C'est cassé\": \"C'est cassé\",\n",
              " 'Nulibrie': 'Nulibrie',\n",
              " 'Abilify Maintena': 'Abilify Maintena',\n",
              " 'NutropineAq': 'NutropineAq',\n",
              " 'Givlaar': 'Maladroit',\n",
              " 'Carbaglu': 'Carbaglu',\n",
              " 'Bexéro': 'Bexéro',\n",
              " 'Vabysmo': 'Vabysmo',\n",
              " 'Sugammadex Piramal': 'Sugammadex Piramal',\n",
              " 'Céprotine': 'Céprotine',\n",
              " 'Libtayo': 'Libtayo',\n",
              " 'Rozlytrek': 'Rozlytrek',\n",
              " 'Zinplava': 'Zinplava',\n",
              " 'Suliqua': 'Suliqua',\n",
              " 'Columvi': 'Columvi',\n",
              " 'Zelboraf': 'Zelboraf',\n",
              " 'Stellaire': 'Stellaire',\n",
              " 'Sylvain': 'Sylvain',\n",
              " 'Sur le plancher': 'Sur le plancher',\n",
              " 'HyQvia': 'HyQvia',\n",
              " 'Iressa': 'Iressa',\n",
              " 'Nimenrix': 'Nimenrix',\n",
              " 'Plégridy': 'Plégrids',\n",
              " 'Kinéret': 'Kinéret',\n",
              " 'Xgeva': 'Xgeva',\n",
              " 'Fareston': 'Fareston',\n",
              " 'Tévagrastim': 'Tévagrastim',\n",
              " 'Spravato': 'Spravato',\n",
              " 'Olanzapine Mylan': 'Olanzapine Mylan',\n",
              " 'Bondronat': 'Bondronat',\n",
              " 'Mépact': 'Mépact',\n",
              " 'Arixtra': 'Arixtra',\n",
              " 'En direct': 'Et directement',\n",
              " 'Ivabradine Zentiva': 'Ivabradine Zentiva',\n",
              " 'Ponvory': 'Ponvory',\n",
              " 'Verzénios': 'Verzénios',\n",
              " 'Lénalidomide Mylan': 'Lénalidomide Mylan',\n",
              " 'Twynsta': 'Twynsta',\n",
              " 'Zercepac': 'Zercepac',\n",
              " 'Firmacombi': 'Firmacombi',\n",
              " 'Lien de Prax': 'Lien de Prax',\n",
              " 'VIPdomet': 'Gamme VIP',\n",
              " 'Efficace': 'Efficace',\n",
              " 'Chlorure de méthylthioninium Proveblue': 'Chlorure de méthylthioninium Proveblue',\n",
              " 'Vazkepa': 'Vazkepa',\n",
              " 'Ronaprévé': 'Ronaprévé',\n",
              " 'Karvéa': 'Karvéa',\n",
              " 'Sarclisa': 'Sarclisa',\n",
              " 'DuoPlavin': 'DuoPlavin',\n",
              " 'Insuline lispro Sanofi': 'Insuline lispro Sanofi',\n",
              " 'Insuline asparte Sanofi': 'Insulines aspartes Sanofi',\n",
              " 'Lévétiracétam Hospira': 'Lévétiracétam Hospira',\n",
              " 'Nexavar': 'Nexavar',\n",
              " 'Truvelog Mélange 30': 'Truvelog Mélange 30',\n",
              " 'Je découvre': 'Je découvre',\n",
              " 'Sugammadex Amomed': 'Sugammadex Amomed',\n",
              " 'Aprovel': 'Aprovel',\n",
              " 'Crysvita': 'Crysvita',\n",
              " 'Byetta': 'Byetta',\n",
              " 'Isturisa': 'Isturisa',\n",
              " 'Menvéo': 'Menvéo',\n",
              " 'Zyclara': 'Zyclara',\n",
              " 'Aldara': 'Aldara',\n",
              " 'Jevtana': 'Jevtana',\n",
              " 'Oxbryta': 'Oxbryta',\n",
              " 'Bekemv': 'Bekemv',\n",
              " 'Bylvay': 'Bylvay',\n",
              " 'Xyrème': 'Xyrème',\n",
              " 'Rivastigmine Actavis': 'Rivastigmine Actavis',\n",
              " 'Livetencity': 'Ville de vie',\n",
              " 'Trydonis': 'Trydonis',\n",
              " 'Ondexxya': 'Ondexxya',\n",
              " 'Ténofovir disoproxil Zentiva': 'Ténofovir disoproxil Zentiva',\n",
              " 'Épidyolex': 'Épidyolex',\n",
              " \"C'est bon\": \"C'est bon\",\n",
              " 'Cimbaqo': 'Cimbaqo',\n",
              " 'Arc Trimbow': 'Arc Trimbow',\n",
              " 'Riarify (auparavant CHF 5993 Chiesi Farmaceutici S.p.A.)': 'Riarify (auparavant CHF 5993 Chiesi Farmaceutici S.p.A.)',\n",
              " 'Sibnayal': 'Sibnayal',\n",
              " 'Carte Mysilde': 'Carte Mysilde',\n",
              " \"Quoi qu'il en soit\": \"Quoi qu'il en soit\",\n",
              " 'Ayvakyt': 'Ayvakyt',\n",
              " 'Luminosité': 'Luminosité',\n",
              " 'Indulgent': 'Indulgent',\n",
              " 'Ontozry': 'Ontozry',\n",
              " 'Renvela': 'Renvela',\n",
              " 'Multaq': 'Multaq',\n",
              " 'Fasturtec': 'Fasturtec',\n",
              " 'Orencia': 'Orencia',\n",
              " 'Accord Témozolomide': 'Accord Témozolomide',\n",
              " 'Apidra': 'Apidra',\n",
              " 'Écalta': 'Exalte',\n",
              " 'Clopidogrel Zentiva (anciennement Clopidogrel Winthrop)': 'Clopidogrel Zentiva (anciennement Clopidogrel Winthrop)',\n",
              " 'Cymbalte': 'Cymbalte',\n",
              " 'Sunlença': 'Sunlença',\n",
              " 'Lévétiracétam ratiopharm': 'Lévétiracétam ratiopharm',\n",
              " 'Hexyon': 'Hexyon',\n",
              " 'Hexacime': 'Hexacime',\n",
              " 'Splendide': 'Magnifique',\n",
              " 'Beyfortus': 'Beyfortus',\n",
              " 'Oxlumo': 'Oxlumo',\n",
              " 'Rivaroxaban Viatris (anciennement Rivaroxaban Mylan)': 'Rivaroxaban Viatris (anciennement Rivaroxaban Mylan)',\n",
              " 'Éliquis': 'Éliquis',\n",
              " 'Quvivic': 'Quvivic',\n",
              " 'Trevicta (anciennement Paliperidone Janssen)': 'Trevicta (anciennement Paliperidone Janssen)',\n",
              " 'Byannli (anciennement Paliperidone Janssen-Cilag International)': 'Byannli (anciennement Paliperidone Janssen-Cilag International)',\n",
              " 'Arexvy': 'Arexvy',\n",
              " 'Mal': 'Mal',\n",
              " 'Lévétiracétam Actavis': 'Lévétiracétam Actavis',\n",
              " 'Emtricitabine/Ténofovir disoproxil Krka d.d.': 'Emtricitabine/ténofovir disoproxil Krka d.d.',\n",
              " 'Rivastigmine Hexal': 'Rivastigmine Hexal',\n",
              " 'Emtricitabine/Ténofovir disoproxil Krka': 'Emtricitabine/Ténofovir disoproxil Krka',\n",
              " 'Rivastigmine 1 A Pharma': 'Rivastigmine 1 A Pharma',\n",
              " 'Sugammadex Mylan': 'Sugammadex Mylan',\n",
              " 'Lévétiracétam Teva': 'Lévétiracétam Teva',\n",
              " 'Giotrif': 'Giotrif',\n",
              " 'Accord de lévétiracétam': 'Accord de lévétiracétam',\n",
              " 'Noxafil': 'Noxafil',\n",
              " 'témodal': 'module de thème',\n",
              " 'Prévymis': 'Prévymis',\n",
              " 'Éfavirenz/Emtricitabine/Ténofovir disoproxil Krka': 'Éfavirenz/Emtricitabine/Ténofovir disoproxil Krka',\n",
              " 'Hemgénix': 'Hemgénix',\n",
              " 'Dexdor': 'Dexdor',\n",
              " 'Duavive': 'Duavive',\n",
              " 'Ximluci': 'Ximluci',\n",
              " 'Bon sang': 'Bon chanté',\n",
              " 'Voriconazole Hikma (anciennement Voriconazole Hospira)': 'Voriconazole Hikma (anciennement Voriconazole Hospira)',\n",
              " 'Irbésartan/Hydrochlorothiazide Teva': 'Irbésartan/Hydrochlorothiazide Teva',\n",
              " 'Vidaza': 'Vidaza',\n",
              " 'Nerlynx': 'Nerlynx',\n",
              " 'Privilège': 'Privilège',\n",
              " 'Grépide': 'Grépide',\n",
              " 'Ils ont été élevés': 'Ils ont été élevés',\n",
              " 'Accord Voriconazole': 'Accord Voriconazole',\n",
              " 'Maviret': 'Maviret',\n",
              " 'La montée': 'La montée',\n",
              " 'Exelon': 'Exelon',\n",
              " 'Evrenzo': 'Evrenzo',\n",
              " 'Amversion': 'Amversion',\n",
              " 'Zonisamide Mylan': 'Zonisamide Mylan',\n",
              " 'Duo Jenda': 'Duo Jenda',\n",
              " 'Chlorure de lutétium (177Lu) Billev (anciennement Illuzyce)': 'Chlorure de lutétium (177Lu) Billev (anciennement Illuzyce)',\n",
              " 'Myozyme': 'Myozyme',\n",
              " 'Atazanavir Krka': 'Atazanavir Krka',\n",
              " 'Ségluromet': 'Ségluromet',\n",
              " 'Ibrance': 'Ibrance',\n",
              " 'Sono Vue': 'Sono Vue',\n",
              " 'Vydura': 'Vydura',\n",
              " 'Nityr': 'Nityr',\n",
              " 'En patrouille': 'En patrouille',\n",
              " 'Oxervat': 'Observer',\n",
              " 'Avec Akée': 'Avec Akée',\n",
              " 'Acide zolédronique Actavis': 'Acide zolédronique Actavis',\n",
              " 'Tadalafil Mylan': 'Tadalafil Mylan',\n",
              " 'Desloratadine Actavis': 'Desloratadine Actavis',\n",
              " 'Vildagliptine/Chlorhydrate de metformine Accord': 'Vildagliptine/Chlorhydrate de metformine Accord',\n",
              " 'Kentera (anciennement Oxybutynin Nicobrand)': 'Kentera (anciennement Oxybutynin Nicobrand)',\n",
              " 'Employé': 'Employé',\n",
              " 'Pioglitazone Actavis': 'Pioglitazone Actavis',\n",
              " 'Ébilfumine': 'Ébilfumine',\n",
              " 'Rébif': 'Rébif',\n",
              " 'Éfavirenz/Emtricitabine/Ténofovir disoproxil Zentiva': 'Éfavirenz/Emtricitabine/Ténofovir disoproxil Zentiva',\n",
              " 'Rapilysine': 'Rapilysine',\n",
              " 'Potactasol': 'Potactasol',\n",
              " 'Vemlidy': 'Vemlidy',\n",
              " 'Dabigatran Etexilate Accord': 'Dabigatran Etexilate Accord',\n",
              " 'Vafséo': 'Vafséo',\n",
              " 'Épysqli': 'Épysqli',\n",
              " 'Pergoveris': 'Pergoveris',\n",
              " 'Édisride': 'Edisride',\n",
              " 'Xigduo': 'Xigduo',\n",
              " 'Qtern': 'Qtern',\n",
              " 'Komboglyze': 'Komboglyze',\n",
              " 'Sitagliptine/Chlorhydrate de metformine Mylan': 'Sitagliptine/Chlorhydrate de metformine Mylan',\n",
              " 'Okedi': 'Okedi',\n",
              " 'Pombiliti': 'Pombiliti',\n",
              " 'Merci beaucoup': 'Merci beaucoup',\n",
              " 'Cinqaéro': 'Cinqaéro',\n",
              " 'Ogluo': 'Ogluo',\n",
              " 'Ixiaro': 'Ixiaro',\n",
              " 'Galafold': 'Galafold',\n",
              " 'Xaluprine (anciennement Mercaptopurine Nova Laboratories)': 'Xaluprine (anciennement Mercaptopurine Nova Laboratories)',\n",
              " 'Sustiva': 'Sustiva',\n",
              " 'Contrôle Pantozol': 'Contrôle Pantozol',\n",
              " 'Elfabrio': 'Elfabrio',\n",
              " 'Trisénox': 'Trisénox',\n",
              " 'Évoluer': 'Évoluer',\n",
              " 'Nexviadyme': 'Nexviadyme',\n",
              " 'Lopinavir/Ritonavir Mylan': 'Lopinavir/Ritonavir Mylan',\n",
              " 'Contrôle de contrôle': 'Contrôle de contrôle',\n",
              " 'Rapiscan': 'Rapiscan',\n",
              " 'Contrôle Somac': 'Contrôle Somac',\n",
              " 'Twinrix Adulte': 'Twinrix Adulte',\n",
              " 'Synflorix': 'Synflorix',\n",
              " 'Fendrix': 'Fendrix',\n",
              " 'Volibris': 'Volibris',\n",
              " 'Constellation': 'Constellation',\n",
              " 'Sevelamer carbonate Winthrop (anciennement Sevelamer carbonate Zentiva)': 'Sevelamer carbonate Winthrop (anciennement Sevelamer carbonate Zentiva)',\n",
              " 'Nivestim': 'Nivestim',\n",
              " 'Darunavir Mylan': 'Darunavir Mylan',\n",
              " 'Cerveau': 'Cerveau',\n",
              " 'Circadin': 'Circadin',\n",
              " 'Néofordex': 'Néofordex',\n",
              " 'Tresa': 'Tresa',\n",
              " 'Accueil Balance': 'Accueil Balance',\n",
              " 'Ritonavir Mylan': 'Ritonavir Mylan',\n",
              " 'Atazanavir Mylan': 'Atazanavir Mylan',\n",
              " 'Bosulif': 'Bosulif',\n",
              " 'Cinacalcet Accordpharma': 'Cinacalcet Accordpharma',\n",
              " 'Tarceva': 'Tarceva',\n",
              " 'Sirturo': 'Sirturo',\n",
              " 'Votrient': 'Votrient',\n",
              " 'BiResp Spiromax': 'BiResp Spiromax',\n",
              " 'Cablivi': 'Cablivi',\n",
              " 'Darunavir Krka': 'Darunavir Krka',\n",
              " 'TachoSil': 'TachoSil',\n",
              " 'Camcevi': 'Camcevi',\n",
              " 'Fébuxostat Krka': 'Fébuxostat Krka',\n",
              " 'DuoResp Spiromax': 'DuoResp Spiromax',\n",
              " 'Évicel': 'Avec un an',\n",
              " 'Tyverb': 'Tyverb',\n",
              " 'Xénique': 'Xénique',\n",
              " 'Kymriah': 'Kymriah',\n",
              " 'Les cascades': 'Les cascades',\n",
              " 'Ozempic': 'Ozempic',\n",
              " 'Xenpozyme': 'Xenpozyme',\n",
              " 'Tegsedi': 'Tegsedi',\n",
              " 'Saumuré': 'Saumur',\n",
              " 'Yselty': 'Yselty',\n",
              " 'Gliolan': 'Gliolan',\n",
              " 'Palynziq': 'Palynziq',\n",
              " 'Biktarvy': 'Biktarvy',\n",
              " 'Acheter': 'Acheter',\n",
              " 'Répatha': 'Répatha',\n",
              " 'Firazyr': 'Firazyr',\n",
              " 'Granupas (anciennement acide para-aminosalicylique Lucane)': 'Granupas (anciennement acide para-aminosalicylique Lucane)',\n",
              " 'Ahura': 'Ahura',\n",
              " 'Cinacalcet Mylan': 'Cinacalcet Mylan',\n",
              " 'Lokelma': 'Lokelma',\n",
              " 'Ambrisentan Mylan': 'Ambrisentan Mylan',\n",
              " 'Enlevé': 'Enlevé',\n",
              " 'NexoBrid': 'NexoBrid',\n",
              " 'Lyumjev (anciennement Liumjev)': 'Lyumjev (anciennement Liumjev)',\n",
              " 'Verkazia': 'Verkazia',\n",
              " 'Stocrine': 'Stocrine',\n",
              " 'Les traducteurs': 'Les traducteurs',\n",
              " 'Évotaz': 'Année',\n",
              " 'Contrôle Nexium': 'Contrôle Nexium',\n",
              " 'Lamivudine Teva Pharma B.V.': 'Lamivudine Teva Pharma B.V.',\n",
              " 'Glissant': 'Glissant',\n",
              " 'Ongleza': 'Parlez',\n",
              " 'Viramune': 'Viramune',\n",
              " \"Accord d'eptifibatide\": \"Accord d'eptifibatide\",\n",
              " 'INOmax': 'INOmax',\n",
              " 'Acide zolédronique Mylan': 'Acide zolédronique Mylan',\n",
              " 'Adénurique': 'Adénurique',\n",
              " 'Mirvaso': 'Mirvaso',\n",
              " 'Vaccins': 'Vaccins',\n",
              " 'Lorviqua': 'Lorviqua',\n",
              " 'Emtriva': 'Emtriva',\n",
              " 'Libmelda': 'Lécher',\n",
              " 'Byooviz': 'Byooviz',\n",
              " 'Rotateq': 'Rotationq',\n",
              " 'Quoi de neuf': 'Quoi de neuf',\n",
              " 'Orfadine': 'Orfadine',\n",
              " 'Zéposia': 'Zéposia',\n",
              " 'Exviera': 'Exviera',\n",
              " 'Irbésartan Hydrochlorothiazide Zentiva (anciennement Irbésartan Hydrochlorothiazide Winthrop)': 'Irbésartan Hydrochlorothiazide Zentiva (anciennement Irbésartan Hydrochlorothiazide Winthrop)',\n",
              " 'Cétrotide': 'Cétrotide',\n",
              " 'Viekirax': 'Viekirax',\n",
              " 'Qdeng': 'Qdeng',\n",
              " 'Aybintio': 'Aybintio',\n",
              " 'Onbevzi': 'Onbevzi',\n",
              " 'Granpidam': 'Granpidam',\n",
              " 'Elonva': 'Elonva',\n",
              " 'Dapagliflozine Viatris': 'Dapagliflozine Viatris',\n",
              " 'Orgalutran': 'Orgalutran',\n",
              " 'Fuzeon': 'Fuzeon',\n",
              " 'Thyrogène': 'Thyrogène',\n",
              " 'Jylamvo': 'Jylamvo',\n",
              " 'Cérézyme': 'Cérézyme',\n",
              " 'Fabrazyme': 'Fabrazyme',\n",
              " 'À Velta': 'Chez Velta',\n",
              " 'Sotyktou': 'Sotycto',\n",
              " 'Dzuvéo': 'Dzuvéo',\n",
              " 'Lydisilka': 'Lydisilka',\n",
              " 'Capécitabine Medac': 'Capécitabine Medac',\n",
              " 'Dravelis': 'Voyageur',\n",
              " 'Merci': 'Merci',\n",
              " 'Mycamine': 'Mycamine',\n",
              " 'Synopsis': 'Synopsis',\n",
              " 'Au sommet': 'Au sommet',\n",
              " 'Azacitidine Accord': 'Azacitidine Accord',\n",
              " 'Imvanex': 'Imvanex',\n",
              " 'Alecensa': 'Alecensa',\n",
              " 'Sancuso': 'Sancuso',\n",
              " 'Purgon': 'Purgon',\n",
              " 'Azopt': 'Azopt',\n",
              " 'Sivextro': 'Sivextro',\n",
              " 'Nyvépria': 'Nyvépria',\n",
              " 'Eucréas': 'Eucréas',\n",
              " 'Mémantine Mylan': 'Mémantine Mylan',\n",
              " 'mimpara': 'mimpara',\n",
              " \"Trioxyde d'arsenic Mylan\": \"Trioxyde d'arsenic Mylan\",\n",
              " 'Déférasirox Mylan': 'Déférasirox Mylan',\n",
              " 'Imraldi': 'Imraldi',\n",
              " 'Chrome': 'Chrome',\n",
              " 'Apprécié': 'Apprécié',\n",
              " 'Kanjinti': 'Kanjinti',\n",
              " 'Taxotère': 'Taxotère',\n",
              " 'Myocet liposomal (anciennement Myocet)': 'Myocet liposomal (anciennement Myocet)',\n",
              " 'Ensemencement': 'Ensemencement',\n",
              " 'Tamiflu': 'Tamiflu',\n",
              " 'Kadcyla': 'Kadcyla',\n",
              " 'Polivy': 'Polivy',\n",
              " 'NovoRapid': 'NovoRapid',\n",
              " 'Keppra': 'Keppra',\n",
              " 'Imcivrée': 'Imcivrée',\n",
              " 'MicardisPlus': 'MicardisPlus',\n",
              " 'Se précipiter': 'Se précipiter',\n",
              " 'Nuwiq': 'Nuwiq',\n",
              " 'Parlé': 'Parlé',\n",
              " 'Inrebic': 'Inrebic',\n",
              " 'Symtuza': 'Symtuza',\n",
              " 'Alkindi': 'Alkindi',\n",
              " 'Zomariste': 'Zomariste',\n",
              " 'Erivedge': 'Erivedge',\n",
              " 'Vous sautez': 'Vous sautez',\n",
              " 'Prégabaline Pfizer': 'Prégabaline Pfizer',\n",
              " 'Herceptine': 'Herceptine',\n",
              " \"J'ai découvert\": \"J'ai découvert\",\n",
              " 'Miglustat Gén. Orph.': 'Miglustat Gén. Orphe.',\n",
              " 'Vérité': 'Vérité',\n",
              " 'Elzonris': 'Elzonris',\n",
              " 'NéoRecormon': 'NéoRecormon',\n",
              " 'Ebvallo': 'Ebvallo',\n",
              " 'Hukyndra': 'Hukyndra',\n",
              " 'Olanzapine Apotex': 'Olanzapine Apotex',\n",
              " 'Stivarga': 'Stivarga',\n",
              " 'Senshio': 'Senshio',\n",
              " 'Mulpleo (anciennement Lusutrombopag Shionogi)': 'Mulpleo (anciennement Lusutrombopag Shionogi)',\n",
              " 'Cotellic': 'Cotellic',\n",
              " 'Cayston': 'Cayston',\n",
              " 'Il a persisté': 'Il a persisté',\n",
              " 'Éfavirenz Teva': 'Éfavirenz Teva',\n",
              " 'HommeQuadfi': 'HommeQuadfi',\n",
              " 'Ivabradine Anpharm': 'Ivabradine Anpharm',\n",
              " 'Mécanicien': 'Mécanicien',\n",
              " 'Ferriprox': 'Ferriprox',\n",
              " 'Bien sûr': 'Bien sûr',\n",
              " 'NovoSeven': 'NovoSeven',\n",
              " 'Pelmeg': 'Pelmeg',\n",
              " 'Cegfila (anciennement Pegfilgrastim Mundipharma)': 'Cegfila (anciennement Pegfilgrastim Mundipharma)',\n",
              " 'Nyxoïde': 'Nyxoïde',\n",
              " 'Bonjour': 'Bonjour',\n",
              " 'Breezhaler ulunaire': 'Breezhaler ulunaire',\n",
              " 'Fulvestrant Mylan': 'Fulvestrant Mylan',\n",
              " 'Vizarsin': 'Vizarsin',\n",
              " 'Rasilez': 'Rasilez',\n",
              " 'Rasagiline Mylan': 'Rasagiline Mylan',\n",
              " 'Zonegran': 'Zonegran',\n",
              " 'Stalevo': 'Stalevo',\n",
              " 'Inovelon': 'Inovelon',\n",
              " 'Cou pémétrexed': 'Cou pémétrexed',\n",
              " 'Lamzédé': 'Lamzédé',\n",
              " 'Nimvastes': 'Nimvastes',\n",
              " 'Tolura': 'Tolura',\n",
              " 'Yargesa': 'Yargesa',\n",
              " 'Taltz': 'Taltz',\n",
              " 'Namuscla': 'Namuscla',\n",
              " 'Cuprieur': 'Cuprieur',\n",
              " 'Saproptérine Dipharma': 'Saproptérine Dipharma',\n",
              " 'Vaxelis': 'Vaxelis',\n",
              " 'Odefsey': 'Odefsey',\n",
              " 'Sphérox': 'Sphérox',\n",
              " 'la magie': 'à la magie',\n",
              " 'Hagrid': 'Hagrid',\n",
              " 'Kérendia': 'Demande-le',\n",
              " 'Découverte': 'Découverte',\n",
              " 'Roclanda': 'Roclanda',\n",
              " 'Intuniv': 'Intuniv',\n",
              " 'Zoély': 'Zoély',\n",
              " 'Strensiq': 'Strensiq',\n",
              " 'Tu es': 'Tu es',\n",
              " 'Zéro': 'Zéro',\n",
              " 'Azacitidine bêtapharm': 'Azacitidine bêtapharm',\n",
              " 'Tracléer': 'Tracléer',\n",
              " 'Rester': 'Rester',\n",
              " 'Hémangiol': 'Hémangiole',\n",
              " 'Prégabaline Zentiva': 'Prégabaline Zentiva',\n",
              " 'suffocation': 'suffocation',\n",
              " 'Flixabi': 'Flixabi',\n",
              " 'Truvada': 'Truvada',\n",
              " 'Stribilde': 'Stribilder',\n",
              " 'Juluca': 'Juluca',\n",
              " 'Test Helicobacter INFAI': 'Test Helicobacter INFAI',\n",
              " 'Liprologue': 'Liprologue',\n",
              " 'Optrum': 'Optrum',\n",
              " 'Coagadex': 'Coagadex',\n",
              " 'Tabrecta': 'Tabrecta',\n",
              " 'Accord dexmédétomidine': 'Accord dexmédétomidine',\n",
              " \"Ne t'inquiète pas\": \"Ne t'inquiète pas\",\n",
              " 'Oncaspar': 'Oncaspar',\n",
              " 'Sitagliptine/Chlorhydrate de metformine Soleil': 'Sitagliptine/Chlorhydrate de metformine Soleil',\n",
              " 'Envarsus': 'Envarsus',\n",
              " 'Métalyse': 'Métalyse',\n",
              " 'Pémétrexed Baxter': 'Pémétrexed Baxter',\n",
              " 'Amgevita': 'Amgevita',\n",
              " 'Lysodrène': 'Lysodrène',\n",
              " 'Avonex': 'Avonex',\n",
              " 'Congrès': 'Congrès',\n",
              " 'Atriance': 'Atriance',\n",
              " 'Aclasta': 'Aclasta',\n",
              " 'Lévodopa/Carbidopa/Entacapone Orion': 'Lévodopa/Carbidopa/Entacapone Orion',\n",
              " 'Extavia': 'Extavia',\n",
              " 'Tériflunomide Mylan': 'Tériflunomide Mylan',\n",
              " 'Corbilta (anciennement Lévodopa/Carbidopa/Entacapone Sandoz)': 'Corbilta (anciennement Lévodopa/Carbidopa/Entacapone Sandoz)',\n",
              " 'Prégabaline Mylan': 'Prégabaline Mylan',\n",
              " 'Vocabulaire': 'Vocabulaire',\n",
              " 'Duaklir Genuair': 'Duaklir Genuair',\n",
              " 'Eklira Genuair': 'Eklira Genuair',\n",
              " 'Libmyris': 'Libmyris',\n",
              " 'Toviaz': 'Toviaz',\n",
              " 'Protopique': 'Protopique',\n",
              " 'Tacforius': 'Tacforius',\n",
              " 'Kynthéum': 'Kynthéum',\n",
              " 'Amvuttra': 'Amvuttra',\n",
              " 'Accord prégabaline': 'Accord prégabaline',\n",
              " 'Mvasi': 'Mvasi',\n",
              " 'Accord acide ibandronique': 'Accord acide ibandronique',\n",
              " 'Bretaris Genuair': 'Bretaris Genuair',\n",
              " 'Viread': 'Viread',\n",
              " 'Quinsair': 'Quinsair',\n",
              " 'Mycapssa': 'Mycapssa',\n",
              " 'Difficulté': 'Difficulté',\n",
              " 'Zaltrap': 'Zaltrap',\n",
              " 'Olanzapine Glenmark Europe': 'Olanzapine Glenmark Europe',\n",
              " 'Olanzapine Glenmark': 'Olanzapine Glenmark',\n",
              " \"Ils l'ont aligné\": \"Ils l'ont aligné\",\n",
              " 'Jemperli': 'Jemperli',\n",
              " 'Simbrinza': 'Simbrinza',\n",
              " 'Posaconazole Accord': 'Posaconazole Accord',\n",
              " 'Axumine': 'Axumine',\n",
              " 'Shingrix': 'Shingrix',\n",
              " 'Humira': 'Humira',\n",
              " 'Ammonaps': 'Ammonaps',\n",
              " 'Cubique': 'Cubique',\n",
              " 'Résolveur': 'Résolveur',\n",
              " 'Élaprase': 'Élaprase',\n",
              " 'Nyxthracis (anciennement Obiltoxaximab SFL)': 'Nyxthracis (anciennement Obiltoxaximab SFL)',\n",
              " 'Imlygique': 'Imlygique',\n",
              " 'Accord Imatinib': 'Accord Imatinib',\n",
              " 'Répaglinide Krka': 'Répaglinide Krka',\n",
              " 'Admissible': 'Admissible',\n",
              " 'Épipleure': 'Épipleure',\n",
              " 'Scintimun': 'Scintimun',\n",
              " \"Onivyde liposomal pégylé (anciennement connu sous le nom d'Onivyde)\": \"Onivyde liposomal pégylé (anciennement connu sous le nom d'Onivyde)\",\n",
              " 'Xermelo': 'Xermelo',\n",
              " 'Ferraccru': 'Ferraccru',\n",
              " 'Velphoro': 'Velphoro',\n",
              " 'Aérinaze': 'Aérinaze',\n",
              " 'Sycrest': 'Sycrest',\n",
              " 'Tookad': 'Tookad',\n",
              " 'Jorvez': 'Jorvez',\n",
              " 'Zytiga': 'Zytiga',\n",
              " 'Steglatro': 'Steglatro',\n",
              " 'Monter': 'Monter',\n",
              " 'Striascan': 'Striascan',\n",
              " 'Pyrukynd': 'Pyrukynd',\n",
              " 'Solution': 'Solution',\n",
              " 'Iclusy': 'Iclusy',\n",
              " 'Kevzara': 'Kevzara',\n",
              " 'Cevenfacta': 'Cevenfacta',\n",
              " 'je ferai le plein': 'je ferai le plein',\n",
              " ...}"
            ]
          },
          "execution_count": 68,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "translations"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "4d273c64",
      "metadata": {
        "id": "4d273c64",
        "outputId": "25399955-5f77-45e4-b4b4-dc2f2912ae7a"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Category</th>\n",
              "      <th>name</th>\n",
              "      <th>International non-proprietary name (INN) / common name</th>\n",
              "      <th>Active substance</th>\n",
              "      <th>Product number</th>\n",
              "      <th>Patient safety</th>\n",
              "      <th>Authorisation status</th>\n",
              "      <th>ATC code</th>\n",
              "      <th>Additional monitoring</th>\n",
              "      <th>Generic</th>\n",
              "      <th>...</th>\n",
              "      <th>Decision date</th>\n",
              "      <th>Revision number</th>\n",
              "      <th>Condition / indication</th>\n",
              "      <th>First published</th>\n",
              "      <th>Revision date</th>\n",
              "      <th>URL</th>\n",
              "      <th>therap_area</th>\n",
              "      <th>therapeutic_indication</th>\n",
              "      <th>usage</th>\n",
              "      <th>risk</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1662</th>\n",
              "      <td>Human</td>\n",
              "      <td>Kuvan</td>\n",
              "      <td>sapropterin</td>\n",
              "      <td>Sapropterin dihydrochloride</td>\n",
              "      <td>EMEA/H/C/000943</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>A16AX07</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2020-01-16 01:00:00</td>\n",
              "      <td>20</td>\n",
              "      <td>Kuvan is indicated for the treatment of hyperp...</td>\n",
              "      <td>2018-04-12 12:00:00</td>\n",
              "      <td>2020-03-04 18:24:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Phenylketonurias</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Kuvan and what is it used for?\\nKuvan ...</td>\n",
              "      <td>What are the risks associated with Kuvan?\\nThe...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1676</th>\n",
              "      <td>Human</td>\n",
              "      <td>Clopidogrel/Acetylsalicylic acid Zentiva (prev...</td>\n",
              "      <td>clopidogrel, acetylsalicylic acid</td>\n",
              "      <td>clopidogrel, Acetylsalicylic acid</td>\n",
              "      <td>EMEA/H/C/001144</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>B01AC30</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-09-19 00:00:00</td>\n",
              "      <td>22</td>\n",
              "      <td>Acute Coronary SyndromeMyocardial Infarction</td>\n",
              "      <td>2018-01-18 14:41:00</td>\n",
              "      <td>2019-11-13 15:20:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Acute Coronary Syndrome\\nMyocardial Infarction</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Clopidogrel/Acetylsalicylic acid Zenti...</td>\n",
              "      <td>What is the risk associated with Clopidogrel/A...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1682</th>\n",
              "      <td>Human</td>\n",
              "      <td>Savene</td>\n",
              "      <td>dexrazoxane</td>\n",
              "      <td>dexrazoxane hydrochloride</td>\n",
              "      <td>EMEA/H/C/000682</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>V03AF02</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-01-11 01:00:00</td>\n",
              "      <td>14</td>\n",
              "      <td>Savene is indicated for the treatment of anthr...</td>\n",
              "      <td>2018-02-08 01:00:00</td>\n",
              "      <td>2019-10-08 14:50:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Extravasation of Diagnostic and Therapeutic Ma...</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Savene used for?\\nSavene is used to tr...</td>\n",
              "      <td>What is the risk associated with Savene?\\nThe ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1688</th>\n",
              "      <td>Human</td>\n",
              "      <td>Vedrop</td>\n",
              "      <td>tocofersolan</td>\n",
              "      <td>tocofersolan</td>\n",
              "      <td>EMEA/H/C/000920</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>A11HA08</td>\n",
              "      <td>yes</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-05-16 00:00:00</td>\n",
              "      <td>13</td>\n",
              "      <td>Vedrop is indicated in vitamin-E deficiency du...</td>\n",
              "      <td>2018-07-24 00:00:00</td>\n",
              "      <td>2019-08-22 14:10:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Cholestasis\\nVitamin E Deficiency</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Vedrop and what is it used for?\\nVedro...</td>\n",
              "      <td>What are the risks associated with Vedrop?\\nTh...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1697</th>\n",
              "      <td>Human</td>\n",
              "      <td>Wilzin</td>\n",
              "      <td>zinc</td>\n",
              "      <td>zinc</td>\n",
              "      <td>EMEA/H/C/000535</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>A16AX05</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-05-16 00:00:00</td>\n",
              "      <td>11</td>\n",
              "      <td>Treatment of Wilson's disease.</td>\n",
              "      <td>2017-02-14 12:04:00</td>\n",
              "      <td>2019-06-14 16:22:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Hepatolenticular Degeneration</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>What is Wilzin used for?\\nWilzin is used to tr...</td>\n",
              "      <td>What is the risk associated with Wilzin?\\nThe ...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "     Category                                               name  \\\n",
              "1662    Human                                              Kuvan   \n",
              "1676    Human  Clopidogrel/Acetylsalicylic acid Zentiva (prev...   \n",
              "1682    Human                                             Savene   \n",
              "1688    Human                                             Vedrop   \n",
              "1697    Human                                             Wilzin   \n",
              "\n",
              "     International non-proprietary name (INN) / common name  \\\n",
              "1662                                        sapropterin       \n",
              "1676                  clopidogrel, acetylsalicylic acid       \n",
              "1682                                        dexrazoxane       \n",
              "1688                                       tocofersolan       \n",
              "1697                                               zinc       \n",
              "\n",
              "                       Active substance   Product number Patient safety  \\\n",
              "1662        Sapropterin dihydrochloride  EMEA/H/C/000943             no   \n",
              "1676  clopidogrel, Acetylsalicylic acid  EMEA/H/C/001144             no   \n",
              "1682          dexrazoxane hydrochloride  EMEA/H/C/000682             no   \n",
              "1688                       tocofersolan  EMEA/H/C/000920             no   \n",
              "1697                               zinc  EMEA/H/C/000535             no   \n",
              "\n",
              "     Authorisation status ATC code Additional monitoring Generic  ...  \\\n",
              "1662           Authorised  A16AX07                    no      no  ...   \n",
              "1676           Authorised  B01AC30                    no      no  ...   \n",
              "1682           Authorised  V03AF02                    no      no  ...   \n",
              "1688           Authorised  A11HA08                   yes      no  ...   \n",
              "1697           Authorised  A16AX05                    no      no  ...   \n",
              "\n",
              "            Decision date Revision number  \\\n",
              "1662  2020-01-16 01:00:00              20   \n",
              "1676  2019-09-19 00:00:00              22   \n",
              "1682  2019-01-11 01:00:00              14   \n",
              "1688  2019-05-16 00:00:00              13   \n",
              "1697  2019-05-16 00:00:00              11   \n",
              "\n",
              "                                 Condition / indication      First published  \\\n",
              "1662  Kuvan is indicated for the treatment of hyperp...  2018-04-12 12:00:00   \n",
              "1676       Acute Coronary SyndromeMyocardial Infarction  2018-01-18 14:41:00   \n",
              "1682  Savene is indicated for the treatment of anthr...  2018-02-08 01:00:00   \n",
              "1688  Vedrop is indicated in vitamin-E deficiency du...  2018-07-24 00:00:00   \n",
              "1697                     Treatment of Wilson's disease.  2017-02-14 12:04:00   \n",
              "\n",
              "            Revision date                                                URL  \\\n",
              "1662  2020-03-04 18:24:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1676  2019-11-13 15:20:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1682  2019-10-08 14:50:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1688  2019-08-22 14:10:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1697  2019-06-14 16:22:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "\n",
              "                                            therap_area  \\\n",
              "1662                                   Phenylketonurias   \n",
              "1676     Acute Coronary Syndrome\\nMyocardial Infarction   \n",
              "1682  Extravasation of Diagnostic and Therapeutic Ma...   \n",
              "1688                  Cholestasis\\nVitamin E Deficiency   \n",
              "1697                      Hepatolenticular Degeneration   \n",
              "\n",
              "                                 therapeutic_indication  \\\n",
              "1662  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1676  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1682  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1688  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1697  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "\n",
              "                                                  usage  \\\n",
              "1662  What is Kuvan and what is it used for?\\nKuvan ...   \n",
              "1676  What is Clopidogrel/Acetylsalicylic acid Zenti...   \n",
              "1682  What is Savene used for?\\nSavene is used to tr...   \n",
              "1688  What is Vedrop and what is it used for?\\nVedro...   \n",
              "1697  What is Wilzin used for?\\nWilzin is used to tr...   \n",
              "\n",
              "                                                   risk  \n",
              "1662  What are the risks associated with Kuvan?\\nThe...  \n",
              "1676  What is the risk associated with Clopidogrel/A...  \n",
              "1682  What is the risk associated with Savene?\\nThe ...  \n",
              "1688  What are the risks associated with Vedrop?\\nTh...  \n",
              "1697  What is the risk associated with Wilzin?\\nThe ...  \n",
              "\n",
              "[5 rows x 30 columns]"
            ]
          },
          "execution_count": 264,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "fulldf.tail()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "a7fa3a37",
      "metadata": {
        "id": "a7fa3a37"
      },
      "outputs": [],
      "source": [
        "fulldf1.replace(translations, inplace = True)\n",
        "fulldf1"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "8f3fda81",
      "metadata": {
        "id": "8f3fda81"
      },
      "outputs": [],
      "source": [
        "fulldf1.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "c2391269",
      "metadata": {
        "id": "c2391269",
        "outputId": "84f1656e-2213-442c-d15c-da9d80093a25"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Catégorie</th>\n",
              "      <th>nom</th>\n",
              "      <th>Dénomination commune internationale (DCI) / nom commun</th>\n",
              "      <th>Substance active</th>\n",
              "      <th>Numéro de produit</th>\n",
              "      <th>Sécurité du patient</th>\n",
              "      <th>Statut d'autorisation</th>\n",
              "      <th>Code ATC</th>\n",
              "      <th>Surveillance supplémentaire</th>\n",
              "      <th>Générique</th>\n",
              "      <th>...</th>\n",
              "      <th>Date de décision</th>\n",
              "      <th>Numéro de révision</th>\n",
              "      <th>État/indication</th>\n",
              "      <th>Première publication</th>\n",
              "      <th>Date de révision</th>\n",
              "      <th>URL</th>\n",
              "      <th>zone_thérapeutique</th>\n",
              "      <th>indication_thérapeutique</th>\n",
              "      <th>usage</th>\n",
              "      <th>risque</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Ryeqo</td>\n",
              "      <td>relugolix, estradiol, norethisterone acetate</td>\n",
              "      <td>Relugolix, acétate de noréthistérone, hémihydr...</td>\n",
              "      <td>EMEA/H/C/005267</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>H01CC54</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-30 01:00:00</td>\n",
              "      <td>6.0</td>\n",
              "      <td>Ryeqo is indicated in adult women of reproduct...</td>\n",
              "      <td>2021-05-19 14:14:00</td>\n",
              "      <td>2023-12-04 18:41:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Léiomyome</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Comment Ryeqo est-il utilisé ?\\nLe médicament ...</td>\n",
              "      <td>Quels sont les risques associés à Ryeqo ?\\nLes...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Des safili</td>\n",
              "      <td>afflibercept</td>\n",
              "      <td>afflibercept</td>\n",
              "      <td>EMEA/H/C/006022</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>S01LA05</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-11-29 01:00:00</td>\n",
              "      <td>1.0</td>\n",
              "      <td>Yesafili is indicated for adults for the treat...</td>\n",
              "      <td>2023-07-17 16:27:00</td>\n",
              "      <td>2023-12-04 18:15:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Œdème maculaire\\nOcclusion de la veine rétinie...</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Comment Yesafil est-il utilisé ?\\nYesafili est...</td>\n",
              "      <td>Quels sont les risques associés à Yesafil ?\\nL...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Léflunomide médicament</td>\n",
              "      <td>léflunomide</td>\n",
              "      <td>léflunomide</td>\n",
              "      <td>EMEA/H/C/001227</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>L04AA13</td>\n",
              "      <td>Non</td>\n",
              "      <td>Oui</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-31 01:00:00</td>\n",
              "      <td>19.0</td>\n",
              "      <td>Leflunomide is indicated for the treatment of ...</td>\n",
              "      <td>2018-01-30 14:10:00</td>\n",
              "      <td>2023-12-04 17:56:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Arthrite rhumatoïde</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Comment Léflunomide medac est-il utilisé ?\\nLe...</td>\n",
              "      <td>Quels sont les avantages et les risques de Léf...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Filgrastim Hexal</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>EMEA/H/C/000918</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>L03AA02</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-11-30 01:00:00</td>\n",
              "      <td>24.0</td>\n",
              "      <td>Reduction in the duration of neutropenia and t...</td>\n",
              "      <td>2018-05-24 17:15:00</td>\n",
              "      <td>2023-12-04 17:43:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Neutropénie\\nTransplantation de cellules souch...</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Comment Filgrastim Hexal est-il utilisé ?\\nFil...</td>\n",
              "      <td>Quel est le risque associé à Filgrastim Hexal ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Opzelura</td>\n",
              "      <td>ruxolitinib</td>\n",
              "      <td>phosphate de ruxolitinib</td>\n",
              "      <td>EMEA/H/C/005843</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>D11AH</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-19 00:00:00</td>\n",
              "      <td>2.0</td>\n",
              "      <td>Opzelura is indicated for the treatment of non...</td>\n",
              "      <td>2023-02-22 15:05:00</td>\n",
              "      <td>2023-12-04 17:35:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Vitiligo</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Comment Opzelura est-il utilisé ?\\nOpzelura n'...</td>\n",
              "      <td>Quels sont les risques liés à Opzelura ?\\nPour...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1335</th>\n",
              "      <td>Humain</td>\n",
              "      <td>J'imagine</td>\n",
              "      <td>sapropterin</td>\n",
              "      <td>Dichlorhydrate de saproptérine</td>\n",
              "      <td>EMEA/H/C/000943</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>A16AX07</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2020-01-16 01:00:00</td>\n",
              "      <td>20.0</td>\n",
              "      <td>Kuvan is indicated for the treatment of hyperp...</td>\n",
              "      <td>2018-04-12 12:00:00</td>\n",
              "      <td>2020-03-04 18:24:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Phénylcétonuries</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Qu’est-ce que Kuvan et à quoi sert-il ?\\nKuvan...</td>\n",
              "      <td>Quels sont les risques associés à Kuvan ?\\nLes...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1336</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Clopidogrel/Acide acétylsalicylique Zentiva (a...</td>\n",
              "      <td>clopidogrel, acetylsalicylic acid</td>\n",
              "      <td>clopidogrel, acide acétylsalicylique</td>\n",
              "      <td>EMEA/H/C/001144</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>B01AC30</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-09-19 00:00:00</td>\n",
              "      <td>22.0</td>\n",
              "      <td>Acute Coronary SyndromeMyocardial Infarction</td>\n",
              "      <td>2018-01-18 14:41:00</td>\n",
              "      <td>2019-11-13 15:20:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Syndrome coronarien aigu\\nInfarctus du myocarde</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>À quoi sert Clopidogrel/Acide acétylsalicyliqu...</td>\n",
              "      <td>Quel est le risque associé à Clopidogrel/Acide...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1337</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Savené</td>\n",
              "      <td>dexrazoxane</td>\n",
              "      <td>chlorhydrate de dexrazoxane</td>\n",
              "      <td>EMEA/H/C/000682</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>V03AF02</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-01-11 01:00:00</td>\n",
              "      <td>14.0</td>\n",
              "      <td>Savene is indicated for the treatment of anthr...</td>\n",
              "      <td>2018-02-08 01:00:00</td>\n",
              "      <td>2019-10-08 14:50:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Extravasation de matériel diagnostique et thér...</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>À quoi sert Savene ?\\nSavene est utilisé pour ...</td>\n",
              "      <td>Quel est le risque associé à Savene ?\\nLes eff...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1338</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Védrop</td>\n",
              "      <td>tocofersolan</td>\n",
              "      <td>tocofersolan</td>\n",
              "      <td>EMEA/H/C/000920</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>A11HA08</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-05-16 00:00:00</td>\n",
              "      <td>13.0</td>\n",
              "      <td>Vedrop is indicated in vitamin-E deficiency du...</td>\n",
              "      <td>2018-07-24 00:00:00</td>\n",
              "      <td>2019-08-22 14:10:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Cholestase\\nCarence en vitamine E</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Qu'est-ce que Vedrop et à quoi sert-il ?\\nVedr...</td>\n",
              "      <td>Quels sont les risques associés à Vedrop ?\\nL’...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1339</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Wilzin</td>\n",
              "      <td>zinc</td>\n",
              "      <td>zinc</td>\n",
              "      <td>EMEA/H/C/000535</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>A16AX05</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-05-16 00:00:00</td>\n",
              "      <td>11.0</td>\n",
              "      <td>Treatment of Wilson's disease.</td>\n",
              "      <td>2017-02-14 12:04:00</td>\n",
              "      <td>2019-06-14 16:22:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Dégénérescence hépatolenticulaire</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Dans quel cas Wilzin est-il utilisé ?\\nWilzin ...</td>\n",
              "      <td>Quel est le risque associé à Wilzin ?\\nLes eff...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>1340 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "     Catégorie                                                nom  \\\n",
              "0       Humain                                              Ryeqo   \n",
              "1       Humain                                         Des safili   \n",
              "2       Humain                             Léflunomide médicament   \n",
              "3       Humain                                   Filgrastim Hexal   \n",
              "4       Humain                                           Opzelura   \n",
              "...        ...                                                ...   \n",
              "1335    Humain                                          J'imagine   \n",
              "1336    Humain  Clopidogrel/Acide acétylsalicylique Zentiva (a...   \n",
              "1337    Humain                                             Savené   \n",
              "1338    Humain                                             Védrop   \n",
              "1339    Humain                                             Wilzin   \n",
              "\n",
              "     Dénomination commune internationale (DCI) / nom commun  \\\n",
              "0          relugolix, estradiol, norethisterone acetate       \n",
              "1                                          afflibercept       \n",
              "2                                           léflunomide       \n",
              "3                                            filgrastim       \n",
              "4                                           ruxolitinib       \n",
              "...                                                 ...       \n",
              "1335                                        sapropterin       \n",
              "1336                  clopidogrel, acetylsalicylic acid       \n",
              "1337                                        dexrazoxane       \n",
              "1338                                       tocofersolan       \n",
              "1339                                               zinc       \n",
              "\n",
              "                                       Substance active Numéro de produit  \\\n",
              "0     Relugolix, acétate de noréthistérone, hémihydr...   EMEA/H/C/005267   \n",
              "1                                          afflibercept   EMEA/H/C/006022   \n",
              "2                                           léflunomide   EMEA/H/C/001227   \n",
              "3                                            filgrastim   EMEA/H/C/000918   \n",
              "4                              phosphate de ruxolitinib   EMEA/H/C/005843   \n",
              "...                                                 ...               ...   \n",
              "1335                     Dichlorhydrate de saproptérine   EMEA/H/C/000943   \n",
              "1336               clopidogrel, acide acétylsalicylique   EMEA/H/C/001144   \n",
              "1337                        chlorhydrate de dexrazoxane   EMEA/H/C/000682   \n",
              "1338                                       tocofersolan   EMEA/H/C/000920   \n",
              "1339                                               zinc   EMEA/H/C/000535   \n",
              "\n",
              "     Sécurité du patient Statut d'autorisation Code ATC  \\\n",
              "0                    Non              Autorisé  H01CC54   \n",
              "1                    Non              Autorisé  S01LA05   \n",
              "2                    Non              Autorisé  L04AA13   \n",
              "3                    Non              Autorisé  L03AA02   \n",
              "4                    Non              Autorisé    D11AH   \n",
              "...                  ...                   ...      ...   \n",
              "1335                 Non              Autorisé  A16AX07   \n",
              "1336                 Non              Autorisé  B01AC30   \n",
              "1337                 Non              Autorisé  V03AF02   \n",
              "1338                 Non              Autorisé  A11HA08   \n",
              "1339                 Non              Autorisé  A16AX05   \n",
              "\n",
              "     Surveillance supplémentaire Générique  ...     Date de décision  \\\n",
              "0                            Oui       Non  ...  2023-10-30 01:00:00   \n",
              "1                            Oui       Non  ...  2023-11-29 01:00:00   \n",
              "2                            Non       Oui  ...  2023-10-31 01:00:00   \n",
              "3                            Non       Non  ...  2023-11-30 01:00:00   \n",
              "4                            Non       Non  ...  2023-10-19 00:00:00   \n",
              "...                          ...       ...  ...                  ...   \n",
              "1335                         Non       Non  ...  2020-01-16 01:00:00   \n",
              "1336                         Non       Non  ...  2019-09-19 00:00:00   \n",
              "1337                         Non       Non  ...  2019-01-11 01:00:00   \n",
              "1338                         Oui       Non  ...  2019-05-16 00:00:00   \n",
              "1339                         Non       Non  ...  2019-05-16 00:00:00   \n",
              "\n",
              "     Numéro de révision                                    État/indication  \\\n",
              "0                   6.0  Ryeqo is indicated in adult women of reproduct...   \n",
              "1                   1.0  Yesafili is indicated for adults for the treat...   \n",
              "2                  19.0  Leflunomide is indicated for the treatment of ...   \n",
              "3                  24.0  Reduction in the duration of neutropenia and t...   \n",
              "4                   2.0  Opzelura is indicated for the treatment of non...   \n",
              "...                 ...                                                ...   \n",
              "1335               20.0  Kuvan is indicated for the treatment of hyperp...   \n",
              "1336               22.0       Acute Coronary SyndromeMyocardial Infarction   \n",
              "1337               14.0  Savene is indicated for the treatment of anthr...   \n",
              "1338               13.0  Vedrop is indicated in vitamin-E deficiency du...   \n",
              "1339               11.0                     Treatment of Wilson's disease.   \n",
              "\n",
              "     Première publication     Date de révision  \\\n",
              "0     2021-05-19 14:14:00  2023-12-04 18:41:00   \n",
              "1     2023-07-17 16:27:00  2023-12-04 18:15:00   \n",
              "2     2018-01-30 14:10:00  2023-12-04 17:56:00   \n",
              "3     2018-05-24 17:15:00  2023-12-04 17:43:00   \n",
              "4     2023-02-22 15:05:00  2023-12-04 17:35:00   \n",
              "...                   ...                  ...   \n",
              "1335  2018-04-12 12:00:00  2020-03-04 18:24:00   \n",
              "1336  2018-01-18 14:41:00  2019-11-13 15:20:00   \n",
              "1337  2018-02-08 01:00:00  2019-10-08 14:50:00   \n",
              "1338  2018-07-24 00:00:00  2019-08-22 14:10:00   \n",
              "1339  2017-02-14 12:04:00  2019-06-14 16:22:00   \n",
              "\n",
              "                                                    URL  \\\n",
              "0     https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1     https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "2     https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "3     https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "4     https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "...                                                 ...   \n",
              "1335  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1336  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1337  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1338  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1339  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "\n",
              "                                     zone_thérapeutique  \\\n",
              "0                                             Léiomyome   \n",
              "1     Œdème maculaire\\nOcclusion de la veine rétinie...   \n",
              "2                                   Arthrite rhumatoïde   \n",
              "3     Neutropénie\\nTransplantation de cellules souch...   \n",
              "4                                              Vitiligo   \n",
              "...                                                 ...   \n",
              "1335                                   Phénylcétonuries   \n",
              "1336    Syndrome coronarien aigu\\nInfarctus du myocarde   \n",
              "1337  Extravasation de matériel diagnostique et thér...   \n",
              "1338                  Cholestase\\nCarence en vitamine E   \n",
              "1339                  Dégénérescence hépatolenticulaire   \n",
              "\n",
              "                               indication_thérapeutique  \\\n",
              "0     Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1     Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "2     Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "3     Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "4     Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "...                                                 ...   \n",
              "1335  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1336  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1337  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1338  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1339  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "\n",
              "                                                  usage  \\\n",
              "0     Comment Ryeqo est-il utilisé ?\\nLe médicament ...   \n",
              "1     Comment Yesafil est-il utilisé ?\\nYesafili est...   \n",
              "2     Comment Léflunomide medac est-il utilisé ?\\nLe...   \n",
              "3     Comment Filgrastim Hexal est-il utilisé ?\\nFil...   \n",
              "4     Comment Opzelura est-il utilisé ?\\nOpzelura n'...   \n",
              "...                                                 ...   \n",
              "1335  Qu’est-ce que Kuvan et à quoi sert-il ?\\nKuvan...   \n",
              "1336  À quoi sert Clopidogrel/Acide acétylsalicyliqu...   \n",
              "1337  À quoi sert Savene ?\\nSavene est utilisé pour ...   \n",
              "1338  Qu'est-ce que Vedrop et à quoi sert-il ?\\nVedr...   \n",
              "1339  Dans quel cas Wilzin est-il utilisé ?\\nWilzin ...   \n",
              "\n",
              "                                                 risque  \n",
              "0     Quels sont les risques associés à Ryeqo ?\\nLes...  \n",
              "1     Quels sont les risques associés à Yesafil ?\\nL...  \n",
              "2     Quels sont les avantages et les risques de Léf...  \n",
              "3     Quel est le risque associé à Filgrastim Hexal ...  \n",
              "4     Quels sont les risques liés à Opzelura ?\\nPour...  \n",
              "...                                                 ...  \n",
              "1335  Quels sont les risques associés à Kuvan ?\\nLes...  \n",
              "1336  Quel est le risque associé à Clopidogrel/Acide...  \n",
              "1337  Quel est le risque associé à Savene ?\\nLes eff...  \n",
              "1338  Quels sont les risques associés à Vedrop ?\\nL’...  \n",
              "1339  Quel est le risque associé à Wilzin ?\\nLes eff...  \n",
              "\n",
              "[1340 rows x 30 columns]"
            ]
          },
          "execution_count": 2,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "data = pd.read_csv('EMAdataFRfinal.csv')\n",
        "data"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "53e850d1",
      "metadata": {
        "id": "53e850d1",
        "outputId": "4b1059d1-d76a-4a23-fcac-583a813755b3"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Category</th>\n",
              "      <th>name</th>\n",
              "      <th>International non-proprietary name (INN) / common name</th>\n",
              "      <th>Active substance</th>\n",
              "      <th>Product number</th>\n",
              "      <th>Patient safety</th>\n",
              "      <th>Authorisation status</th>\n",
              "      <th>ATC code</th>\n",
              "      <th>Additional monitoring</th>\n",
              "      <th>Generic</th>\n",
              "      <th>...</th>\n",
              "      <th>Decision date</th>\n",
              "      <th>Revision number</th>\n",
              "      <th>Condition / indication</th>\n",
              "      <th>First published</th>\n",
              "      <th>Revision date</th>\n",
              "      <th>URL</th>\n",
              "      <th>therap_area</th>\n",
              "      <th>therapeutic_indication</th>\n",
              "      <th>usage</th>\n",
              "      <th>risk</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Human</td>\n",
              "      <td>Ryeqo</td>\n",
              "      <td>relugolix, estradiol, norethisterone acetate</td>\n",
              "      <td>Relugolix, norethisterone acetate, estradiol h...</td>\n",
              "      <td>EMEA/H/C/005267</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>H01CC54</td>\n",
              "      <td>yes</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-30 01:00:00</td>\n",
              "      <td>6</td>\n",
              "      <td>Ryeqo is indicated in adult women of reproduct...</td>\n",
              "      <td>2021-05-19 14:14:00</td>\n",
              "      <td>2023-12-04 18:41:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Leiomyoma</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Ryeqo used?\\nThe medicine can only be o...</td>\n",
              "      <td>What are the risks associated with Ryeqo?\\nThe...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Human</td>\n",
              "      <td>Yesafili</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>EMEA/H/C/006022</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>S01LA05</td>\n",
              "      <td>yes</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-11-29 01:00:00</td>\n",
              "      <td>1</td>\n",
              "      <td>Yesafili is indicated for adults for the treat...</td>\n",
              "      <td>2023-07-17 16:27:00</td>\n",
              "      <td>2023-12-04 18:15:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Macular Edema\\nRetinal Vein Occlusion\\nDiabeti...</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Yesafili used?\\nYesafili is available a...</td>\n",
              "      <td>What are the risks associated with Yesafili?\\n...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Human</td>\n",
              "      <td>Leflunomide medac</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>EMEA/H/C/001227</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L04AA13</td>\n",
              "      <td>no</td>\n",
              "      <td>yes</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-31 01:00:00</td>\n",
              "      <td>19</td>\n",
              "      <td>Leflunomide is indicated for the treatment of ...</td>\n",
              "      <td>2018-01-30 14:10:00</td>\n",
              "      <td>2023-12-04 17:56:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Arthritis, Rheumatoid</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Leflunomide medac used?\\nLeflunomide me...</td>\n",
              "      <td>What are the benefit and risk of Leflunomide m...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Human</td>\n",
              "      <td>Filgrastim Hexal</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>filgrastim</td>\n",
              "      <td>EMEA/H/C/000918</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>L03AA02</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-11-30 01:00:00</td>\n",
              "      <td>24</td>\n",
              "      <td>Reduction in the duration of neutropenia and t...</td>\n",
              "      <td>2018-05-24 17:15:00</td>\n",
              "      <td>2023-12-04 17:43:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Neutropenia\\nHematopoietic Stem Cell Transplan...</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Filgrastim Hexal used?\\nFilgrastim Hexa...</td>\n",
              "      <td>What is the risk associated with Filgrastim He...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Human</td>\n",
              "      <td>Opzelura</td>\n",
              "      <td>ruxolitinib</td>\n",
              "      <td>ruxolitinib phosphate</td>\n",
              "      <td>EMEA/H/C/005843</td>\n",
              "      <td>no</td>\n",
              "      <td>Authorised</td>\n",
              "      <td>D11AH</td>\n",
              "      <td>no</td>\n",
              "      <td>no</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-10-19 00:00:00</td>\n",
              "      <td>2</td>\n",
              "      <td>Opzelura is indicated for the treatment of non...</td>\n",
              "      <td>2023-02-22 15:05:00</td>\n",
              "      <td>2023-12-04 17:35:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Vitiligo</td>\n",
              "      <td>Therapeutic indication\\nKirsty is indicated fo...</td>\n",
              "      <td>How is Opzelura used?\\nOpzelura can only be ob...</td>\n",
              "      <td>What are the risks associated with Opzelura?\\n...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "  Category               name  \\\n",
              "0    Human              Ryeqo   \n",
              "1    Human           Yesafili   \n",
              "2    Human  Leflunomide medac   \n",
              "3    Human   Filgrastim Hexal   \n",
              "4    Human           Opzelura   \n",
              "\n",
              "  International non-proprietary name (INN) / common name  \\\n",
              "0       relugolix, estradiol, norethisterone acetate       \n",
              "1                                        aflibercept       \n",
              "2                                        leflunomide       \n",
              "3                                         filgrastim       \n",
              "4                                        ruxolitinib       \n",
              "\n",
              "                                    Active substance   Product number  \\\n",
              "0  Relugolix, norethisterone acetate, estradiol h...  EMEA/H/C/005267   \n",
              "1                                        aflibercept  EMEA/H/C/006022   \n",
              "2                                        leflunomide  EMEA/H/C/001227   \n",
              "3                                         filgrastim  EMEA/H/C/000918   \n",
              "4                              ruxolitinib phosphate  EMEA/H/C/005843   \n",
              "\n",
              "  Patient safety Authorisation status ATC code Additional monitoring Generic  \\\n",
              "0             no           Authorised  H01CC54                   yes      no   \n",
              "1             no           Authorised  S01LA05                   yes      no   \n",
              "2             no           Authorised  L04AA13                    no     yes   \n",
              "3             no           Authorised  L03AA02                    no      no   \n",
              "4             no           Authorised    D11AH                    no      no   \n",
              "\n",
              "   ...        Decision date Revision number  \\\n",
              "0  ...  2023-10-30 01:00:00               6   \n",
              "1  ...  2023-11-29 01:00:00               1   \n",
              "2  ...  2023-10-31 01:00:00              19   \n",
              "3  ...  2023-11-30 01:00:00              24   \n",
              "4  ...  2023-10-19 00:00:00               2   \n",
              "\n",
              "                              Condition / indication      First published  \\\n",
              "0  Ryeqo is indicated in adult women of reproduct...  2021-05-19 14:14:00   \n",
              "1  Yesafili is indicated for adults for the treat...  2023-07-17 16:27:00   \n",
              "2  Leflunomide is indicated for the treatment of ...  2018-01-30 14:10:00   \n",
              "3  Reduction in the duration of neutropenia and t...  2018-05-24 17:15:00   \n",
              "4  Opzelura is indicated for the treatment of non...  2023-02-22 15:05:00   \n",
              "\n",
              "         Revision date                                                URL  \\\n",
              "0  2023-12-04 18:41:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1  2023-12-04 18:15:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "2  2023-12-04 17:56:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "3  2023-12-04 17:43:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "4  2023-12-04 17:35:00  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "\n",
              "                                         therap_area  \\\n",
              "0                                          Leiomyoma   \n",
              "1  Macular Edema\\nRetinal Vein Occlusion\\nDiabeti...   \n",
              "2                              Arthritis, Rheumatoid   \n",
              "3  Neutropenia\\nHematopoietic Stem Cell Transplan...   \n",
              "4                                           Vitiligo   \n",
              "\n",
              "                              therapeutic_indication  \\\n",
              "0  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "1  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "2  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "3  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "4  Therapeutic indication\\nKirsty is indicated fo...   \n",
              "\n",
              "                                               usage  \\\n",
              "0  How is Ryeqo used?\\nThe medicine can only be o...   \n",
              "1  How is Yesafili used?\\nYesafili is available a...   \n",
              "2  How is Leflunomide medac used?\\nLeflunomide me...   \n",
              "3  How is Filgrastim Hexal used?\\nFilgrastim Hexa...   \n",
              "4  How is Opzelura used?\\nOpzelura can only be ob...   \n",
              "\n",
              "                                                risk  \n",
              "0  What are the risks associated with Ryeqo?\\nThe...  \n",
              "1  What are the risks associated with Yesafili?\\n...  \n",
              "2  What are the benefit and risk of Leflunomide m...  \n",
              "3  What is the risk associated with Filgrastim He...  \n",
              "4  What are the risks associated with Opzelura?\\n...  \n",
              "\n",
              "[5 rows x 30 columns]"
            ]
          },
          "execution_count": 270,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "fulldf.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "89f052f9",
      "metadata": {
        "id": "89f052f9"
      },
      "outputs": [],
      "source": [
        "fulldf1 = fulldf1.rename(columns={\"Code ATC\": \"ATC code\"})"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "67101d45",
      "metadata": {
        "id": "67101d45",
        "outputId": "34e03864-2d5c-452d-f10d-fde1db810b54"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Catégorie</th>\n",
              "      <th>nom</th>\n",
              "      <th>Dénomination commune internationale (DCI) / nom commun</th>\n",
              "      <th>Substance active</th>\n",
              "      <th>Numéro de produit</th>\n",
              "      <th>Sécurité du patient</th>\n",
              "      <th>Statut d'autorisation</th>\n",
              "      <th>ATC code</th>\n",
              "      <th>Surveillance supplémentaire</th>\n",
              "      <th>Générique</th>\n",
              "      <th>...</th>\n",
              "      <th>Date de décision</th>\n",
              "      <th>Numéro de révision</th>\n",
              "      <th>État/indication</th>\n",
              "      <th>Première publication</th>\n",
              "      <th>Date de révision</th>\n",
              "      <th>URL</th>\n",
              "      <th>zone_thérapeutique</th>\n",
              "      <th>indication_thérapeutique</th>\n",
              "      <th>usage</th>\n",
              "      <th>risque</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1662</th>\n",
              "      <td>Humain</td>\n",
              "      <td>J'imagine</td>\n",
              "      <td>sapropterin</td>\n",
              "      <td>Dichlorhydrate de saproptérine</td>\n",
              "      <td>EMEA/H/C/000943</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>A16AX07</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2020-01-16 01:00:00</td>\n",
              "      <td>20</td>\n",
              "      <td>Kuvan is indicated for the treatment of hyperp...</td>\n",
              "      <td>2018-04-12 12:00:00</td>\n",
              "      <td>2020-03-04 18:24:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Phénylcétonuries</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Qu’est-ce que Kuvan et à quoi sert-il ?\\nKuvan...</td>\n",
              "      <td>Quels sont les risques associés à Kuvan ?\\nLes...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1676</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Clopidogrel/Acide acétylsalicylique Zentiva (a...</td>\n",
              "      <td>clopidogrel, acetylsalicylic acid</td>\n",
              "      <td>clopidogrel, acide acétylsalicylique</td>\n",
              "      <td>EMEA/H/C/001144</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>B01AC30</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-09-19 00:00:00</td>\n",
              "      <td>22</td>\n",
              "      <td>Acute Coronary SyndromeMyocardial Infarction</td>\n",
              "      <td>2018-01-18 14:41:00</td>\n",
              "      <td>2019-11-13 15:20:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Syndrome coronarien aigu\\nInfarctus du myocarde</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>À quoi sert Clopidogrel/Acide acétylsalicyliqu...</td>\n",
              "      <td>Quel est le risque associé à Clopidogrel/Acide...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1682</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Savené</td>\n",
              "      <td>dexrazoxane</td>\n",
              "      <td>chlorhydrate de dexrazoxane</td>\n",
              "      <td>EMEA/H/C/000682</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>V03AF02</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-01-11 01:00:00</td>\n",
              "      <td>14</td>\n",
              "      <td>Savene is indicated for the treatment of anthr...</td>\n",
              "      <td>2018-02-08 01:00:00</td>\n",
              "      <td>2019-10-08 14:50:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Extravasation de matériel diagnostique et thér...</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>À quoi sert Savene ?\\nSavene est utilisé pour ...</td>\n",
              "      <td>Quel est le risque associé à Savene ?\\nLes eff...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1688</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Védrop</td>\n",
              "      <td>tocofersolan</td>\n",
              "      <td>tocofersolan</td>\n",
              "      <td>EMEA/H/C/000920</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>A11HA08</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-05-16 00:00:00</td>\n",
              "      <td>13</td>\n",
              "      <td>Vedrop is indicated in vitamin-E deficiency du...</td>\n",
              "      <td>2018-07-24 00:00:00</td>\n",
              "      <td>2019-08-22 14:10:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Cholestase\\nCarence en vitamine E</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Qu'est-ce que Vedrop et à quoi sert-il ?\\nVedr...</td>\n",
              "      <td>Quels sont les risques associés à Vedrop ?\\nL’...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1697</th>\n",
              "      <td>Humain</td>\n",
              "      <td>Wilzin</td>\n",
              "      <td>zinc</td>\n",
              "      <td>zinc</td>\n",
              "      <td>EMEA/H/C/000535</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>A16AX05</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-05-16 00:00:00</td>\n",
              "      <td>11</td>\n",
              "      <td>Treatment of Wilson's disease.</td>\n",
              "      <td>2017-02-14 12:04:00</td>\n",
              "      <td>2019-06-14 16:22:00</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Dégénérescence hépatolenticulaire</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Dans quel cas Wilzin est-il utilisé ?\\nWilzin ...</td>\n",
              "      <td>Quel est le risque associé à Wilzin ?\\nLes eff...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "     Catégorie                                                nom  \\\n",
              "1662    Humain                                          J'imagine   \n",
              "1676    Humain  Clopidogrel/Acide acétylsalicylique Zentiva (a...   \n",
              "1682    Humain                                             Savené   \n",
              "1688    Humain                                             Védrop   \n",
              "1697    Humain                                             Wilzin   \n",
              "\n",
              "     Dénomination commune internationale (DCI) / nom commun  \\\n",
              "1662                                        sapropterin       \n",
              "1676                  clopidogrel, acetylsalicylic acid       \n",
              "1682                                        dexrazoxane       \n",
              "1688                                       tocofersolan       \n",
              "1697                                               zinc       \n",
              "\n",
              "                          Substance active Numéro de produit  \\\n",
              "1662        Dichlorhydrate de saproptérine   EMEA/H/C/000943   \n",
              "1676  clopidogrel, acide acétylsalicylique   EMEA/H/C/001144   \n",
              "1682           chlorhydrate de dexrazoxane   EMEA/H/C/000682   \n",
              "1688                          tocofersolan   EMEA/H/C/000920   \n",
              "1697                                  zinc   EMEA/H/C/000535   \n",
              "\n",
              "     Sécurité du patient Statut d'autorisation ATC code  \\\n",
              "1662                 Non              Autorisé  A16AX07   \n",
              "1676                 Non              Autorisé  B01AC30   \n",
              "1682                 Non              Autorisé  V03AF02   \n",
              "1688                 Non              Autorisé  A11HA08   \n",
              "1697                 Non              Autorisé  A16AX05   \n",
              "\n",
              "     Surveillance supplémentaire Générique  ...    Date de décision  \\\n",
              "1662                         Non       Non  ... 2020-01-16 01:00:00   \n",
              "1676                         Non       Non  ... 2019-09-19 00:00:00   \n",
              "1682                         Non       Non  ... 2019-01-11 01:00:00   \n",
              "1688                         Oui       Non  ... 2019-05-16 00:00:00   \n",
              "1697                         Non       Non  ... 2019-05-16 00:00:00   \n",
              "\n",
              "     Numéro de révision                                    État/indication  \\\n",
              "1662                 20  Kuvan is indicated for the treatment of hyperp...   \n",
              "1676                 22       Acute Coronary SyndromeMyocardial Infarction   \n",
              "1682                 14  Savene is indicated for the treatment of anthr...   \n",
              "1688                 13  Vedrop is indicated in vitamin-E deficiency du...   \n",
              "1697                 11                     Treatment of Wilson's disease.   \n",
              "\n",
              "     Première publication    Date de révision  \\\n",
              "1662  2018-04-12 12:00:00 2020-03-04 18:24:00   \n",
              "1676  2018-01-18 14:41:00 2019-11-13 15:20:00   \n",
              "1682  2018-02-08 01:00:00 2019-10-08 14:50:00   \n",
              "1688  2018-07-24 00:00:00 2019-08-22 14:10:00   \n",
              "1697  2017-02-14 12:04:00 2019-06-14 16:22:00   \n",
              "\n",
              "                                                    URL  \\\n",
              "1662  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1676  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1682  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1688  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1697  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "\n",
              "                                     zone_thérapeutique  \\\n",
              "1662                                   Phénylcétonuries   \n",
              "1676    Syndrome coronarien aigu\\nInfarctus du myocarde   \n",
              "1682  Extravasation de matériel diagnostique et thér...   \n",
              "1688                  Cholestase\\nCarence en vitamine E   \n",
              "1697                  Dégénérescence hépatolenticulaire   \n",
              "\n",
              "                               indication_thérapeutique  \\\n",
              "1662  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1676  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1682  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1688  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1697  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "\n",
              "                                                  usage  \\\n",
              "1662  Qu’est-ce que Kuvan et à quoi sert-il ?\\nKuvan...   \n",
              "1676  À quoi sert Clopidogrel/Acide acétylsalicyliqu...   \n",
              "1682  À quoi sert Savene ?\\nSavene est utilisé pour ...   \n",
              "1688  Qu'est-ce que Vedrop et à quoi sert-il ?\\nVedr...   \n",
              "1697  Dans quel cas Wilzin est-il utilisé ?\\nWilzin ...   \n",
              "\n",
              "                                                 risque  \n",
              "1662  Quels sont les risques associés à Kuvan ?\\nLes...  \n",
              "1676  Quel est le risque associé à Clopidogrel/Acide...  \n",
              "1682  Quel est le risque associé à Savene ?\\nLes eff...  \n",
              "1688  Quels sont les risques associés à Vedrop ?\\nL’...  \n",
              "1697  Quel est le risque associé à Wilzin ?\\nLes eff...  \n",
              "\n",
              "[5 rows x 30 columns]"
            ]
          },
          "execution_count": 274,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "fulldf1.tail()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "815a63d9",
      "metadata": {
        "id": "815a63d9",
        "outputId": "135e7494-de07-4ff7-978e-7efb7c5d792a"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "Index(['Catégorie', 'nom',\n",
              "       'Dénomination commune internationale (DCI) / nom commun',\n",
              "       'Substance active', 'Numéro de produit', 'Sécurité du patient',\n",
              "       'Statut d'autorisation', 'ATC code', 'Surveillance supplémentaire',\n",
              "       'Générique', 'Biosimilaire', 'Approbation conditionnelle',\n",
              "       'Circonstances exceptionnelles', 'Évaluation accélérée',\n",
              "       'Médecine orpheline', 'Date de l'autorisation de mise sur le marché',\n",
              "       'Date de refus d'autorisation de mise sur le marché',\n",
              "       'Titulaire de l'autorisation de mise sur le marché/nom de l'entreprise',\n",
              "       'Groupe pharmacothérapeutique humain', 'Date de l'avis',\n",
              "       'Date de décision', 'Numéro de révision', 'État/indication',\n",
              "       'Première publication', 'Date de révision', 'URL_df1',\n",
              "       'zone_thérapeutique', 'indication_thérapeutique', 'usage_df1', 'risque',\n",
              "       'Category', 'name',\n",
              "       'International non-proprietary name (INN) / common name',\n",
              "       'Active substance', 'Product number', 'Patient safety',\n",
              "       'Authorisation status', 'Additional monitoring', 'Generic',\n",
              "       'Biosimilar', 'Conditional approval', 'Exceptional circumstances',\n",
              "       'Accelerated assessment', 'Orphan medicine',\n",
              "       'Marketing authorisation date',\n",
              "       'Date of refusal of marketing authorisation',\n",
              "       'Marketing authorisation holder/company name',\n",
              "       'Human pharmacotherapeutic group', 'Date of opinion', 'Decision date',\n",
              "       'Revision number', 'Condition / indication', 'First published',\n",
              "       'Revision date', 'URL_df2', 'therap_area', 'therapeutic_indication',\n",
              "       'usage_df2', 'risk'],\n",
              "      dtype='object')"
            ]
          },
          "execution_count": 13,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "newdf = fulldf1.join(fulldf.set_index('ATC code'), on='ATC code', lsuffix='_df1', rsuffix='_df2')\n",
        "newdf.columns\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "e5e46c9c",
      "metadata": {
        "id": "e5e46c9c",
        "outputId": "b9125a19-1efe-4dad-ae92-867235d257b4"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Catégorie</th>\n",
              "      <th>Numéro de produit</th>\n",
              "      <th>Sécurité du patient</th>\n",
              "      <th>Statut d'autorisation</th>\n",
              "      <th>ATC code</th>\n",
              "      <th>Surveillance supplémentaire</th>\n",
              "      <th>Générique</th>\n",
              "      <th>Biosimilaire</th>\n",
              "      <th>Approbation conditionnelle</th>\n",
              "      <th>Circonstances exceptionnelles</th>\n",
              "      <th>...</th>\n",
              "      <th>URL_df1</th>\n",
              "      <th>zone_thérapeutique</th>\n",
              "      <th>indication_thérapeutique</th>\n",
              "      <th>usage_df1</th>\n",
              "      <th>risque</th>\n",
              "      <th>Category</th>\n",
              "      <th>name</th>\n",
              "      <th>International non-proprietary name (INN) / common name</th>\n",
              "      <th>Active substance</th>\n",
              "      <th>Human pharmacotherapeutic group</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Humain</td>\n",
              "      <td>EMEA/H/C/005267</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>H01CC54</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Léiomyome</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Comment Ryeqo est-il utilisé ?\\nLe médicament ...</td>\n",
              "      <td>Quels sont les risques associés à Ryeqo ?\\nLes...</td>\n",
              "      <td>Human</td>\n",
              "      <td>Ryeqo</td>\n",
              "      <td>relugolix, estradiol, norethisterone acetate</td>\n",
              "      <td>Relugolix, norethisterone acetate, estradiol h...</td>\n",
              "      <td>Pituitary and hypothalamic hormones and analogues</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Humain</td>\n",
              "      <td>EMEA/H/C/006022</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>S01LA05</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Œdème maculaire\\nOcclusion de la veine rétinie...</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Comment Yesafil est-il utilisé ?\\nYesafili est...</td>\n",
              "      <td>Quels sont les risques associés à Yesafil ?\\nL...</td>\n",
              "      <td>Human</td>\n",
              "      <td>Yesafili</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>Ophthalmologicals</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Humain</td>\n",
              "      <td>EMEA/H/C/006022</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>S01LA05</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Œdème maculaire\\nOcclusion de la veine rétinie...</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Comment Yesafil est-il utilisé ?\\nYesafili est...</td>\n",
              "      <td>Quels sont les risques associés à Yesafil ?\\nL...</td>\n",
              "      <td>Human</td>\n",
              "      <td>Eylea</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>aflibercept</td>\n",
              "      <td>Ophthalmologicals</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Humain</td>\n",
              "      <td>EMEA/H/C/001227</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>L04AA13</td>\n",
              "      <td>Non</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Arthrite rhumatoïde</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Comment Léflunomide medac est-il utilisé ?\\nLe...</td>\n",
              "      <td>Quels sont les avantages et les risques de Léf...</td>\n",
              "      <td>Human</td>\n",
              "      <td>Leflunomide medac</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>Selective immunosuppressants</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Humain</td>\n",
              "      <td>EMEA/H/C/001227</td>\n",
              "      <td>Non</td>\n",
              "      <td>Autorisé</td>\n",
              "      <td>L04AA13</td>\n",
              "      <td>Non</td>\n",
              "      <td>Oui</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>Non</td>\n",
              "      <td>...</td>\n",
              "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
              "      <td>Arthrite rhumatoïde</td>\n",
              "      <td>Indication thérapeutique\\nKirsty est indiqué d...</td>\n",
              "      <td>Comment Léflunomide medac est-il utilisé ?\\nLe...</td>\n",
              "      <td>Quels sont les avantages et les risques de Léf...</td>\n",
              "      <td>Human</td>\n",
              "      <td>Leflunomide Zentiva (previously Leflunomide Wi...</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>leflunomide</td>\n",
              "      <td>Immunosuppressants</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 30 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "  Catégorie Numéro de produit Sécurité du patient Statut d'autorisation  \\\n",
              "0    Humain   EMEA/H/C/005267                 Non              Autorisé   \n",
              "1    Humain   EMEA/H/C/006022                 Non              Autorisé   \n",
              "1    Humain   EMEA/H/C/006022                 Non              Autorisé   \n",
              "2    Humain   EMEA/H/C/001227                 Non              Autorisé   \n",
              "2    Humain   EMEA/H/C/001227                 Non              Autorisé   \n",
              "\n",
              "  ATC code Surveillance supplémentaire Générique Biosimilaire  \\\n",
              "0  H01CC54                         Oui       Non          Non   \n",
              "1  S01LA05                         Oui       Non          Oui   \n",
              "1  S01LA05                         Oui       Non          Oui   \n",
              "2  L04AA13                         Non       Oui          Non   \n",
              "2  L04AA13                         Non       Oui          Non   \n",
              "\n",
              "  Approbation conditionnelle Circonstances exceptionnelles  ...  \\\n",
              "0                        Non                           Non  ...   \n",
              "1                        Non                           Non  ...   \n",
              "1                        Non                           Non  ...   \n",
              "2                        Non                           Non  ...   \n",
              "2                        Non                           Non  ...   \n",
              "\n",
              "                                             URL_df1  \\\n",
              "0  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "1  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "2  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "2  https://www.ema.europa.eu/en/medicines/human/E...   \n",
              "\n",
              "                                  zone_thérapeutique  \\\n",
              "0                                          Léiomyome   \n",
              "1  Œdème maculaire\\nOcclusion de la veine rétinie...   \n",
              "1  Œdème maculaire\\nOcclusion de la veine rétinie...   \n",
              "2                                Arthrite rhumatoïde   \n",
              "2                                Arthrite rhumatoïde   \n",
              "\n",
              "                            indication_thérapeutique  \\\n",
              "0  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "1  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "2  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "2  Indication thérapeutique\\nKirsty est indiqué d...   \n",
              "\n",
              "                                           usage_df1  \\\n",
              "0  Comment Ryeqo est-il utilisé ?\\nLe médicament ...   \n",
              "1  Comment Yesafil est-il utilisé ?\\nYesafili est...   \n",
              "1  Comment Yesafil est-il utilisé ?\\nYesafili est...   \n",
              "2  Comment Léflunomide medac est-il utilisé ?\\nLe...   \n",
              "2  Comment Léflunomide medac est-il utilisé ?\\nLe...   \n",
              "\n",
              "                                              risque Category  \\\n",
              "0  Quels sont les risques associés à Ryeqo ?\\nLes...    Human   \n",
              "1  Quels sont les risques associés à Yesafil ?\\nL...    Human   \n",
              "1  Quels sont les risques associés à Yesafil ?\\nL...    Human   \n",
              "2  Quels sont les avantages et les risques de Léf...    Human   \n",
              "2  Quels sont les avantages et les risques de Léf...    Human   \n",
              "\n",
              "                                                name  \\\n",
              "0                                              Ryeqo   \n",
              "1                                           Yesafili   \n",
              "1                                              Eylea   \n",
              "2                                  Leflunomide medac   \n",
              "2  Leflunomide Zentiva (previously Leflunomide Wi...   \n",
              "\n",
              "  International non-proprietary name (INN) / common name  \\\n",
              "0       relugolix, estradiol, norethisterone acetate       \n",
              "1                                        aflibercept       \n",
              "1                                        aflibercept       \n",
              "2                                        leflunomide       \n",
              "2                                        leflunomide       \n",
              "\n",
              "                                    Active substance  \\\n",
              "0  Relugolix, norethisterone acetate, estradiol h...   \n",
              "1                                        aflibercept   \n",
              "1                                        aflibercept   \n",
              "2                                        leflunomide   \n",
              "2                                        leflunomide   \n",
              "\n",
              "                     Human pharmacotherapeutic group  \n",
              "0  Pituitary and hypothalamic hormones and analogues  \n",
              "1                                  Ophthalmologicals  \n",
              "1                                  Ophthalmologicals  \n",
              "2                       Selective immunosuppressants  \n",
              "2                                 Immunosuppressants  \n",
              "\n",
              "[5 rows x 30 columns]"
            ]
          },
          "execution_count": 14,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "newdf = newdf.drop(['nom', 'Substance active','Dénomination commune internationale (DCI) / nom commun', \"Titulaire de l'autorisation de mise sur le marché/nom de l'entreprise\", \"Groupe pharmacothérapeutique humain\", 'Product number', 'Patient safety',\n",
        "       'Authorisation status', 'Additional monitoring', 'Generic',\n",
        "       'Biosimilar', 'Conditional approval', 'Exceptional circumstances',\n",
        "       'Accelerated assessment', 'Orphan medicine',\n",
        "       'Marketing authorisation date',\n",
        "       'Date of refusal of marketing authorisation',\n",
        "       'Marketing authorisation holder/company name', 'Date of opinion', 'Decision date',\n",
        "       'Revision number', 'Condition / indication', 'First published',\n",
        "       'Revision date', 'URL_df2', 'therap_area', 'therapeutic_indication',\n",
        "       'usage_df2', 'risk'], axis=1)\n",
        "newdf.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "8c9b0b23",
      "metadata": {
        "id": "8c9b0b23",
        "outputId": "11ed17c5-a9c2-4952-bee0-25497cc2cae7"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "Index(['Catégorie', 'Numéro de produit', 'Sécurité du patient',\n",
              "       'Statut d'autorisation', 'ATC code', 'Surveillance supplémentaire',\n",
              "       'Générique', 'Biosimilaire', 'Approbation conditionnelle',\n",
              "       'Circonstances exceptionnelles', 'Évaluation accélérée',\n",
              "       'Médecine orpheline', 'Date de l'autorisation de mise sur le marché',\n",
              "       'Date de refus d'autorisation de mise sur le marché', 'Date de l'avis',\n",
              "       'Date de décision', 'Numéro de révision', 'État/indication',\n",
              "       'Première publication', 'Date de révision', 'URL_df1',\n",
              "       'zone_thérapeutique', 'usage_df1', 'risque', 'Category', 'name',\n",
              "       'International non-proprietary name (INN) / common name',\n",
              "       'Active substance', 'Human pharmacotherapeutic group'],\n",
              "      dtype='object')"
            ]
          },
          "execution_count": 15,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "newdf = newdf.drop(['indication_thérapeutique'], axis=1)\n",
        "newdf.columns"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "c49f99cb",
      "metadata": {
        "id": "c49f99cb"
      },
      "outputs": [],
      "source": [
        "newdf.to_csv('EMAdataFRfinal2.csv', index=False)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "1c48e6cf",
      "metadata": {
        "id": "1c48e6cf"
      },
      "outputs": [],
      "source": []
    }
  ],
  "metadata": {
    "kernelspec": {
      "display_name": "Python 3 (ipykernel)",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.9.12"
    },
    "colab": {
      "provenance": []
    }
  },
  "nbformat": 4,
  "nbformat_minor": 5
}
